activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	119278	CHEMBL811043	Inhibition of Stress activated protein kinase 2b at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.0	CHEMBL3961	Homo sapiens	Inhibition	%	4.0
	119278	CHEMBL811043	Inhibition of Stress activated protein kinase 2b at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.0	CHEMBL3961	Homo sapiens	Inhibition	%	4.0
	133237	CHEMBL811043	Inhibition of Stress activated protein kinase 2b at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	59.0	CHEMBL3961	Homo sapiens	Inhibition	%	59.0
	138062	CHEMBL811043	Inhibition of Stress activated protein kinase 2b at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Br)cc12)C1CC1		CHEMBL259270	=	Inhibition	%	11.0	CHEMBL3961	Homo sapiens	Inhibition	%	11.0
	144080	CHEMBL811043	Inhibition of Stress activated protein kinase 2b at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL405145	=	Inhibition	%	10.0	CHEMBL3961	Homo sapiens	Inhibition	%	10.0
	177498	CHEMBL811037	Inhibition of Stress activated protein kinase 2b	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	94.0	CHEMBL3961	Homo sapiens	Activity	%	94.0
	178811	CHEMBL811037	Inhibition of Stress activated protein kinase 2b	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	102.0	CHEMBL3961	Homo sapiens	Activity	%	102.0
	182558	CHEMBL811037	Inhibition of Stress activated protein kinase 2b	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	106.0	CHEMBL3961	Homo sapiens	Activity	%	106.0
	345873	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	O=C1NCc2nc(Sc3ccccc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL340687	=	IC50	nM	1490.0	CHEMBL3961	Homo sapiens	IC50	nM	1490.0
	345875	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	O=C(O)c1cc(Cl)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL128414	=	IC50	nM	530.0	CHEMBL3961	Homo sapiens	IC50	nM	530.0
	347251	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	COC(=O)c1cc(C)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL129375	=	IC50	nM	250.0	CHEMBL3961	Homo sapiens	IC50	nM	250.0
	348504	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	Cc1ccccc1Sc1ccc2c(n1)CNC(=O)N2c1c(Cl)cccc1Cl		CHEMBL443285	=	IC50	nM	800.0	CHEMBL3961	Homo sapiens	IC50	nM	800.0
	348506	CHEMBL737067	Inhibition of Mitogen-activated protein kinase p38 beta at 300 nM	B	CC(=O)c1cc(C)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL128686	=	Inhibition	%	80.0	CHEMBL3961	Homo sapiens	Inhibition	%	80.0
	348508	CHEMBL737066	Inhibition of Mitogen-activated protein kinase p38 beta at 2000 nM	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1c(F)cccc1Cl		CHEMBL128781	=	Inhibition	%	86.0	CHEMBL3961	Homo sapiens	Inhibition	%	86.0
	349858	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	COc1ccccc1Sc1ccc2c(n1)CNC(=O)N2c1c(Cl)cccc1Cl		CHEMBL339095	=	IC50	nM	3430.0	CHEMBL3961	Homo sapiens	IC50	nM	3430.0
	349860	CHEMBL737064	Inhibition of Mitogen-activated protein kinase p38 beta at 10000 nM	B	O=C1NCc2nc(Sc3cccc(Sc4ccc(F)cc4)c3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL131026	=	Inhibition	%	6.0	CHEMBL3961	Homo sapiens	Inhibition	%	6.0
	349862	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	O=C1NCc2nc(NCc3ccc(Cl)cc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL338949	=	Inhibition	%	15.0	CHEMBL3961	Homo sapiens	Inhibition	%	15.0
	349864	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	Cc1cc([N+](=O)[O-])cc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL127275	=	Inhibition	%	66.0	CHEMBL3961	Homo sapiens	Inhibition	%	66.0
	349866	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	CN(C)CCNC(=O)c1cc(Cl)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL434434	=	IC50	nM	1230.0	CHEMBL3961	Homo sapiens	IC50	nM	1230.0
	351336	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	Cc1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL128756	=	IC50	nM	270.0	CHEMBL3961	Homo sapiens	IC50	nM	270.0
	351338	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	Cc1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL128756	=	IC50	nM	220.0	CHEMBL3961	Homo sapiens	IC50	nM	220.0
	352680	CHEMBL737063	Inhibition of Mitogen-activated protein kinase p38 beta at 1000 nM	B	Cc1ccccc1N1C(=O)NCc2nc(Sc3ccc(F)cc3Cl)ccc21		CHEMBL128516	=	IC50	nM	52.0	CHEMBL3961	Homo sapiens	IC50	nM	52.0
	354238	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	Nc1cc(F)ccc1Sc1ccc2c(n1)CNC(=O)N2c1c(Cl)cccc1Cl		CHEMBL128239	=	IC50	nM	1340.0	CHEMBL3961	Homo sapiens	IC50	nM	1340.0
	354240	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	COc1ccc(CSc2ccc3c(n2)CNC(=O)N3c2c(Cl)cccc2Cl)cc1		CHEMBL129508	=	Inhibition	%	3.0	CHEMBL3961	Homo sapiens	Inhibition	%	3.0
	354242	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1c(Cl)cccc1CO		CHEMBL129057	=	Inhibition	%	23.0	CHEMBL3961	Homo sapiens	Inhibition	%	23.0
	355680	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	O=C1NCc2nc(Sc3ccc(Cl)cc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL128440	=	IC50	nM	190.0	CHEMBL3961	Homo sapiens	IC50	nM	190.0
	355682	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	O=C1NCc2nc(Sc3ccccc3C(F)(F)F)ccc2N1c1c(Cl)cccc1Cl		CHEMBL340742	=	Inhibition	%	67.0	CHEMBL3961	Homo sapiens	Inhibition	%	67.0
	357126	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	O=C1NCc2nc(SCc3ccc(F)cc3F)ccc2N1c1c(Cl)cccc1Cl		CHEMBL419987	=	Inhibition	%	6.0	CHEMBL3961	Homo sapiens	Inhibition	%	6.0
	357128	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1ccccc1		CHEMBL129380	=	Inhibition	%	26.0	CHEMBL3961	Homo sapiens	Inhibition	%	26.0
	359980	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	O=C1NCc2nc(Sc3ccccc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL340687	=	IC50	nM	393.0	CHEMBL3961	Homo sapiens	IC50	nM	393.0
	359982	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	Cc1cccc(C)c1Sc1ccc2c(n1)CNC(=O)N2c1c(Cl)cccc1Cl		CHEMBL129174	=	IC50	nM	980.0	CHEMBL3961	Homo sapiens	IC50	nM	980.0
	359984	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	COc1cccc(C)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL341364	=	Inhibition	%	66.0	CHEMBL3961	Homo sapiens	Inhibition	%	66.0
	361115	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	O=C1NCc2nc(NCc3ccc(F)cc3F)ccc2N1c1c(Cl)cccc1Cl		CHEMBL423517	=	Inhibition	%	42.0	CHEMBL3961	Homo sapiens	Inhibition	%	42.0
	361117	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	COC(=O)c1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL129112	=	Inhibition	%	67.0	CHEMBL3961	Homo sapiens	Inhibition	%	67.0
	362414	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	COC(=O)c1cc(Cl)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL129628	=	IC50	nM	73.0	CHEMBL3961	Homo sapiens	IC50	nM	73.0
	364071	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	O=C1NCc2nc(NCc3ccc(Cl)cc3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL128042	=	Inhibition	%	12.0	CHEMBL3961	Homo sapiens	Inhibition	%	12.0
	364073	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1c(Cl)cccc1C(F)(F)F		CHEMBL129305	=	IC50	nM	950.0	CHEMBL3961	Homo sapiens	IC50	nM	950.0
	365560	CHEMBL734578	Inhibition of Mitogen-activated protein kinase p38 beta at 80000 nM	B	O=C1NCc2nc(Sc3cccc(C(F)(F)F)c3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL129446	=	Inhibition	%	66.0	CHEMBL3961	Homo sapiens	Inhibition	%	66.0
	365562	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	CCc1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL129704	=	IC50	nM	200.0	CHEMBL3961	Homo sapiens	IC50	nM	200.0
	365564	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	O=C1NCc2nc(Sc3ccc(F)cc3F)ccc2N1c1c(Cl)cccc1Cl		CHEMBL92788	=	IC50	nM	250.0	CHEMBL3961	Homo sapiens	IC50	nM	250.0
	367090	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	O=C1NCc2nc(Sc3ccccc3F)ccc2N1c1c(Cl)cccc1Cl		CHEMBL340377	=	Inhibition	%	74.0	CHEMBL3961	Homo sapiens	Inhibition	%	74.0
	368416	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	NC(=O)Oc1cc(Cl)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL129720	=	IC50	nM	220.0	CHEMBL3961	Homo sapiens	IC50	nM	220.0
	369856	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	NC(=O)Oc1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL262983	=	Inhibition	%	10.0	CHEMBL3961	Homo sapiens	Inhibition	%	10.0
	369858	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	Cc1cccc(O)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL335945	=	Inhibition	%	16.0	CHEMBL3961	Homo sapiens	Inhibition	%	16.0
	372582	CHEMBL737064	Inhibition of Mitogen-activated protein kinase p38 beta at 10000 nM	B	O=C1NCc2nc(Sc3ccc(C(F)(F)F)cc3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL129576	=	Inhibition	%	31.0	CHEMBL3961	Homo sapiens	Inhibition	%	31.0
	372584	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	O=C(O)c1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL335292	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	Inhibition	%	0.0
	374118	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1ccccc1Cl		CHEMBL338612	=	IC50	nM	530.0	CHEMBL3961	Homo sapiens	IC50	nM	530.0
	375441	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	Nc1ccccc1Sc1ccc2c(n1)CNC(=O)N2c1c(Cl)cccc1Cl		CHEMBL128257	=	IC50	nM	2750.0	CHEMBL3961	Homo sapiens	IC50	nM	2750.0
	376839	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	O=C1NCc2nc(NCc3ccccc3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL335878	=	IC50	nM	980.0	CHEMBL3961	Homo sapiens	IC50	nM	980.0
	376841	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1ccccc1-c1ccccc1		CHEMBL340069	=	Inhibition	%	16.0	CHEMBL3961	Homo sapiens	Inhibition	%	16.0
	378237	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	O=C1NCc2nc(Sc3ccc(F)cc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL128813	=	IC50	nM	57.0	CHEMBL3961	Homo sapiens	IC50	nM	57.0
	378240	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	O=C1NCc2nc(Sc3ccccc3Br)ccc2N1c1c(Cl)cccc1Cl		CHEMBL131194	=	IC50	nM	1480.0	CHEMBL3961	Homo sapiens	IC50	nM	1480.0
	378242	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	Nc1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL131399	=	Inhibition	%	11.0	CHEMBL3961	Homo sapiens	Inhibition	%	11.0
	379610	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1c(Cl)cc(C(F)(F)F)cc1Cl		CHEMBL128515	=	Inhibition	%	56.0	CHEMBL3961	Homo sapiens	Inhibition	%	56.0
	381082	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	O=C1NCc2nc(Sc3ccc(F)cc3F)ccc2N1c1c(Cl)cccc1Cl		CHEMBL92788	=	IC50	nM	250.0	CHEMBL3961	Homo sapiens	IC50	nM	250.0
	381084	CHEMBL734579	Inhibition of Mitogen-activated protein kinase p38 beta at 1250 nM	B	O=C1NCc2nc(Sc3cc(Cl)ccc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL129659	=	Inhibition	%	47.0	CHEMBL3961	Homo sapiens	Inhibition	%	47.0
	382529	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	O=C1NCc2nc(Sc3cccc(Cl)c3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL130076	=	Inhibition	%	67.0	CHEMBL3961	Homo sapiens	Inhibition	%	67.0
	383944	CHEMBL737065	Inhibition of Mitogen-activated protein kinase p38 beta by 1 uM.	B	O=C1NCc2nc(SCc3ccccc3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL130077	=	Inhibition	%	13.0	CHEMBL3961	Homo sapiens	Inhibition	%	13.0
	385354	CHEMBL737068	Inhibition of Mitogen-activated protein kinase p38 beta at 340 nM	B	O=C1NCc2nc(Sc3c(Cl)cccc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL341029	=	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	Inhibition	%	50.0
	385356	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	CC(=O)c1cc(Cl)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL129775	=	IC50	nM	210.0	CHEMBL3961	Homo sapiens	IC50	nM	210.0
	389864	CHEMBL737062	Inhibitory activity against mitogen-activated protein kinase p38 beta	B	O=C1NCc2nc(Sc3ccccc3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL131176	=	IC50	nM	2370.0	CHEMBL3961	Homo sapiens	IC50	nM	2370.0
	528423	CHEMBL734581	Inhibition of Mitogen-activated protein kinase p38 beta at 1 uM	B	Cc1cc(F)ccc1Nc1ccc(C(=O)c2ccccc2C)c(Cl)c1		CHEMBL152208	=	Inhibition	%	92.0	CHEMBL3961	Homo sapiens	Inhibition	%	92.0
	529874	CHEMBL734581	Inhibition of Mitogen-activated protein kinase p38 beta at 1 uM	B	Cc1ccccc1C(=O)c1ccc(Nc2ccc(Br)cc2N)cc1Cl		CHEMBL347496	=	Inhibition	%	93.0	CHEMBL3961	Homo sapiens	Inhibition	%	93.0
	532526	CHEMBL734581	Inhibition of Mitogen-activated protein kinase p38 beta at 1 uM	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccncc2)cc1		CHEMBL279416	=	Inhibition	%	59.0	CHEMBL3961	Homo sapiens	Inhibition	%	59.0
	535199	CHEMBL734581	Inhibition of Mitogen-activated protein kinase p38 beta at 1 uM	B	Cc1ccccc1C(=O)c1ccc(Nc2ccccc2N)cc1Cl		CHEMBL152767	=	Inhibition	%	93.0	CHEMBL3961	Homo sapiens	Inhibition	%	93.0
	554907	CHEMBL811039	Inhibition of SAPK2b in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	Inhibition	%	0.0
	559751	CHEMBL811040	Inhibition of SAPK2b in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL288143	=	Inhibition	%	5.0	CHEMBL3961	Homo sapiens	Inhibition	%	5.0
	572994	CHEMBL811040	Inhibition of SAPK2b in presence of 10 uM ATP	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	Inhibition	%	11.0	CHEMBL3961	Homo sapiens	Inhibition	%	11.0
	586385	CHEMBL811039	Inhibition of SAPK2b in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL258701	=	Inhibition	%	7.0	CHEMBL3961	Homo sapiens	Inhibition	%	7.0
	590223	CHEMBL811041	Inhibition of SAPK2b in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3F)cc12		CHEMBL407373	=	Inhibition	%	4.0	CHEMBL3961	Homo sapiens	Inhibition	%	4.0
	684090	CHEMBL737061	Inhibition of Mitogen-activated protein kinase p38 beta	B	C[S+]([O-])c1ccc(-c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1		CHEMBL88486	=	IC50	nM	8.1	CHEMBL3961	Homo sapiens	IC50	uM	0.0081
	700254	CHEMBL737061	Inhibition of Mitogen-activated protein kinase p38 beta	B	CS(=O)(=O)c1ccc(-c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1		CHEMBL316275	=	IC50	nM	10.0	CHEMBL3961	Homo sapiens	IC50	uM	0.01
	706788	CHEMBL737061	Inhibition of Mitogen-activated protein kinase p38 beta	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	78.0	CHEMBL3961	Homo sapiens	IC50	uM	0.078
	736008	CHEMBL842193	Inhibition of human p38 beta MAP kinase	B	CN1CCC(O)(c2nc(-c3ccc(F)cc3)c(-c3ccncc3)o2)CC1		CHEMBL22978	=	IC50	nM	2408.0	CHEMBL3961	Homo sapiens	IC50	uM	2.408
	763508	CHEMBL731912	Inhibition of Mitogen-activated protein kinase p38 beta	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cc2ccncc2)cc1		CHEMBL288812	=	IC50	nM	110.0	CHEMBL3961	Homo sapiens	IC50	nM	110.0
	915728	CHEMBL811038	Inhibition of human Stress activated protein kinase 2b at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	105.0	CHEMBL3961	Homo sapiens	Activity	%	105.0
	931189	CHEMBL811038	Inhibition of human Stress activated protein kinase 2b at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	104.0	CHEMBL3961	Homo sapiens	Activity	%	104.0
	1034893	CHEMBL811042	Inhibition of Stress activated protein kinase 2b, p38-beta at 10 uM	B	COc1ccc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)cc1		CHEMBL158208	=	Inhibition	%	5.0	CHEMBL3961	Homo sapiens	Inhibition	%	5.0
	1036288	CHEMBL811042	Inhibition of Stress activated protein kinase 2b, p38-beta at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	Inhibition	%	0.0
	1048354	CHEMBL811042	Inhibition of Stress activated protein kinase 2b, p38-beta at 10 uM	B	COc1ccccc1C1=C(N2CCc3ccccc32)C(=O)NC1=O		CHEMBL160585	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	Inhibition	%	0.0
	1055600	CHEMBL811042	Inhibition of Stress activated protein kinase 2b, p38-beta at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160586	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	Inhibition	%	0.0
	1058286	CHEMBL811042	Inhibition of Stress activated protein kinase 2b, p38-beta at 10 uM	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156379	=	Inhibition	%	1.0	CHEMBL3961	Homo sapiens	Inhibition	%	1.0
	1179984	CHEMBL734580	Inhibition of Mitogen-activated protein kinase p38 beta	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2cccc(N)c2)n1		CHEMBL64040	=	IC50	nM	52.0	CHEMBL3961	Homo sapiens	IC50	nM	52.0
	1441914	CHEMBL831932	Inhibition of Stress activated protein kinase 2b at 10 uM with 100 uM ATP	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CCCC1		CHEMBL182419	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	Inhibition	%	0.0
	1475827	CHEMBL830599	Percent inhibition against p38b at 10 uM using 100 uM ATP	B	CCn1c(-c2nonc2N)nc2cnccc21		CHEMBL189657	=	Inhibition	%	18.0	CHEMBL3961	Homo sapiens	Inhibition	%	18.0
	1498768	CHEMBL827916	Inhibition of Stress activated protein kinase 2b	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n(C2CCCC2)c1=O		CHEMBL365847	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	1512986	CHEMBL829556	Inhibition of Mitogen-activated protein kinase 11 (P38 beta) at 100 uM ATP	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	500.0	CHEMBL3961	Homo sapiens	IC50	nM	500.0
	1606846	CHEMBL882124	Inhibitory concentration against p38 beta	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc(NC2CCCC2)c1C#N		CHEMBL383172	<	IC50	nM	100.0	CHEMBL3961	Homo sapiens	IC50	uM	0.1
	1608379	CHEMBL881509	Inhibitory concentration against mitogen-activated protein kinase p38-beta	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	=	IC50	nM	200.0	CHEMBL3961	Homo sapiens	IC50	uM	0.2
Not Active	1650306	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL3961	Homo sapiens	Kd		
Not Active	1650307	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL3961	Homo sapiens	Kd		
Not Active	1650308	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL3961	Homo sapiens	Kd		
Not Active	1650309	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL3961	Homo sapiens	Kd		
Not Active	1650310	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL3961	Homo sapiens	Kd		
Not Active	1650311	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL3961	Homo sapiens	Kd		
	1650312	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	200.0	CHEMBL3961	Homo sapiens	Kd	uM	0.2
Not Active	1650313	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL3961	Homo sapiens	Kd		
Not Active	1650314	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL3961	Homo sapiens	Kd		
Not Active	1652039	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		Kd			CHEMBL3961	Homo sapiens	Kd		
	1652040	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	120.0	CHEMBL3961	Homo sapiens	Kd	uM	0.12
	1652041	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	250.0	CHEMBL3961	Homo sapiens	Kd	uM	0.25
	1652042	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	160.0	CHEMBL3961	Homo sapiens	Kd	uM	0.16
	1652043	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	220.0	CHEMBL3961	Homo sapiens	Kd	uM	0.22
Not Active	1652044	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL3961	Homo sapiens	Kd		
Not Active	1652045	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL3961	Homo sapiens	Kd		
Not Active	1652046	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL3961	Homo sapiens	Kd		
Not Active	1652047	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL3961	Homo sapiens	Kd		
Not Active	1652048	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL3961	Homo sapiens	Kd		
Not Active	1652049	CHEMBL860916	Average Binding Constant for p38-beta; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL3961	Homo sapiens	Kd		
	1665733	CHEMBL860231	Inhibition of SAPK2b at 10 uM	B	CN1C(=O)C(C(=O)Nc2nncs2)c2cc3occc3cc21		CHEMBL200906	=	Inhibition	%	5.0	CHEMBL3961	Homo sapiens	Inhibition	%	5.0
	1666390	CHEMBL865779	Inhibition of p38-beta MAPK activity at 10 uM	B	Oc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)ccc1Cl		CHEMBL373011	=	Inhibition	%	81.0	CHEMBL3961	Homo sapiens	Inhibition	%	81.0
	1666391	CHEMBL865779	Inhibition of p38-beta MAPK activity at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	9.0	CHEMBL3961	Homo sapiens	Inhibition	%	9.0
	1671488	CHEMBL858541	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	Cc1c(Nc2ccc(Br)cc2F)c(C(=O)NOCCO)cn(C)c1=O		CHEMBL199860	=	Inhibition	%	16.0	CHEMBL3961	Homo sapiens	Inhibition	%	16.0
	1671517	CHEMBL858541	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(F)c1Nc1ccc(Br)cc1F		CHEMBL201426	=	Inhibition	%	9.0	CHEMBL3961	Homo sapiens	Inhibition	%	9.0
	1671541	CHEMBL858541	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	CONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL426840	=	Inhibition	%	5.0	CHEMBL3961	Homo sapiens	Inhibition	%	5.0
	1671633	CHEMBL858541	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL203138	=	Inhibition	%	13.0	CHEMBL3961	Homo sapiens	Inhibition	%	13.0
	1689334	CHEMBL862347	Inhibition of p38-beta at 10 uM	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	Kd	nM	50.0	CHEMBL3961	Homo sapiens	Kd	uM	0.05
	1699573	CHEMBL861582	Inhibition of P38-beta at 10 uM in presence of 100 uM ATP	B	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202887	=	Inhibition	%	26.0	CHEMBL3961	Homo sapiens	Inhibition	%	26.0
	1734138	CHEMBL862836	Residual activity at human SAPK2b at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	89.0	CHEMBL3961	Homo sapiens	Activity	%	89.0
	1769465	CHEMBL910953	Inhibition of SAPK2beta	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL3961	Homo sapiens	IC50	uM	1.0
	1790003	CHEMBL911617	Percentage activity of human SAPK2b in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	1790320	CHEMBL873760	Percent residual activity, relative to control, of SAPK2b/p38ss2 at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	80.0	CHEMBL3961	Homo sapiens	Activity	%	80.0
	1790374	CHEMBL873760	Percent residual activity, relative to control, of SAPK2b/p38ss2 at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	85.0	CHEMBL3961	Homo sapiens	Activity	%	85.0
	1808473	CHEMBL911325	Inhibition of p38beta	B	O=c1ccc(Nc2ccccc2Cl)nn1-c1ccccc1Cl		CHEMBL222109	=	IC50	nM	990.0	CHEMBL3961	Homo sapiens	IC50	nM	990.0
	1808480	CHEMBL911325	Inhibition of p38beta	B	Cc1cc(Cl)ccc1-n1nc(Sc2ccc(F)cc2F)ccc1=O		CHEMBL221071	=	IC50	nM	850.0	CHEMBL3961	Homo sapiens	IC50	nM	850.0
	1808481	CHEMBL911325	Inhibition of p38beta	B	O=c1ccc(Sc2ccccc2F)nn1-c1ccccc1Cl		CHEMBL373934	=	IC50	nM	450.0	CHEMBL3961	Homo sapiens	IC50	nM	450.0
	1808482	CHEMBL911325	Inhibition of p38beta	B	COc1ccccc1Nc1ccc(=O)n(-c2ccccc2Cl)n1		CHEMBL373767	=	IC50	nM	920.0	CHEMBL3961	Homo sapiens	IC50	nM	920.0
	1808483	CHEMBL911325	Inhibition of p38beta	B	Cc1ccccc1Nc1ccc(=O)n(-c2ccccc2Cl)n1		CHEMBL221791	=	IC50	nM	450.0	CHEMBL3961	Homo sapiens	IC50	nM	450.0
Not Active	1808485	CHEMBL911326	Inhibition of p38beta at 20 uM	B	O=c1ccc(Nc2ccccc2-c2ccccc2)nn1-c1ccccc1Cl		CHEMBL375138		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	1808489	CHEMBL911326	Inhibition of p38beta at 20 uM	B	Cc1cc(Cl)ccc1-n1nc(OCc2ccccc2C(F)(F)F)ccc1=O		CHEMBL221311		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	1808490	CHEMBL911326	Inhibition of p38beta at 20 uM	B	Cc1ccccc1CNc1ccc(=O)n(-c2ccccc2Cl)n1		CHEMBL374312		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	1808491	CHEMBL911326	Inhibition of p38beta at 20 uM	B	O=c1ccc(Oc2ccc(F)cc2F)nn1-c1ccccc1Cl		CHEMBL221494		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	1808492	CHEMBL911326	Inhibition of p38beta at 20 uM	B	O=c1ccc(Oc2ccc(F)cc2Cl)nn1-c1ccccc1Cl		CHEMBL555838		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	1808493	CHEMBL911326	Inhibition of p38beta at 20 uM	B	Cc1cc(Cl)ccc1-n1nc(Sc2ccc(Cl)cc2)ccc1=O		CHEMBL221072		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	1808494	CHEMBL911326	Inhibition of p38beta at 20 uM	B	CCc1ccccc1Nc1ccc(=O)n(-c2ccccc2Cl)n1		CHEMBL373545		Activity			CHEMBL3961	Homo sapiens	Activity		
	1808506	CHEMBL911325	Inhibition of p38beta	B	O=c1ccc(N(CCO)c2ccc(F)cc2Cl)nn1-c1ccccc1Cl		CHEMBL221312	=	IC50	nM	135.0	CHEMBL3961	Homo sapiens	IC50	nM	135.0
	1808507	CHEMBL911325	Inhibition of p38beta	B	O=C(NCCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl)C1CCC(C(F)(F)F)CC1		CHEMBL221700	=	IC50	nM	2.0	CHEMBL3961	Homo sapiens	IC50	nM	2.0
	1808508	CHEMBL911325	Inhibition of p38beta	B	O=C(NCCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl)C1CCNCC1		CHEMBL221648	=	IC50	nM	29.0	CHEMBL3961	Homo sapiens	IC50	nM	29.0
	1808509	CHEMBL911325	Inhibition of p38beta	B	O=C(CC1CCCN1)NCCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl		CHEMBL218661	=	IC50	nM	31.0	CHEMBL3961	Homo sapiens	IC50	nM	31.0
	1808510	CHEMBL911325	Inhibition of p38beta	B	CNCC(=O)NCCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl		CHEMBL221246	=	IC50	nM	29.0	CHEMBL3961	Homo sapiens	IC50	nM	29.0
	1808511	CHEMBL911325	Inhibition of p38beta	B	NCC(=O)NCCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl		CHEMBL376045	=	IC50	nM	41.0	CHEMBL3961	Homo sapiens	IC50	nM	41.0
	1808512	CHEMBL911325	Inhibition of p38beta	B	O=C1c2ccccc2C(=O)N1CCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccc(F)cc1Cl		CHEMBL221595	=	IC50	nM	20.0	CHEMBL3961	Homo sapiens	IC50	nM	20.0
	1808513	CHEMBL911325	Inhibition of p38beta	B	O=C1c2ccccc2C(=O)N1CCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl		CHEMBL221547	=	IC50	nM	15.0	CHEMBL3961	Homo sapiens	IC50	nM	15.0
	1808514	CHEMBL911325	Inhibition of p38beta	B	COc1ccc(CNCCCN(c2ccc(=O)n(-c3ccccc3Cl)n2)c2ccccc2Cl)c(OC)c1OC		CHEMBL374216	=	IC50	nM	600.0	CHEMBL3961	Homo sapiens	IC50	nM	600.0
	1808515	CHEMBL911325	Inhibition of p38beta	B	NCCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl		CHEMBL221546	=	IC50	nM	211.0	CHEMBL3961	Homo sapiens	IC50	nM	211.0
Not Active	1808557	CHEMBL911326	Inhibition of p38beta at 20 uM	B	O=c1ccc(-c2cccc(F)c2)nn1-c1ccccc1Cl		CHEMBL220918		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	1808559	CHEMBL911326	Inhibition of p38beta at 20 uM	B	O=c1ccc(-c2cccc(Cl)c2)nn1-c1ccccc1Cl		CHEMBL375431		Activity			CHEMBL3961	Homo sapiens	Activity		
	1812469	CHEMBL911352	Inhibition of p38beta	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	<	IC50	nM	15848.93	CHEMBL3961	Homo sapiens	Log IC50		-4.8
	1837908	CHEMBL920452	Inhibition of SAPK2b/p38--beta-2 at 10 uM relative to control	B	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL376505	=	Inhibition	%	65.0	CHEMBL3961	Homo sapiens	Inhibition	%	65.0
	1837947	CHEMBL920452	Inhibition of SAPK2b/p38--beta-2 at 10 uM relative to control	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Inhibition	%	103.0	CHEMBL3961	Homo sapiens	Inhibition	%	103.0
	1838309	CHEMBL904278	Inhibition of human p38beta	B	CONC(=O)c1ccc(C)c(Nc2nc(N(C)CC(C)(C)C)nc(N3CCCN(C)CC3)n2)c1		CHEMBL225088	=	IC50	nM	22.0	CHEMBL3961	Homo sapiens	IC50	uM	0.022
Not Active	1912288	CHEMBL889665	Binding affinity to p38beta2	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)NC(C)C		CHEMBL450013		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	1912304	CHEMBL889665	Binding affinity to p38beta2	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)Nc1ccccc1		CHEMBL226939		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	1912305	CHEMBL889665	Binding affinity to p38beta2	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)NCc1ccccc1		CHEMBL226836		Activity			CHEMBL3961	Homo sapiens	Activity		
	1922425	CHEMBL895924	Inhibition of p38beta	B	CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(OC[C@@H]5CCCN5C)c4)nc3c2)ccn1		CHEMBL231568	>	IC50	nM	40000.0	CHEMBL3961	Homo sapiens	IC50	uM	40.0
	2025198	CHEMBL887026	Inhibition of human SAPK2b at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	119.0	CHEMBL3961	Homo sapiens	Inhibition	%	119.0
	2025486	CHEMBL887026	Inhibition of human SAPK2b at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	104.0	CHEMBL3961	Homo sapiens	Inhibition	%	104.0
	2025487	CHEMBL887026	Inhibition of human SAPK2b at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	99.0	CHEMBL3961	Homo sapiens	Inhibition	%	99.0
	2025488	CHEMBL887026	Inhibition of human SAPK2b at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	114.0	CHEMBL3961	Homo sapiens	Inhibition	%	114.0
	2064110	CHEMBL926218	Inhibition of p38beta	B	CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NOC)ccc3C)c2c1C		CHEMBL252128	=	IC50	nM	15.0	CHEMBL3961	Homo sapiens	IC50	nM	15.0
	2077648	CHEMBL945008	Residual activity of p38beta at 10 uM relative to control	B	O=c1[nH]c2ccccc2c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL434737	=	Activity	%	97.0	CHEMBL3961	Homo sapiens	Activity	%	97.0
	2077649	CHEMBL945008	Residual activity of p38beta at 10 uM relative to control	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	95.0	CHEMBL3961	Homo sapiens	Activity	%	95.0
	2077650	CHEMBL945008	Residual activity of p38beta at 10 uM relative to control	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	98.0	CHEMBL3961	Homo sapiens	Activity	%	98.0
	2082298	CHEMBL928968	Inhibition of human p38beta	B	CC[C@@H](C)Nc1ncc(C(=O)Nc2cc(C(=O)NC)ccc2C)s1		CHEMBL258202	=	IC50	nM	1.5	CHEMBL3961	Homo sapiens	IC50	nM	1.5
	2086324	CHEMBL946950	Inhibition of p38beta	B	COc1cccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)c1		CHEMBL271271	=	IC50	nM	700.0	CHEMBL3961	Homo sapiens	IC50	uM	0.7
	2086325	CHEMBL946950	Inhibition of p38beta	B	COc1cccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)c1		CHEMBL271271	=	Ki	nM	160.0	CHEMBL3961	Homo sapiens	Ki	uM	0.16
	2086326	CHEMBL946950	Inhibition of p38beta	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL273158	=	IC50	nM	1800.0	CHEMBL3961	Homo sapiens	IC50	uM	1.8
	2086327	CHEMBL946950	Inhibition of p38beta	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL273158	=	Ki	nM	440.0	CHEMBL3961	Homo sapiens	Ki	uM	0.44
	2099512	CHEMBL948226	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	CN(C)CCCOc1cc2c(cc1O)c1c3c(c(-c4ccccc4Cl)cc1n2C)C(=O)NC3=O		CHEMBL410261	=	Inhibition	%	86.0	CHEMBL3961	Homo sapiens	Inhibition	%	86.0
	2099556	CHEMBL948226	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	Cn1c2cc(C(=O)NCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL272267	=	Inhibition	%	68.0	CHEMBL3961	Homo sapiens	Inhibition	%	68.0
	2099557	CHEMBL948226	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	Cn1c2cc(SCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL404335	=	Inhibition	%	74.0	CHEMBL3961	Homo sapiens	Inhibition	%	74.0
	2099558	CHEMBL948226	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCOCC3)cc2n1CCO		CHEMBL271715	=	Inhibition	%	78.0	CHEMBL3961	Homo sapiens	Inhibition	%	78.0
	2099559	CHEMBL948226	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCCC3)cc2n1CCO		CHEMBL270021	=	Inhibition	%	83.0	CHEMBL3961	Homo sapiens	Inhibition	%	83.0
	2099560	CHEMBL948226	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	Cn1c2cc(OCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL255427	=	Inhibition	%	59.0	CHEMBL3961	Homo sapiens	Inhibition	%	59.0
	2137214	CHEMBL921081	Inhibition of SAPK2b/p38beta	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	IC50	nM	2000.0	CHEMBL3961	Homo sapiens	IC50	nM	2000.0
	2137324	CHEMBL939211	Inhibition of p38-beta MAP kinase	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	100.0	CHEMBL3961	Homo sapiens	IC50	nM	100.0
	2137338	CHEMBL939211	Inhibition of p38-beta MAP kinase	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	IC50	nM	44.0	CHEMBL3961	Homo sapiens	IC50	nM	44.0
	2147386	CHEMBL922173	Activity of human SAPK2b kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	95.0	CHEMBL3961	Homo sapiens	Activity	%	95.0
	2153673	CHEMBL928269	Inhibition of Sapk2-beta at 20 uM	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	=	Inhibition	%	29.0	CHEMBL3961	Homo sapiens	Inhibition	%	29.0
	2153679	CHEMBL928269	Inhibition of Sapk2-beta at 20 uM	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	=	Inhibition	%	47.0	CHEMBL3961	Homo sapiens	Inhibition	%	47.0
	2158792	CHEMBL922523	Inhibition of p38beta	B	CNC(=O)c1ccc(C)c(Nc2nc(NC)nc3c2cnn3-c2ccccc2)c1		CHEMBL412281	=	IC50	nM	12.0	CHEMBL3961	Homo sapiens	IC50	nM	12.0
	2186793	CHEMBL969398	Inhibition of wild type p38beta	B	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3F)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199679	=	IC50	nM	0.25	CHEMBL3961	Homo sapiens	IC50	nM	0.25
	2186794	CHEMBL970276	Inhibition of p38beta T106M mutant	B	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3F)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199679	=	IC50	nM	260.0	CHEMBL3961	Homo sapiens	IC50	nM	260.0
	2186797	CHEMBL969398	Inhibition of wild type p38beta	B	C[C@H](Nc1cc(-c2c(-c3cccc(C(F)(F)F)c3)nc(C3CCNCC3)n2C)ccn1)c1ccccc1		CHEMBL303144	=	IC50	nM	0.1	CHEMBL3961	Homo sapiens	IC50	nM	0.1
	2206921	CHEMBL990556	Inhibition of p38beta	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	200.0	CHEMBL3961	Homo sapiens	Kd	nM	200.0
	2239710	CHEMBL996939	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCc1nnn[nH]1		CHEMBL471329	=	Inhibition	%	99.0	CHEMBL3961	Homo sapiens	INH	%	99.0
	2239738	CHEMBL996939	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	CS(=O)(=O)NC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL460940	=	Inhibition	%	89.0	CHEMBL3961	Homo sapiens	INH	%	89.0
	2239766	CHEMBL996939	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	CN(C)CCNC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL462011	=	Inhibition	%	108.0	CHEMBL3961	Homo sapiens	INH	%	108.0
	2239794	CHEMBL996939	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL508541	=	Inhibition	%	61.0	CHEMBL3961	Homo sapiens	INH	%	61.0
	2239822	CHEMBL996939	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL455192	=	Inhibition	%	83.0	CHEMBL3961	Homo sapiens	INH	%	83.0
	2239850	CHEMBL996939	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1c(Cl)cccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL471163	=	Inhibition	%	13.0	CHEMBL3961	Homo sapiens	INH	%	13.0
	2239878	CHEMBL996939	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL411662	=	Inhibition	%	49.0	CHEMBL3961	Homo sapiens	INH	%	49.0
	2239905	CHEMBL996939	Inhibition of SAPK2b/p38--beta-2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Inhibition	%	69.0	CHEMBL3961	Homo sapiens	INH	%	69.0
	2250947	CHEMBL1011041	Inhibition of P38beta	B	Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1		CHEMBL524266	>	IC50	nM	4000.0	CHEMBL3961	Homo sapiens	IC50	uM	4.0
	2279731	CHEMBL958296	Inhibition of p38beta at 10 uM	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
Not Active	2298930	CHEMBL1020725	Inhibition of human SAPK2B/P38-beta-2 at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C(=O)N(C)C)cc1)c1ccccc1		CHEMBL525203		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	2298966	CHEMBL1020725	Inhibition of human SAPK2B/P38-beta-2 at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497049		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	2298967	CHEMBL1020725	Inhibition of human SAPK2B/P38-beta-2 at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	2302149	CHEMBL950818	Inhibition of SAPK2b at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	2356942	CHEMBL955838	Inhibition of p38beta at 1 uM relative to control	B	Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL504805	>	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	2366696	CHEMBL1035799	Inhibition of human recombinant GST-tagged p38beta-induced ATF2 phosphorylation	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	=	Ki	nM	1.8	CHEMBL3961	Homo sapiens	Ki	nM	1.8
	2366698	CHEMBL1035801	Inhibition of p38beta at 1 uM relative to control	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	2393743	CHEMBL1004486	Binding affinity to human recombinant MAPK11 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	<	Tm	degrees C	2.0	CHEMBL3961	Homo sapiens	Tm	degrees C	2.0
	2393744	CHEMBL1004486	Binding affinity to human recombinant MAPK11 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	<	Tm	degrees C	2.0	CHEMBL3961	Homo sapiens	Tm	degrees C	2.0
	2393745	CHEMBL1004486	Binding affinity to human recombinant MAPK11 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc2c(c(OC)c1)C(=O)O[C@@H](C)CCC[C@@H](O)[C@@H](C)CC/C=C/2		CHEMBL454394	<	Tm	degrees C	2.0	CHEMBL3961	Homo sapiens	Tm	degrees C	2.0
	2393746	CHEMBL1004486	Binding affinity to human recombinant MAPK11 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc2c(c(OC)c1)C(=O)O[C@@H](C)CCCC(=O)[C@@H](C)CC/C=C/2		CHEMBL453389	<	Tm	degrees C	2.0	CHEMBL3961	Homo sapiens	Tm	degrees C	2.0
	2393747	CHEMBL1004486	Binding affinity to human recombinant MAPK11 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc(O)c2c(c1)/C=C/CC[C@H](C)C(=O)CCC[C@H](C)OC2=O		CHEMBL510836	<	Tm	degrees C	2.0	CHEMBL3961	Homo sapiens	Tm	degrees C	2.0
	2393748	CHEMBL1004486	Binding affinity to human recombinant MAPK11 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@H]1CCCC(=O)CCC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL454173	<	Tm	degrees C	2.0	CHEMBL3961	Homo sapiens	Tm	degrees C	2.0
	2393749	CHEMBL1004486	Binding affinity to human recombinant MAPK11 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@H]1CCCC(=O)[C@@H](C)CC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL453375	<	Tm	degrees C	2.0	CHEMBL3961	Homo sapiens	Tm	degrees C	2.0
	2451255	CHEMBL1013115	Inhibition of human SAPK2b/p38--beta-2 at 10 uM	B	CCC(Nc1cc(-c2[nH]c(SC)nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL494666	=	Inhibition	%	98.0	CHEMBL3961	Homo sapiens	INH	%	98.0
	2451335	CHEMBL1013115	Inhibition of human SAPK2b/p38--beta-2 at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Inhibition	%	97.0	CHEMBL3961	Homo sapiens	INH	%	97.0
	2451336	CHEMBL1013115	Inhibition of human SAPK2b/p38--beta-2 at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	97.0	CHEMBL3961	Homo sapiens	INH	%	97.0
	2451337	CHEMBL1013115	Inhibition of human SAPK2b/p38--beta-2 at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	90.0	CHEMBL3961	Homo sapiens	INH	%	90.0
	2451338	CHEMBL1013115	Inhibition of human SAPK2b/p38--beta-2 at 10 uM	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC2CCCCC2)c1		CHEMBL481943	=	Inhibition	%	100.0	CHEMBL3961	Homo sapiens	INH	%	100.0
	2451339	CHEMBL1013115	Inhibition of human SAPK2b/p38--beta-2 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCC3CCCO3)c2)[nH]1		CHEMBL480952	=	Inhibition	%	96.0	CHEMBL3961	Homo sapiens	INH	%	96.0
	2451340	CHEMBL1013115	Inhibition of human SAPK2b/p38--beta-2 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCCc3cccs3)c2)[nH]1		CHEMBL519617	=	Inhibition	%	99.0	CHEMBL3961	Homo sapiens	INH	%	99.0
	2451341	CHEMBL1013115	Inhibition of human SAPK2b/p38--beta-2 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCc3ccccc3)c2)[nH]1		CHEMBL493669	=	Inhibition	%	96.0	CHEMBL3961	Homo sapiens	INH	%	96.0
	2451342	CHEMBL1013115	Inhibition of human SAPK2b/p38--beta-2 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCc4ccccc43)c2)[nH]1		CHEMBL494871	=	Inhibition	%	90.0	CHEMBL3961	Homo sapiens	INH	%	90.0
	2452083	CHEMBL1013115	Inhibition of human SAPK2b/p38--beta-2 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCCC(C)C)c2)[nH]1		CHEMBL518964	=	Inhibition	%	96.0	CHEMBL3961	Homo sapiens	INH	%	96.0
	2470300	CHEMBL987220	Inhibition of p38-beta at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3961	Homo sapiens	INH	%	10.0
Not Evaluated	2476754	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Evaluated	2478593	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Evaluated	2478796	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Evaluated	2479651	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Evaluated	2479854	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Evaluated	2480651	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Evaluated	2480853	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL3961	Homo sapiens	Activity		
	2558423	CHEMBL989970	Inhibition of p38beta	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	<	IC50	nM	1000.0	CHEMBL3961	Homo sapiens	IC50	uM	1.0
	2558425	CHEMBL989970	Inhibition of p38beta	B	Cc1ccc(NC(=O)c2ccnc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476141	<	IC50	nM	1000.0	CHEMBL3961	Homo sapiens	IC50	uM	1.0
	2558435	CHEMBL989977	Inhibition of p38beta/gamma	B	Cc1ccc(NC(=O)c2ccnc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476141	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	2558438	CHEMBL989977	Inhibition of p38beta/gamma	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	2560729	CHEMBL983812	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38beta by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	Ki	nM	24.0	CHEMBL3961	Homo sapiens	Ki	nM	24.0
	2562288	CHEMBL984701	Inhibition of human p38beta at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	9.0	CHEMBL3961	Homo sapiens	INH	%	9.0
	2562310	CHEMBL984701	Inhibition of human p38beta at 10 uM	B	O/N=C1\CCc2cc(-c3cc(CN4CCOCC4)oc3-c3ccncc3)ccc21		CHEMBL476732	=	Inhibition	%	12.0	CHEMBL3961	Homo sapiens	INH	%	12.0
Not Evaluated	2577272	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Evaluated	2577475	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL3961	Homo sapiens	Activity		
	2593680	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	5.2	CHEMBL3961	Homo sapiens	Activity	%	5.2
	2593946	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	12.9	CHEMBL3961	Homo sapiens	Activity	%	12.9
Active	2594149	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL3961	Homo sapiens	Activity		
Active	2594889	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL3961	Homo sapiens	Activity		
Active	2595092	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Evaluated	2596289	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL3961	Homo sapiens	Activity		
	2596492	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	11.1	CHEMBL3961	Homo sapiens	Activity	%	11.1
Not Evaluated	2597761	CHEMBL983552	Binding affinity to human P38B at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL3961	Homo sapiens	Activity		
	2613327	CHEMBL1016942	Inhibition of SAPK2b/p38b2	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	nM	10000.0
	2635186	CHEMBL1000624	Inhibition of p38beta at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	<	Residual_activity	%	25.0	CHEMBL3961	Homo sapiens	Residual_activity	%	25.0
	2635929	CHEMBL1000624	Inhibition of p38beta at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	<	Residual_activity	%	25.0	CHEMBL3961	Homo sapiens	Residual_activity	%	25.0
	2635997	CHEMBL1000624	Inhibition of p38beta at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	<	Residual_activity	%	25.0	CHEMBL3961	Homo sapiens	Residual_activity	%	25.0
	2651610	CHEMBL1026920	Inhibition of GST-fused human p38beta expressed in Escherichia coli at 10 uM	B	Cc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1		CHEMBL570533	=	Inhibition	%	-5.0	CHEMBL3961	Homo sapiens	INH	%	-5.0
	2661427	CHEMBL1058633	Inhibition of P38beta	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	2691872	CHEMBL1054696	Inhibition of human p38beta assessed as remaining activity at 10 uM	B	Cc1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL551717	=	Activity	%	-1.0	CHEMBL3961	Homo sapiens	Activity	%	-1.0
	2711438	CHEMBL1063391	Inhibition of p38beta	B	Cn1c(=O)cc(Nc2cc(C(=O)NC3CC3)ccc2Cl)c2cnn(-c3ccc(F)cc3)c21		CHEMBL561932	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
Active	2719547	CHEMBL1059997	Inhibition of p38beta at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	2721719	CHEMBL1055123	Inhibition of SAPK2b at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
Antagonist	2891781	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	13.0	CHEMBL3961	Homo sapiens	Activity	%	13.0
Antagonist	2891782	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	5.0	CHEMBL3961	Homo sapiens	Activity	%	5.0
	2891783	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	97.0	CHEMBL3961	Homo sapiens	Activity	%	97.0
	2891784	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	94.0	CHEMBL3961	Homo sapiens	Activity	%	94.0
	2891785	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	86.0	CHEMBL3961	Homo sapiens	Activity	%	86.0
	2891786	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	95.0	CHEMBL3961	Homo sapiens	Activity	%	95.0
	2891787	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	91.0	CHEMBL3961	Homo sapiens	Activity	%	91.0
	2891788	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	106.0	CHEMBL3961	Homo sapiens	Activity	%	106.0
	2891789	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	96.0	CHEMBL3961	Homo sapiens	Activity	%	96.0
	2891790	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	103.0	CHEMBL3961	Homo sapiens	Activity	%	103.0
	2891791	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	95.0	CHEMBL3961	Homo sapiens	Activity	%	95.0
	2891792	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	90.0	CHEMBL3961	Homo sapiens	Activity	%	90.0
	2891793	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	92.0	CHEMBL3961	Homo sapiens	Activity	%	92.0
	2891794	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	2891795	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	91.0	CHEMBL3961	Homo sapiens	Activity	%	91.0
	2891796	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	103.0	CHEMBL3961	Homo sapiens	Activity	%	103.0
	2891797	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	89.0	CHEMBL3961	Homo sapiens	Activity	%	89.0
	2891798	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	77.0	CHEMBL3961	Homo sapiens	Activity	%	77.0
Antagonist	2891799	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	48.0	CHEMBL3961	Homo sapiens	Activity	%	48.0
	2891800	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	53.0	CHEMBL3961	Homo sapiens	Activity	%	53.0
	2891801	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	84.0	CHEMBL3961	Homo sapiens	Activity	%	84.0
	2891802	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	87.0	CHEMBL3961	Homo sapiens	Activity	%	87.0
	2891803	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	83.0	CHEMBL3961	Homo sapiens	Activity	%	83.0
	2891804	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	90.0	CHEMBL3961	Homo sapiens	Activity	%	90.0
	2891805	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	108.0	CHEMBL3961	Homo sapiens	Activity	%	108.0
Antagonist	2891806	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	38.0	CHEMBL3961	Homo sapiens	Activity	%	38.0
	2895071	CHEMBL1062864	Binding constant for full-length p38-beta	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895072	CHEMBL1062864	Binding constant for full-length p38-beta	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895073	CHEMBL1062864	Binding constant for full-length p38-beta	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	430.0	CHEMBL3961	Homo sapiens	Kd	nM	430.0
	2895074	CHEMBL1062864	Binding constant for full-length p38-beta	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895075	CHEMBL1062864	Binding constant for full-length p38-beta	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1500.0	CHEMBL3961	Homo sapiens	Kd	nM	1500.0
	2895076	CHEMBL1062864	Binding constant for full-length p38-beta	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895077	CHEMBL1062864	Binding constant for full-length p38-beta	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895078	CHEMBL1062864	Binding constant for full-length p38-beta	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895079	CHEMBL1062864	Binding constant for full-length p38-beta	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895080	CHEMBL1062864	Binding constant for full-length p38-beta	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895081	CHEMBL1062864	Binding constant for full-length p38-beta	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895082	CHEMBL1062864	Binding constant for full-length p38-beta	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	410.0	CHEMBL3961	Homo sapiens	Kd	nM	410.0
	2895083	CHEMBL1062864	Binding constant for full-length p38-beta	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895084	CHEMBL1062864	Binding constant for full-length p38-beta	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895085	CHEMBL1062864	Binding constant for full-length p38-beta	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895086	CHEMBL1062864	Binding constant for full-length p38-beta	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895087	CHEMBL1062864	Binding constant for full-length p38-beta	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895088	CHEMBL1062864	Binding constant for full-length p38-beta	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895089	CHEMBL1062864	Binding constant for full-length p38-beta	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895090	CHEMBL1062864	Binding constant for full-length p38-beta	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895091	CHEMBL1062864	Binding constant for full-length p38-beta	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895092	CHEMBL1062864	Binding constant for full-length p38-beta	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895093	CHEMBL1062864	Binding constant for full-length p38-beta	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895094	CHEMBL1062864	Binding constant for full-length p38-beta	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895095	CHEMBL1062864	Binding constant for full-length p38-beta	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895096	CHEMBL1062864	Binding constant for full-length p38-beta	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895097	CHEMBL1062864	Binding constant for full-length p38-beta	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895098	CHEMBL1062864	Binding constant for full-length p38-beta	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895099	CHEMBL1062864	Binding constant for full-length p38-beta	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	32.0	CHEMBL3961	Homo sapiens	Kd	nM	32.0
	2895100	CHEMBL1062864	Binding constant for full-length p38-beta	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	70.0	CHEMBL3961	Homo sapiens	Kd	nM	70.0
	2895101	CHEMBL1062864	Binding constant for full-length p38-beta	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895102	CHEMBL1062864	Binding constant for full-length p38-beta	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	230.0	CHEMBL3961	Homo sapiens	Kd	nM	230.0
	2895103	CHEMBL1062864	Binding constant for full-length p38-beta	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895104	CHEMBL1062864	Binding constant for full-length p38-beta	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895105	CHEMBL1062864	Binding constant for full-length p38-beta	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895106	CHEMBL1062864	Binding constant for full-length p38-beta	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2895107	CHEMBL1062864	Binding constant for full-length p38-beta	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	74.0	CHEMBL3961	Homo sapiens	Kd	nM	74.0
	2895108	CHEMBL1062864	Binding constant for full-length p38-beta	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	2897147	CHEMBL1061119	Percent residual p38beta activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	92.0	CHEMBL3961	Homo sapiens	Activity	%	92.0
	2897148	CHEMBL1061119	Percent residual p38beta activity in the presence of 10uM inhibitor	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Activity	%	87.0	CHEMBL3961	Homo sapiens	Activity	%	87.0
	2897149	CHEMBL1061119	Percent residual p38beta activity in the presence of 10uM inhibitor	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Activity	%	101.0	CHEMBL3961	Homo sapiens	Activity	%	101.0
	2903428	CHEMBL1062771	Percentage p38beta activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	94.0	CHEMBL3961	Homo sapiens	Activity	%	94.0
	2903429	CHEMBL1062771	Percentage p38beta activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	114.0	CHEMBL3961	Homo sapiens	Activity	%	114.0
	2903430	CHEMBL1062771	Percentage p38beta activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	105.0	CHEMBL3961	Homo sapiens	Activity	%	105.0
	2903431	CHEMBL1056154	Percentage p38beta activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	2903432	CHEMBL1056154	Percentage p38beta activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	71.0	CHEMBL3961	Homo sapiens	Activity	%	71.0
	2903433	CHEMBL1056154	Percentage p38beta activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	105.0	CHEMBL3961	Homo sapiens	Activity	%	105.0
	2904292	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	96.0	CHEMBL3961	Homo sapiens	Activity	%	96.0
	2904293	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	103.0	CHEMBL3961	Homo sapiens	Activity	%	103.0
Antagonist	2904294	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	46.0	CHEMBL3961	Homo sapiens	Activity	%	46.0
	2904295	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	55.0	CHEMBL3961	Homo sapiens	Activity	%	55.0
	2904296	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	101.0	CHEMBL3961	Homo sapiens	Activity	%	101.0
	2904297	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	2904298	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	87.0	CHEMBL3961	Homo sapiens	Activity	%	87.0
	2904299	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	109.0	CHEMBL3961	Homo sapiens	Activity	%	109.0
	2904300	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	93.0	CHEMBL3961	Homo sapiens	Activity	%	93.0
	2904301	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	89.0	CHEMBL3961	Homo sapiens	Activity	%	89.0
	2904302	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	96.0	CHEMBL3961	Homo sapiens	Activity	%	96.0
	2904303	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	102.0	CHEMBL3961	Homo sapiens	Activity	%	102.0
	2904304	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	109.0	CHEMBL3961	Homo sapiens	Activity	%	109.0
	2904305	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	99.0	CHEMBL3961	Homo sapiens	Activity	%	99.0
Antagonist	2904306	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	24.0	CHEMBL3961	Homo sapiens	Activity	%	24.0
Antagonist	2904307	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	15.0	CHEMBL3961	Homo sapiens	Activity	%	15.0
Antagonist	2904308	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	15.0	CHEMBL3961	Homo sapiens	Activity	%	15.0
Antagonist	2904309	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	22.0	CHEMBL3961	Homo sapiens	Activity	%	22.0
	2904310	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	98.0	CHEMBL3961	Homo sapiens	Activity	%	98.0
	2904311	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	84.0	CHEMBL3961	Homo sapiens	Activity	%	84.0
	2904312	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	107.0	CHEMBL3961	Homo sapiens	Activity	%	107.0
	2904313	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	91.0	CHEMBL3961	Homo sapiens	Activity	%	91.0
	2904314	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	114.0	CHEMBL3961	Homo sapiens	Activity	%	114.0
	2904315	CHEMBL1060213	Percentage p38beta activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	97.0	CHEMBL3961	Homo sapiens	Activity	%	97.0
	2904316	CHEMBL1060213	Percentage p38beta activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	101.0	CHEMBL3961	Homo sapiens	Activity	%	101.0
	2904317	CHEMBL1060152	Percentage p38beta activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	85.0	CHEMBL3961	Homo sapiens	Activity	%	85.0
	2904318	CHEMBL1062017	Percentage p38beta activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	85.0	CHEMBL3961	Homo sapiens	Activity	%	85.0
Antagonist	2904319	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	13.0	CHEMBL3961	Homo sapiens	Activity	%	13.0
	2904320	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	87.0	CHEMBL3961	Homo sapiens	Activity	%	87.0
	2904321	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	85.0	CHEMBL3961	Homo sapiens	Activity	%	85.0
	2904322	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	73.0	CHEMBL3961	Homo sapiens	Activity	%	73.0
	2904323	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	91.0	CHEMBL3961	Homo sapiens	Activity	%	91.0
	2904324	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	78.0	CHEMBL3961	Homo sapiens	Activity	%	78.0
	2904325	CHEMBL1052111	Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	102.0	CHEMBL3961	Homo sapiens	Activity	%	102.0
	2904646	CHEMBL1056154	Percentage p38beta activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	90.0	CHEMBL3961	Homo sapiens	Activity	%	90.0
	2904647	CHEMBL1056154	Percentage p38beta activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	99.0	CHEMBL3961	Homo sapiens	Activity	%	99.0
	2904648	CHEMBL1056154	Percentage p38beta activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	2904649	CHEMBL1056154	Percentage p38beta activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	109.0	CHEMBL3961	Homo sapiens	Activity	%	109.0
	2904650	CHEMBL1062016	Percentage p38beta activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	96.0	CHEMBL3961	Homo sapiens	Activity	%	96.0
	2921237	CHEMBL1048301	Inhibition of p38beta assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	99.0	CHEMBL3961	Homo sapiens	Activity	%	99.0
	2924689	CHEMBL1047333	Inhibition of P38beta assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	91.0	CHEMBL3961	Homo sapiens	Activity	%	91.0
	2924690	CHEMBL1047333	Inhibition of P38beta assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	2924691	CHEMBL1047333	Inhibition of P38beta assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	96.0	CHEMBL3961	Homo sapiens	Activity	%	96.0
	2924692	CHEMBL1047333	Inhibition of P38beta assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	80.0	CHEMBL3961	Homo sapiens	Activity	%	80.0
	2926193	CHEMBL1046786	Inhibition of p38beta assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	93.0	CHEMBL3961	Homo sapiens	Activity	%	93.0
	2926287	CHEMBL1057671	Inhibition of p38beta assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	83.0	CHEMBL3961	Homo sapiens	Activity	%	83.0
	2938474	CHEMBL1041391	Inhibition of P38beta at 2 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	25.0	CHEMBL3961	Homo sapiens	INH	%	25.0
	2992190	CHEMBL1044494	Inhibition of p38beta by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	IC50	nM	5400.0	CHEMBL3961	Homo sapiens	IC50	uM	5.4
	2998985	CHEMBL1048075	Inhibition of p38beta assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	95.0	CHEMBL3961	Homo sapiens	Activity	%	95.0
	2999775	CHEMBL1048075	Inhibition of p38beta assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	98.0	CHEMBL3961	Homo sapiens	Activity	%	98.0
	2999852	CHEMBL1047253	Inhibition of p38beta assessed as residual activity at 0.1 uM by Cherenkov counting relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	17.0	CHEMBL3961	Homo sapiens	Activity	%	17.0
	2999928	CHEMBL1047253	Inhibition of p38beta assessed as residual activity at 0.1 uM by Cherenkov counting relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	46.0	CHEMBL3961	Homo sapiens	Activity	%	46.0
	3000057	CHEMBL1045475	Inhibition of p38beta at 0.1 uM by Cherenkov counting	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Inhibition	%	83.0	CHEMBL3961	Homo sapiens	INH	%	83.0
	3000061	CHEMBL1045475	Inhibition of p38beta at 0.1 uM by Cherenkov counting	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Inhibition	%	54.0	CHEMBL3961	Homo sapiens	INH	%	54.0
Not Active	3006215	CHEMBL1047295	Inhibition of p38beta2 at 10 uM	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	3006216	CHEMBL1047295	Inhibition of p38beta2 at 10 uM	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	3006217	CHEMBL1047295	Inhibition of p38beta2 at 10 uM	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887		Activity			CHEMBL3961	Homo sapiens	Activity		
Not Active	3006218	CHEMBL1047295	Inhibition of p38beta2 at 10 uM	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989		Activity			CHEMBL3961	Homo sapiens	Activity		
	3052425	CHEMBL1069806	Residual activity of p38beta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	105.0	CHEMBL3961	Homo sapiens	Residual activity	%	105.0
	3052677	CHEMBL1041164	Residual activity of p38beta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	129.0	CHEMBL3961	Homo sapiens	Residual activity	%	129.0
	3053986	CHEMBL1050317	Residual activity of p38beta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	337.0	CHEMBL3961	Homo sapiens	Residual activity	%	337.0
	3054238	CHEMBL1069806	Residual activity of p38beta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	90.0	CHEMBL3961	Homo sapiens	Residual activity	%	90.0
	3055525	CHEMBL1041164	Residual activity of p38beta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	126.0	CHEMBL3961	Homo sapiens	Residual activity	%	126.0
	3056830	CHEMBL1050317	Residual activity of p38beta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	350.0	CHEMBL3961	Homo sapiens	Residual activity	%	350.0
	3057082	CHEMBL1069806	Residual activity of p38beta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	104.0	CHEMBL3961	Homo sapiens	Residual activity	%	104.0
	3058402	CHEMBL1041164	Residual activity of p38beta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	125.0	CHEMBL3961	Homo sapiens	Residual activity	%	125.0
	3059686	CHEMBL1050317	Residual activity of p38beta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	337.0	CHEMBL3961	Homo sapiens	Residual activity	%	337.0
	3062491	CHEMBL1037978	Binding affinity to human p38beta at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	3063626	CHEMBL1074892	Binding affinity to human p38beta at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	3063716	CHEMBL1042478	Binding affinity to human p38beta at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	3066871	CHEMBL1066077	Inhibition of p38beta at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	INH	%	0.0
	3066961	CHEMBL1066077	Inhibition of p38beta at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	32.0	CHEMBL3961	Homo sapiens	INH	%	32.0
	3098290	CHEMBL1067805	Inhibition of p38beta	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	=	IC50	nM	98.0	CHEMBL3961	Homo sapiens	IC50	nM	98.0
	3201942	CHEMBL1099701	Inhibition of p38beta	B	O=C(NC1CC1)c1ccc(Cl)c(Nc2nncc3c2cnn3-c2c(F)cccc2F)c1		CHEMBL1082158	=	IC50	nM	4.0	CHEMBL3961	Homo sapiens	IC50	nM	4.0
	3213990	CHEMBL1116738	Inhibition of P38beta at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	93.0	CHEMBL3961	Homo sapiens	INH	%	93.0
	3224871	CHEMBL1100949	Inhibition of p38beta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	=	Inhibition	%	82.0	CHEMBL3961	Homo sapiens	INH	%	82.0
	3225121	CHEMBL1100949	Inhibition of p38beta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	=	Inhibition	%	82.0	CHEMBL3961	Homo sapiens	INH	%	82.0
	3244750	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Fc1ccc(-c2n[nH]c(C3CCCNC3)c2-c2ccncc2)cc1		CHEMBL1091552	=	IC50	nM	404.0	CHEMBL3961	Homo sapiens	IC50	nM	404.0
	3244751	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCCC(c2[nH]nc(-c3ccc(F)cc3)c2-c2ccncc2)C1		CHEMBL1091560	=	IC50	nM	2520.0	CHEMBL3961	Homo sapiens	IC50	nM	2520.0
	3244752	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Fc1ccc(-c2n[nH]c(C3CCNCC3)c2-c2ccncc2)cc1		CHEMBL1091667	=	IC50	nM	510.0	CHEMBL3961	Homo sapiens	IC50	nM	510.0
	3244753	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCC(c2[nH]nc(-c3ccc(F)cc3)c2-c2ccncc2)CC1		CHEMBL1091668	=	IC50	nM	1960.0	CHEMBL3961	Homo sapiens	IC50	nM	1960.0
	3244754	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1092902	=	IC50	nM	2680.0	CHEMBL3961	Homo sapiens	IC50	nM	2680.0
	3244755	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCC(c2[nH]nc(-c3cccc(Cl)c3)c2-c2ccncc2)CC1		CHEMBL1092903	=	IC50	nM	1050.0	CHEMBL3961	Homo sapiens	IC50	nM	1050.0
	3244756	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCC(c2[nH]nc(-c3ccc(C(F)(F)F)cc3)c2-c2ccncc2)CC1		CHEMBL1090511	=	IC50	nM	3770.0	CHEMBL3961	Homo sapiens	IC50	nM	3770.0
	3244757	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCC(c2[nH]nc(-c3cccc(C(F)(F)F)c3)c2-c2ccncc2)CC1		CHEMBL1090512	=	IC50	nM	164.0	CHEMBL3961	Homo sapiens	IC50	nM	164.0
	3244758	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Cc1ccc(-c2n[nH]c(C3CCN(C)CC3)c2-c2ccncc2)cc1		CHEMBL1090836	=	IC50	nM	3070.0	CHEMBL3961	Homo sapiens	IC50	nM	3070.0
	3244759	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Cc1cccc(-c2n[nH]c(C3CCN(C)CC3)c2-c2ccncc2)c1		CHEMBL1090837	=	IC50	nM	2350.0	CHEMBL3961	Homo sapiens	IC50	nM	2350.0
	3244760	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	OCCN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1093456	=	IC50	nM	3390.0	CHEMBL3961	Homo sapiens	IC50	nM	3390.0
	3244761	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	COCCN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1089197	=	IC50	nM	6720.0	CHEMBL3961	Homo sapiens	IC50	nM	6720.0
	3244762	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	COCCCN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1089198	=	IC50	nM	6550.0	CHEMBL3961	Homo sapiens	IC50	nM	6550.0
	3244763	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	NS(=O)(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1089520	=	IC50	nM	1650.0	CHEMBL3961	Homo sapiens	IC50	nM	1650.0
	3244764	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CS(=O)(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1088897	=	IC50	nM	3530.0	CHEMBL3961	Homo sapiens	IC50	nM	3530.0
	3244765	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	O=C(O)CN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1092383	=	IC50	nM	4340.0	CHEMBL3961	Homo sapiens	IC50	nM	4340.0
	3244766	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CC(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1091921	=	IC50	nM	3130.0	CHEMBL3961	Homo sapiens	IC50	nM	3130.0
	3244767	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1091922	=	IC50	nM	1790.0	CHEMBL3961	Homo sapiens	IC50	nM	1790.0
	3244768	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	COCC(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1091923	=	IC50	nM	3450.0	CHEMBL3961	Homo sapiens	IC50	nM	3450.0
	3244769	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN(C)CC(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1092246	=	IC50	nM	6720.0	CHEMBL3961	Homo sapiens	IC50	nM	6720.0
	3244770	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1092722	=	IC50	nM	2320.0	CHEMBL3961	Homo sapiens	IC50	nM	2320.0
	3244771	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	OCCN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1093007	=	IC50	nM	2540.0	CHEMBL3961	Homo sapiens	IC50	nM	2540.0
	3244772	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CC(C)(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1092906	=	IC50	nM	2780.0	CHEMBL3961	Homo sapiens	IC50	nM	2780.0
	3244773	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CC(C)(O)CN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1092907	=	IC50	nM	9780.0	CHEMBL3961	Homo sapiens	IC50	nM	9780.0
	3244774	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Clc1ccc(-c2n[nH]c(C3CCN(C4CCOC4)CC3)c2-c2ccncn2)cc1		CHEMBL1092001	=	IC50	nM	7410.0	CHEMBL3961	Homo sapiens	IC50	nM	7410.0
	3244775	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Clc1ccc(-c2n[nH]c(C3CCN(C4CCOCC4)CC3)c2-c2ccncn2)cc1		CHEMBL1092648	=	IC50	nM	9500.0	CHEMBL3961	Homo sapiens	IC50	nM	9500.0
	3244776	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	O[C@H]1CCC[C@@H]1N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1089172	=	IC50	nM	3380.0	CHEMBL3961	Homo sapiens	IC50	nM	3380.0
	3244777	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Clc1ccc(-c2n[nH]c(C3CCN(Cc4ccncc4)CC3)c2-c2ccncn2)cc1		CHEMBL1093301	=	IC50	nM	3290.0	CHEMBL3961	Homo sapiens	IC50	nM	3290.0
	3244778	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CC(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1089173	=	IC50	nM	3710.0	CHEMBL3961	Homo sapiens	IC50	nM	3710.0
	3244779	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	O=C(CO)N1CCC(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1090173	=	IC50	nM	3450.0	CHEMBL3961	Homo sapiens	IC50	nM	3450.0
	3244780	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	COCC(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1090174	=	IC50	nM	3250.0	CHEMBL3961	Homo sapiens	IC50	nM	3250.0
	3244781	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN(C)C(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1091912	=	IC50	nM	3480.0	CHEMBL3961	Homo sapiens	IC50	nM	3480.0
	3244782	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CS(=O)(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1088914	=	IC50	nM	4100.0	CHEMBL3961	Homo sapiens	IC50	nM	4100.0
	3244787	CHEMBL1107047	Inhibition of p38beta assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CC(=O)N1CCC(c2[nH]nc(-c3ccc(F)cc3)c2-c2ccncc2)CC1		CHEMBL1092901	=	IC50	nM	1680.0	CHEMBL3961	Homo sapiens	IC50	nM	1680.0
	3251651	CHEMBL1104509	Inhibition of p38beta at 1 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1089865	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	3251655	CHEMBL1104512	Binding affinity to p38beta	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1089865	=	Kd	nM	0.67	CHEMBL3961	Homo sapiens	Kd	nM	0.67
	3251660	CHEMBL1104517	Inhibition of p38beta	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1089865	=	Ki	nM	2.5	CHEMBL3961	Homo sapiens	Ki	nM	2.5
	3260077	CHEMBL1104314	Inhibition of p38beta at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	63.0	CHEMBL3961	Homo sapiens	Activity	%	63.0
	3260840	CHEMBL1111806	Binding affinity to p38beta	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	=	Kd	nM	120.0	CHEMBL3961	Homo sapiens	Kd	uM	0.12
	3260849	CHEMBL1111806	Binding affinity to p38beta	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	=	Kd	nM	15.0	CHEMBL3961	Homo sapiens	Kd	uM	0.015
	3260851	CHEMBL1111806	Binding affinity to p38beta	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	=	Kd	nM	17.0	CHEMBL3961	Homo sapiens	Kd	uM	0.017
	3261396	CHEMBL1104314	Inhibition of p38beta at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	81.0	CHEMBL3961	Homo sapiens	Activity	%	81.0
	3261937	CHEMBL1111806	Binding affinity to p38beta	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	=	Ki	nM	25.12	CHEMBL3961	Homo sapiens	pKi		7.6
	3332062	CHEMBL1166600	Inhibition of p38-beta at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	3333477	CHEMBL1166600	Inhibition of p38-beta at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	3334882	CHEMBL1166600	Inhibition of p38-beta at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	3336302	CHEMBL1166600	Inhibition of p38-beta at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	3337599	CHEMBL1166600	Inhibition of p38-beta at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	3338930	CHEMBL1166600	Inhibition of p38-beta at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	3339184	CHEMBL1166600	Inhibition of p38-beta at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	3340487	CHEMBL1166600	Inhibition of p38-beta at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	3341844	CHEMBL1166600	Inhibition of p38-beta at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	3343291	CHEMBL1166600	Inhibition of p38-beta at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	3355427	CHEMBL1174573	Inhibition of p38beta	B	Cc1ccccc1C(=O)c1c[nH]c(C(=O)NCc2ccco2)c1		CHEMBL1171204	=	IC50	nM	6309.57	CHEMBL3961	Homo sapiens	pIC50		5.2
	3355438	CHEMBL1174588	Binding affinity to p38beta at 10 uM assessed as binding remaining relative to control	B	Cc1ccccc1C(=O)c1c[nH]c(C(=O)NCc2ccco2)c1		CHEMBL1171204	=	Activity	%	17.0	CHEMBL3961	Homo sapiens	Activity	%	17.0
	3358710	CHEMBL1174952	Inhibition of p38beta at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	INH	%	0.0
	3359152	CHEMBL1174952	Inhibition of p38beta at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	INH	%	0.0
	3381363	CHEMBL1211155	Inhibition of p38beta	B	Fc1ccc(-c2[nH]cc(C3=C[C@@H]4CCCN4CC3)c2-c2ccncc2)cc1		CHEMBL1209288	=	IC50	nM	572.0	CHEMBL3961	Homo sapiens	IC50	uM	0.572
	3400041	CHEMBL1217238	Inhibition of human SAPK2b at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	98.0	CHEMBL3961	Homo sapiens	INH	%	98.0
	3419154	CHEMBL1228784	Inhibition of SAPK2	B	NC(=O)c1sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[n+]1[O-]		CHEMBL476124	>	IC50	nM	100000.0	CHEMBL3961	Homo sapiens	IC50	uM	100.0
	3419171	CHEMBL1228784	Inhibition of SAPK2	B	NC(=O)c1sc2c([N+](=O)[O-])cc(SC(F)(F)F)cc2[n+]1[O-]		CHEMBL1222044	>	IC50	nM	100000.0	CHEMBL3961	Homo sapiens	IC50	uM	100.0
	3420243	CHEMBL1226939	Inhibition of P38beta	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	nM	10000.0
	3443442	CHEMBL1244208	Inhibition of p38beta at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	59.0	CHEMBL3961	Homo sapiens	INH	%	59.0
	3443659	CHEMBL1244208	Inhibition of p38beta at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	8.0	CHEMBL3961	Homo sapiens	INH	%	8.0
	3444814	CHEMBL1244208	Inhibition of p38beta at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	11.0	CHEMBL3961	Homo sapiens	INH	%	11.0
	3445438	CHEMBL1244208	Inhibition of p38beta at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	10.0	CHEMBL3961	Homo sapiens	INH	%	10.0
	3445655	CHEMBL1244208	Inhibition of p38beta at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	6.0	CHEMBL3961	Homo sapiens	INH	%	6.0
	3445858	CHEMBL1244208	Inhibition of p38beta at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	18.0	CHEMBL3961	Homo sapiens	INH	%	18.0
	3446048	CHEMBL1244208	Inhibition of p38beta at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	7.0	CHEMBL3961	Homo sapiens	INH	%	7.0
	3446546	CHEMBL1249570	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 1 uM	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Inhibition	%	92.0	CHEMBL3961	Homo sapiens	INH	%	92.0
	3446575	CHEMBL1249570	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 1 uM	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	97.0	CHEMBL3961	Homo sapiens	INH	%	97.0
	3446599	CHEMBL1249570	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 1 uM	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Inhibition	%	88.0	CHEMBL3961	Homo sapiens	INH	%	88.0
	3446624	CHEMBL1247634	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 20 uM	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Inhibition	%	150.0	CHEMBL3961	Homo sapiens	INH	%	150.0
	3446651	CHEMBL1249546	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 50 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Inhibition	%	98.0	CHEMBL3961	Homo sapiens	INH	%	98.0
	3446679	CHEMBL1249570	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 1 uM	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Inhibition	%	74.0	CHEMBL3961	Homo sapiens	INH	%	74.0
	3446684	CHEMBL1249810	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	100.0	CHEMBL3961	Homo sapiens	IC50	nM	100.0
	3446705	CHEMBL1247610	Inhibition of Gst-tagged human SAPK2b/p38--beta-2 expressed in Escherichia coli at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	3.0	CHEMBL3961	Homo sapiens	INH	%	3.0
	3446729	CHEMBL1247610	Inhibition of Gst-tagged human SAPK2b/p38--beta-2 expressed in Escherichia coli at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	10.0	CHEMBL3961	Homo sapiens	INH	%	10.0
	3446753	CHEMBL1249546	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 50 uM	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Inhibition	%	95.0	CHEMBL3961	Homo sapiens	INH	%	95.0
	3446778	CHEMBL1247610	Inhibition of Gst-tagged human SAPK2b/p38--beta-2 expressed in Escherichia coli at 10 uM	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Inhibition	%	119.0	CHEMBL3961	Homo sapiens	INH	%	119.0
	3446810	CHEMBL1247610	Inhibition of Gst-tagged human SAPK2b/p38--beta-2 expressed in Escherichia coli at 10 uM	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Inhibition	%	90.0	CHEMBL3961	Homo sapiens	INH	%	90.0
	3446837	CHEMBL1247610	Inhibition of Gst-tagged human SAPK2b/p38--beta-2 expressed in Escherichia coli at 10 uM	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Inhibition	%	98.0	CHEMBL3961	Homo sapiens	INH	%	98.0
	3446864	CHEMBL1247634	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 20 uM	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Inhibition	%	127.0	CHEMBL3961	Homo sapiens	INH	%	127.0
	3446895	CHEMBL1247634	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 20 uM	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Inhibition	%	97.0	CHEMBL3961	Homo sapiens	INH	%	97.0
	3447272	CHEMBL1247610	Inhibition of Gst-tagged human SAPK2b/p38--beta-2 expressed in Escherichia coli at 10 uM	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Inhibition	%	107.0	CHEMBL3961	Homo sapiens	INH	%	107.0
	3447306	CHEMBL1247610	Inhibition of Gst-tagged human SAPK2b/p38--beta-2 expressed in Escherichia coli at 10 uM	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	97.0	CHEMBL3961	Homo sapiens	INH	%	97.0
	3447323	CHEMBL1249570	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 1 uM	B	NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL270875	=	Inhibition	%	115.0	CHEMBL3961	Homo sapiens	INH	%	115.0
	3447347	CHEMBL1249570	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 1 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Inhibition	%	88.0	CHEMBL3961	Homo sapiens	INH	%	88.0
	3447371	CHEMBL1249570	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 1 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ccccc23)C1=O		CHEMBL291725	=	Inhibition	%	104.0	CHEMBL3961	Homo sapiens	INH	%	104.0
	3447395	CHEMBL1249570	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 1 uM	B	Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL269264	=	Inhibition	%	104.0	CHEMBL3961	Homo sapiens	INH	%	104.0
	3447419	CHEMBL1249570	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 1 uM	B	Cn1cc(C2=C(c3c4n(c5ccccc35)CCC(CN)C4)C(=O)NC2=O)c2ccccc21		CHEMBL421565	=	Inhibition	%	102.0	CHEMBL3961	Homo sapiens	INH	%	102.0
	3447443	CHEMBL1249570	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 1 uM	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Inhibition	%	81.0	CHEMBL3961	Homo sapiens	INH	%	81.0
	3447467	CHEMBL1247610	Inhibition of Gst-tagged human SAPK2b/p38--beta-2 expressed in Escherichia coli at 10 uM	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL16958	=	Inhibition	%	88.0	CHEMBL3961	Homo sapiens	INH	%	88.0
	3447491	CHEMBL1247610	Inhibition of Gst-tagged human SAPK2b/p38--beta-2 expressed in Escherichia coli at 10 uM	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Inhibition	%	98.0	CHEMBL3961	Homo sapiens	INH	%	98.0
	3447517	CHEMBL1249570	Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 1 uM	B	CC[C@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O		CHEMBL1242366	=	Inhibition	%	91.0	CHEMBL3961	Homo sapiens	INH	%	91.0
	3448052	CHEMBL1249673	Inhibition of human SAPK2b activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	INH	%	0.0
	3448128	CHEMBL1249673	Inhibition of human SAPK2b activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	INH	%	0.0
	3448538	CHEMBL1244546	Binding affinity to p38-beta	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	3449292	CHEMBL1244546	Binding affinity to p38-beta	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	230.0	CHEMBL3961	Homo sapiens	Kd	nM	230.0
	3449768	CHEMBL1244546	Binding affinity to p38-beta	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	3449946	CHEMBL1244546	Binding affinity to p38-beta	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	3450375	CHEMBL1244546	Binding affinity to p38-beta	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	3450827	CHEMBL1244546	Binding affinity to p38-beta	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	3451086	CHEMBL1244546	Binding affinity to p38-beta	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	uM	10.0
	3463276	CHEMBL1252479	Inhibition of MAPK11 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	6.0	CHEMBL3961	Homo sapiens	INH	%	6.0
	3463820	CHEMBL1252479	Inhibition of MAPK11 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	4.0	CHEMBL3961	Homo sapiens	INH	%	4.0
	3464039	CHEMBL1252479	Inhibition of MAPK11 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	6.0	CHEMBL3961	Homo sapiens	INH	%	6.0
	3525163	CHEMBL1274107	Inhibition of p38beta2 at 1 uM	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	Inhibition	%	98.0	CHEMBL3961	Homo sapiens	INH	%	98.0
Not Determined	3525193	CHEMBL1274107	Inhibition of p38beta2 at 1 uM	B	O=C1Nc2ccccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL500435		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	3525223	CHEMBL1274107	Inhibition of p38beta2 at 1 uM	B	CN(C)C(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL1272078	=	Inhibition	%	100.0	CHEMBL3961	Homo sapiens	INH	%	100.0
Not Determined	3525253	CHEMBL1274107	Inhibition of p38beta2 at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272128		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
Not Determined	3525283	CHEMBL1274107	Inhibition of p38beta2 at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL1272289		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
Not Determined	3525313	CHEMBL1274107	Inhibition of p38beta2 at 1 uM	B	CCNCc1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271471		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	3526971	CHEMBL1274173	Inhibition of P38beta	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1		CHEMBL1270230	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	5120273	CHEMBL1646647	Inhibition of human SAPK2b at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	90.0	CHEMBL3961	Homo sapiens	INH	%	90.0
	5132611	CHEMBL1648754	Inhibition of p38beta assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	95.0	CHEMBL3961	Homo sapiens	Activity	%	95.0
	5133754	CHEMBL1648754	Inhibition of p38beta assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	5133917	CHEMBL1648754	Inhibition of p38beta assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	5191339	CHEMBL1663971	Inhibition of p38beta MAPK at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC	Outside typical range	CHEMBL1236782	=	Inhibition	%	-12.0	CHEMBL3961	Homo sapiens	INH	%	-12.0
	5191340	CHEMBL1663971	Inhibition of p38beta MAPK at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	26.0	CHEMBL3961	Homo sapiens	INH	%	26.0
	5243766	CHEMBL1685870	Inhibition of SAPK2b at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	100.0	CHEMBL3961	Homo sapiens	INH	%	100.0
	5243874	CHEMBL1686086	Inhibition of SAPK2b at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	86.0	CHEMBL3961	Homo sapiens	INH	%	86.0
	5243987	CHEMBL1685870	Inhibition of SAPK2b at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	100.0	CHEMBL3961	Homo sapiens	INH	%	100.0
	5244095	CHEMBL1686086	Inhibition of SAPK2b at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	91.0	CHEMBL3961	Homo sapiens	INH	%	91.0
	5244968	CHEMBL1685870	Inhibition of SAPK2b at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	93.0	CHEMBL3961	Homo sapiens	INH	%	93.0
	5245076	CHEMBL1686086	Inhibition of SAPK2b at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	97.0	CHEMBL3961	Homo sapiens	INH	%	97.0
	5245227	CHEMBL1685870	Inhibition of SAPK2b at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	104.0	CHEMBL3961	Homo sapiens	INH	%	104.0
	5246057	CHEMBL1686086	Inhibition of SAPK2b at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	102.0	CHEMBL3961	Homo sapiens	INH	%	102.0
	6167663	CHEMBL1769204	Inhibition of P38beta	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL3961	Homo sapiens	Ki	uM	1.0
	6172866	CHEMBL1769106	Inhibition of P38beta at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	>	Inhibition	%	85.0	CHEMBL3961	Homo sapiens	INH	%	85.0
	6172878	CHEMBL1769118	Inhibition of P38beta	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	=	Kd	nM	120.0	CHEMBL3961	Homo sapiens	Kd	nM	120.0
	6172930	CHEMBL1769106	Inhibition of P38beta at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	>	Inhibition	%	85.0	CHEMBL3961	Homo sapiens	INH	%	85.0
	6172942	CHEMBL1769118	Inhibition of P38beta	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	=	Kd	nM	29.0	CHEMBL3961	Homo sapiens	Kd	nM	29.0
	6194949	CHEMBL1775261	Inhibition of p38beta	B	NS(=O)(=O)N1CCC(Nc2nccc(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)n2)CC1		CHEMBL1773329	=	IC50	nM	210.0	CHEMBL3961	Homo sapiens	IC50	uM	0.21
	6194950	CHEMBL1775261	Inhibition of p38beta	B	O=S(=O)(c1ccc(-c2ccnc(NC3CCNCC3)n2)cc1)N1CCNCC1		CHEMBL1773334	>	IC50	nM	30000.0	CHEMBL3961	Homo sapiens	IC50	uM	30.0
	6208257	CHEMBL1781012	Inhibition of p38beta	B	C[C@H](CS(C)(=O)=O)Nc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL1232769	=	Kd	nM	8.7	CHEMBL3961	Homo sapiens	Kd	nM	8.7
	6208258	CHEMBL1781012	Inhibition of p38beta	B	C[C@H](CS(C)(=O)=O)Nc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12		CHEMBL1236810	=	Kd	nM	25.0	CHEMBL3961	Homo sapiens	Kd	nM	25.0
	6208300	CHEMBL1781143	Inhibition of p38beta at 10 uM	B	C[C@H](CS(C)(=O)=O)Nc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL1232769	=	Inhibition	%	100.0	CHEMBL3961	Homo sapiens	INH	%	100.0
	6230237	CHEMBL1787753	Inhibition of GST-tagged p38beta by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cn1		CHEMBL1784172	=	Ki	nM	25.12	CHEMBL3961	Homo sapiens	pKi		7.6
	6230243	CHEMBL1787753	Inhibition of GST-tagged p38beta by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)C)cn1		CHEMBL1784173	=	Ki	nM	158.49	CHEMBL3961	Homo sapiens	pKi		6.8
Not Determined	6230249	CHEMBL1787753	Inhibition of GST-tagged p38beta by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@H](C)C(C)C)cn1		CHEMBL1784174		pKi			CHEMBL3961	Homo sapiens	pKi		
Not Determined	6230255	CHEMBL1787753	Inhibition of GST-tagged p38beta by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@@H](C)C(C)C)cn1		CHEMBL1784175		pKi			CHEMBL3961	Homo sapiens	pKi		
	6230261	CHEMBL1787753	Inhibition of GST-tagged p38beta by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	=	Ki	nM	25.12	CHEMBL3961	Homo sapiens	pKi		7.6
Not Determined	6230267	CHEMBL1787753	Inhibition of GST-tagged p38beta by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@H](C)C(C)(C)C)cn1		CHEMBL1784176		pKi			CHEMBL3961	Homo sapiens	pKi		
Not Determined	6230273	CHEMBL1787753	Inhibition of GST-tagged p38beta by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@@H](C)C(C)(C)C)cn1		CHEMBL1784177		pKi			CHEMBL3961	Homo sapiens	pKi		
	6261931	CHEMBL1798626	Inhibition of p38beta kinase	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(C)c1=O		CHEMBL1795685	=	Ki	nM	17.0	CHEMBL3961	Homo sapiens	Ki	uM	0.017
	6261932	CHEMBL1798626	Inhibition of p38beta kinase	B	CCc1c(OCc2ccc(F)cc2F)ncn(-c2cc(C(=O)NCCO)ccc2C)c1=O		CHEMBL1795686	=	Ki	nM	6.0	CHEMBL3961	Homo sapiens	Ki	uM	0.006
	6262786	CHEMBL1798626	Inhibition of p38beta kinase	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	=	IC50	nM	249.0	CHEMBL3961	Homo sapiens	IC50	uM	0.249
	6262789	CHEMBL1798626	Inhibition of p38beta kinase	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	Ki	nM	40.0	CHEMBL3961	Homo sapiens	Ki	nM	40.0
	6265564	CHEMBL1798273	Inhibition of p38 beta at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL3961	Homo sapiens	INH	%	65.0
	6265668	CHEMBL1798273	Inhibition of p38 beta at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL3961	Homo sapiens	INH	%	65.0
Active	6267545	CHEMBL1799045	Inhibition of p38beta at 10 uM	B	O=c1c(Cl)c(OCc2ccc(F)cc2F)cc(CO)n1-c1c(F)cccc1F		CHEMBL1797211		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
Active	6267546	CHEMBL1799045	Inhibition of p38beta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(C(N)=O)c1		CHEMBL1797224		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	6273830	CHEMBL1806005	Inhibition of P38beta MAPK assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	94.0	CHEMBL3961	Homo sapiens	Activity	%	94.0
	6299723	CHEMBL1811289	Inhibition of p38beta	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807446	=	IC50	nM	19.0	CHEMBL3961	Homo sapiens	IC50	nM	19.0
	6341101	CHEMBL1826673	Activity of p38-beta kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	6352251	CHEMBL1825899	Inhibition of p38beta MAPK assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	102.0	CHEMBL3961	Homo sapiens	Activity	%	102.0
	7567285	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7567744	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7568215	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7568241	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	97.0	CHEMBL3961	Homo sapiens	Kd	nM	97.0
	7568673	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7569258	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7569718	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7570211	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7570638	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7571234	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7571725	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7572188	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7572604	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7573215	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7573230	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	410.0	CHEMBL3961	Homo sapiens	Kd	nM	410.0
	7573706	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7574175	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7574583	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7575212	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7575683	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7576148	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7576556	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7576725	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7577184	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	760.0	CHEMBL3961	Homo sapiens	Kd	nM	760.0
	7577662	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1400.0	CHEMBL3961	Homo sapiens	Kd	nM	1400.0
	7578132	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7578537	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7578733	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7579107	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	7.2	CHEMBL3961	Homo sapiens	Kd	nM	7.2
	7579557	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7580031	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7580500	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7580903	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7581091	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7581476	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7581921	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7582392	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7583437	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	370.0	CHEMBL3961	Homo sapiens	Kd	nM	370.0
	7583834	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7584279	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7584770	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7585174	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	74.0	CHEMBL3961	Homo sapiens	Kd	nM	74.0
	7585767	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7586175	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7586621	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7586650	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7587104	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7587728	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7588147	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7588629	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7589080	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	70.0	CHEMBL3961	Homo sapiens	Kd	nM	70.0
	7589693	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7590142	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7590616	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7591067	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7591646	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7592118	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7592591	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7593044	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7593191	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	430.0	CHEMBL3961	Homo sapiens	Kd	nM	430.0
	7593626	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7594098	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7594571	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	36.0	CHEMBL3961	Homo sapiens	Kd	nM	36.0
	7595023	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	230.0	CHEMBL3961	Homo sapiens	Kd	nM	230.0
	7595159	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7595603	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7596077	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7596548	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7597131	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7597584	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7598057	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7598527	CHEMBL1908587	Binding constant for p38-beta kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL3961	Homo sapiens	Kd	nM	10000.0
	7939960	CHEMBL1919730	Inhibition of human SAPK2b	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	7961077	CHEMBL1931520	Inhibition of P38beta2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	=	IC50	nM	50.0	CHEMBL3961	Homo sapiens	IC50	uM	0.05
	7961078	CHEMBL1931520	Inhibition of P38beta2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	7.0	CHEMBL3961	Homo sapiens	IC50	uM	0.007
	7969768	CHEMBL1929687	Inhibition of p38beta MAPK assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	25.0	CHEMBL3961	Homo sapiens	Activity	%	25.0
	7982598	CHEMBL1936981	Inhibition of MAPK11 at 10 uM after 1 hr by competitive binding assay	B	CNC(=O)NC[C@H]1O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL1079596	=	Inhibition	%	37.0	CHEMBL3961	Homo sapiens	INH	%	37.0
Active	8010535	CHEMBL1942366	Inhibition of p38beta MAPK at 10 uM	B	CSC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc2ccc3nnc(C(C)C)n3c2)n(-c2cccc(O)c2)n1		CHEMBL1938741		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	8010640	CHEMBL1942371	Inhibition of p38beta MAPK	B	CC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc2ccc3nnc(-c4ccccc4SCCO)n3c2)n(-c2ccc(O)c(Cl)c2)n1		CHEMBL1938400	=	IC50	nM	23.0	CHEMBL3961	Homo sapiens	IC50	nM	23.0
	8020343	CHEMBL1948787	Binding affinity to P38beta at 10 uM relative to control	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(F)cccc3Cl)n21		CHEMBL1945723	=	Activity	%	0.0	CHEMBL3961	Homo sapiens	Activity	%	0.0
	8047146	CHEMBL1958975	Inhibition of p38-beta at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	8061311	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	13.55	CHEMBL3961	Homo sapiens	Inhibition	%	13.55
	8061488	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-2.27	CHEMBL3961	Homo sapiens	Inhibition	%	-2.27
	8061819	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	81.43	CHEMBL3961	Homo sapiens	Inhibition	%	81.43
	8062010	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.65	CHEMBL3961	Homo sapiens	Inhibition	%	3.65
	8062350	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.09	CHEMBL3961	Homo sapiens	Inhibition	%	3.09
	8062512	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	17.5	CHEMBL3961	Homo sapiens	Inhibition	%	17.5
	8062736	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	5.3	CHEMBL3961	Homo sapiens	Inhibition	%	5.3
	8062834	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.34	CHEMBL3961	Homo sapiens	Inhibition	%	2.34
	8063190	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	53.97	CHEMBL3961	Homo sapiens	Inhibition	%	53.97
	8063357	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.93	CHEMBL3961	Homo sapiens	Inhibition	%	2.93
	8063689	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	5.42	CHEMBL3961	Homo sapiens	Inhibition	%	5.42
	8063871	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.58	CHEMBL3961	Homo sapiens	Inhibition	%	5.58
	8064095	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	14.06	CHEMBL3961	Homo sapiens	Inhibition	%	14.06
	8064210	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	0.59	CHEMBL3961	Homo sapiens	Inhibition	%	0.59
	8064420	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	3.3	CHEMBL3961	Homo sapiens	Inhibition	%	3.3
	8064644	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	6.17	CHEMBL3961	Homo sapiens	Inhibition	%	6.17
	8064782	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.96	CHEMBL3961	Homo sapiens	Inhibition	%	1.96
	8064948	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	16.79	CHEMBL3961	Homo sapiens	Inhibition	%	16.79
	8065172	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.79	CHEMBL3961	Homo sapiens	Inhibition	%	2.79
	8065288	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	10.58	CHEMBL3961	Homo sapiens	Inhibition	%	10.58
	8065687	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	52.22	CHEMBL3961	Homo sapiens	Inhibition	%	52.22
	8065802	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.19	CHEMBL3961	Homo sapiens	Inhibition	%	1.19
	8066026	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.94	CHEMBL3961	Homo sapiens	Inhibition	%	1.94
	8066236	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.18	CHEMBL3961	Homo sapiens	Inhibition	%	2.18
	8066372	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	4.99	CHEMBL3961	Homo sapiens	Inhibition	%	4.99
	8066762	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	8.84	CHEMBL3961	Homo sapiens	Inhibition	%	8.84
	8066886	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	7.96	CHEMBL3961	Homo sapiens	Inhibition	%	7.96
	8067110	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	16.97	CHEMBL3961	Homo sapiens	Inhibition	%	16.97
	8067285	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	8.26	CHEMBL3961	Homo sapiens	Inhibition	%	8.26
	8067630	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	7.33	CHEMBL3961	Homo sapiens	Inhibition	%	7.33
	8067840	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.56	CHEMBL3961	Homo sapiens	Inhibition	%	1.56
	8067975	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.14	CHEMBL3961	Homo sapiens	Inhibition	%	2.14
	8068199	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	10.72	CHEMBL3961	Homo sapiens	Inhibition	%	10.72
	8068363	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.51	CHEMBL3961	Homo sapiens	Inhibition	%	1.51
	8068712	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.36	CHEMBL3961	Homo sapiens	Inhibition	%	1.36
	8068886	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	8.9	CHEMBL3961	Homo sapiens	Inhibition	%	8.9
	8069235	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	38.74	CHEMBL3961	Homo sapiens	Inhibition	%	38.74
	8069530	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	1.22	CHEMBL3961	Homo sapiens	Inhibition	%	1.22
	8069691	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	5.93	CHEMBL3961	Homo sapiens	Inhibition	%	5.93
	8070041	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.91	CHEMBL3961	Homo sapiens	Inhibition	%	-0.91
	8070213	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.87	CHEMBL3961	Homo sapiens	Inhibition	%	3.87
	8070437	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	7.24	CHEMBL3961	Homo sapiens	Inhibition	%	7.24
	8070562	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.06	CHEMBL3961	Homo sapiens	Inhibition	%	1.06
	8070860	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	9.37	CHEMBL3961	Homo sapiens	Inhibition	%	9.37
	8071017	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.77	CHEMBL3961	Homo sapiens	Inhibition	%	3.77
	8071241	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	7.2	CHEMBL3961	Homo sapiens	Inhibition	%	7.2
	8071367	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.93	CHEMBL3961	Homo sapiens	Inhibition	%	-0.93
	8071764	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.09	CHEMBL3961	Homo sapiens	Inhibition	%	3.09
	8071889	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	8.12	CHEMBL3961	Homo sapiens	Inhibition	%	8.12
	8072203	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.03	CHEMBL3961	Homo sapiens	Inhibition	%	1.03
	8072584	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.05	CHEMBL3961	Homo sapiens	Inhibition	%	3.05
	8072709	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.8	CHEMBL3961	Homo sapiens	Inhibition	%	0.8
	8072933	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-4.05	CHEMBL3961	Homo sapiens	Inhibition	%	-4.05
	8073100	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.71	CHEMBL3961	Homo sapiens	Inhibition	%	3.71
	8073225	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	7.18	CHEMBL3961	Homo sapiens	Inhibition	%	7.18
	8073449	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	51.45	CHEMBL3961	Homo sapiens	Inhibition	%	51.45
	8073568	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	3.1	CHEMBL3961	Homo sapiens	Inhibition	%	3.1
	8073801	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.94	CHEMBL3961	Homo sapiens	Inhibition	%	1.94
	8074025	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-2.47	CHEMBL3961	Homo sapiens	Inhibition	%	-2.47
	8074177	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	8.13	CHEMBL3961	Homo sapiens	Inhibition	%	8.13
	8074531	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.82	CHEMBL3961	Homo sapiens	Inhibition	%	1.82
	8074688	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.51	CHEMBL3961	Homo sapiens	Inhibition	%	3.51
	8075039	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.29	CHEMBL3961	Homo sapiens	Inhibition	%	-0.29
	8075150	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	6.52	CHEMBL3961	Homo sapiens	Inhibition	%	6.52
	8075374	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	3.21	CHEMBL3961	Homo sapiens	Inhibition	%	3.21
	8075611	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.28	CHEMBL3961	Homo sapiens	Inhibition	%	0.28
	8075752	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.66	CHEMBL3961	Homo sapiens	Inhibition	%	3.66
	8076118	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.35	CHEMBL3961	Homo sapiens	Inhibition	%	-0.35
	8076266	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	12.99	CHEMBL3961	Homo sapiens	Inhibition	%	12.99
	8076624	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.54	CHEMBL3961	Homo sapiens	Inhibition	%	0.54
	8076950	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	8.94	CHEMBL3961	Homo sapiens	Inhibition	%	8.94
	8077197	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-1.84	CHEMBL3961	Homo sapiens	Inhibition	%	-1.84
	8077325	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.6	CHEMBL3961	Homo sapiens	Inhibition	%	4.6
	8077549	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	5.2	CHEMBL3961	Homo sapiens	Inhibition	%	5.2
	8077700	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.3	CHEMBL3961	Homo sapiens	Inhibition	%	0.3
	8077843	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.65	CHEMBL3961	Homo sapiens	Inhibition	%	3.65
	8078067	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.87	CHEMBL3961	Homo sapiens	Inhibition	%	2.87
	8078206	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.5	CHEMBL3961	Homo sapiens	Inhibition	%	-1.5
	8078532	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	7.03	CHEMBL3961	Homo sapiens	Inhibition	%	7.03
	8078782	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	2.96	CHEMBL3961	Homo sapiens	Inhibition	%	2.96
	8079122	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	22.85	CHEMBL3961	Homo sapiens	Inhibition	%	22.85
	8079280	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.66	CHEMBL3961	Homo sapiens	Inhibition	%	-1.66
	8079646	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.66	CHEMBL3961	Homo sapiens	Inhibition	%	3.66
	8079785	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	6.83	CHEMBL3961	Homo sapiens	Inhibition	%	6.83
	8080114	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	33.11	CHEMBL3961	Homo sapiens	Inhibition	%	33.11
	8080366	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.49	CHEMBL3961	Homo sapiens	Inhibition	%	-0.49
	8080705	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.79	CHEMBL3961	Homo sapiens	Inhibition	%	2.79
	8080869	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.86	CHEMBL3961	Homo sapiens	Inhibition	%	1.86
	8081093	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	7.96	CHEMBL3961	Homo sapiens	Inhibition	%	7.96
	8081228	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	6.24	CHEMBL3961	Homo sapiens	Inhibition	%	6.24
	8081372	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	6.28	CHEMBL3961	Homo sapiens	Inhibition	%	6.28
	8081596	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	14.26	CHEMBL3961	Homo sapiens	Inhibition	%	14.26
	8081699	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.96	CHEMBL3961	Homo sapiens	Inhibition	%	1.96
	8081951	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	7.86	CHEMBL3961	Homo sapiens	Inhibition	%	7.86
	8082175	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.77	CHEMBL3961	Homo sapiens	Inhibition	%	-1.77
	8082288	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	7.38	CHEMBL3961	Homo sapiens	Inhibition	%	7.38
	8082685	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	49.21	CHEMBL3961	Homo sapiens	Inhibition	%	49.21
	8082808	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	10.74	CHEMBL3961	Homo sapiens	Inhibition	%	10.74
	8083188	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.07	CHEMBL3961	Homo sapiens	Inhibition	%	5.07
	8083287	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	4.99	CHEMBL3961	Homo sapiens	Inhibition	%	4.99
	8083511	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.35	CHEMBL3961	Homo sapiens	Inhibition	%	2.35
	8083765	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.28	CHEMBL3961	Homo sapiens	Inhibition	%	0.28
	8083875	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	5.11	CHEMBL3961	Homo sapiens	Inhibition	%	5.11
	8084099	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	30.63	CHEMBL3961	Homo sapiens	Inhibition	%	30.63
	8084284	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	7.81	CHEMBL3961	Homo sapiens	Inhibition	%	7.81
	8084402	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	48.22	CHEMBL3961	Homo sapiens	Inhibition	%	48.22
	8084626	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.35	CHEMBL3961	Homo sapiens	Inhibition	%	2.35
	8084787	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	9.47	CHEMBL3961	Homo sapiens	Inhibition	%	9.47
	8085109	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	10.07	CHEMBL3961	Homo sapiens	Inhibition	%	10.07
	8085365	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.2	CHEMBL3961	Homo sapiens	Inhibition	%	-3.2
	8085697	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	50.66	CHEMBL3961	Homo sapiens	Inhibition	%	50.66
	8085886	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	26.67	CHEMBL3961	Homo sapiens	Inhibition	%	26.67
	8086225	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	4.06	CHEMBL3961	Homo sapiens	Inhibition	%	4.06
	8086387	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	4.89	CHEMBL3961	Homo sapiens	Inhibition	%	4.89
	8086710	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.84	CHEMBL3961	Homo sapiens	Inhibition	%	2.84
	8086921	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.44	CHEMBL3961	Homo sapiens	Inhibition	%	2.44
	8087303	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	6.54	CHEMBL3961	Homo sapiens	Inhibition	%	6.54
	8087417	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.67	CHEMBL3961	Homo sapiens	Inhibition	%	3.67
	8087641	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.31	CHEMBL3961	Homo sapiens	Inhibition	%	4.31
	8087779	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	11.53	CHEMBL3961	Homo sapiens	Inhibition	%	11.53
	8088145	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.3	CHEMBL3961	Homo sapiens	Inhibition	%	5.3
	8088293	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.8	CHEMBL3961	Homo sapiens	Inhibition	%	1.8
	8088645	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.1	CHEMBL3961	Homo sapiens	Inhibition	%	3.1
	8088962	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.06	CHEMBL3961	Homo sapiens	Inhibition	%	4.06
	8089090	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.2	CHEMBL3961	Homo sapiens	Inhibition	%	0.2
	8089462	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.78	CHEMBL3961	Homo sapiens	Inhibition	%	0.78
	8089806	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	2.55	CHEMBL3961	Homo sapiens	Inhibition	%	2.55
	8089986	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	10.52	CHEMBL3961	Homo sapiens	Inhibition	%	10.52
	8090151	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.96	CHEMBL3961	Homo sapiens	Inhibition	%	2.96
	8090375	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.23	CHEMBL3961	Homo sapiens	Inhibition	%	3.23
	8090542	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.59	CHEMBL3961	Homo sapiens	Inhibition	%	1.59
	8090681	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.69	CHEMBL3961	Homo sapiens	Inhibition	%	2.69
	8090905	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	4.81	CHEMBL3961	Homo sapiens	Inhibition	%	4.81
	8091110	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.9	CHEMBL3961	Homo sapiens	Inhibition	%	2.9
	8091247	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	4.25	CHEMBL3961	Homo sapiens	Inhibition	%	4.25
	8091471	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.75	CHEMBL3961	Homo sapiens	Inhibition	%	2.75
	8091626	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	36.75	CHEMBL3961	Homo sapiens	Inhibition	%	36.75
	8091966	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	7.08	CHEMBL3961	Homo sapiens	Inhibition	%	7.08
	8092103	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	29.1	CHEMBL3961	Homo sapiens	Inhibition	%	29.1
	8092327	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	75.76	CHEMBL3961	Homo sapiens	Inhibition	%	75.76
	8092478	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.8	CHEMBL3961	Homo sapiens	Inhibition	%	1.8
	8092626	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.17	CHEMBL3961	Homo sapiens	Inhibition	%	0.17
	8092850	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.98	CHEMBL3961	Homo sapiens	Inhibition	%	-0.98
	8092979	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	2.35	CHEMBL3961	Homo sapiens	Inhibition	%	2.35
	8093291	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	22.66	CHEMBL3961	Homo sapiens	Inhibition	%	22.66
	8093431	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.06	CHEMBL3961	Homo sapiens	Inhibition	%	0.06
	8093655	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-1.91	CHEMBL3961	Homo sapiens	Inhibition	%	-1.91
	8093794	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	5.29	CHEMBL3961	Homo sapiens	Inhibition	%	5.29
	8094138	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	5.3	CHEMBL3961	Homo sapiens	Inhibition	%	5.3
	8094318	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.14	CHEMBL3961	Homo sapiens	Inhibition	%	3.14
	8094717	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.51	CHEMBL3961	Homo sapiens	Inhibition	%	1.51
	8094873	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.11	CHEMBL3961	Homo sapiens	Inhibition	%	2.11
	8095237	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	16.71	CHEMBL3961	Homo sapiens	Inhibition	%	16.71
	8095440	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.87	CHEMBL3961	Homo sapiens	Inhibition	%	4.87
	8095805	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	7.8	CHEMBL3961	Homo sapiens	Inhibition	%	7.8
	8095953	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.39	CHEMBL3961	Homo sapiens	Inhibition	%	1.39
	8096294	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.28	CHEMBL3961	Homo sapiens	Inhibition	%	5.28
	8096657	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.98	CHEMBL3961	Homo sapiens	Inhibition	%	1.98
	8096813	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.36	CHEMBL3961	Homo sapiens	Inhibition	%	3.36
	8097184	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.33	CHEMBL3961	Homo sapiens	Inhibition	%	-0.33
	8097271	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	4.3	CHEMBL3961	Homo sapiens	Inhibition	%	4.3
	8097491	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	68.68	CHEMBL3961	Homo sapiens	Inhibition	%	68.68
	8097865	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.34	CHEMBL3961	Homo sapiens	Inhibition	%	1.34
	8097998	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.94	CHEMBL3961	Homo sapiens	Inhibition	%	0.94
	8098222	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.18	CHEMBL3961	Homo sapiens	Inhibition	%	-1.18
	8098342	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.92	CHEMBL3961	Homo sapiens	Inhibition	%	1.92
	8098522	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.31	CHEMBL3961	Homo sapiens	Inhibition	%	3.31
	8098746	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.43	CHEMBL3961	Homo sapiens	Inhibition	%	1.43
	8098931	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	9.48	CHEMBL3961	Homo sapiens	Inhibition	%	9.48
	8099075	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.13	CHEMBL3961	Homo sapiens	Inhibition	%	1.13
	8099299	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	5.1	CHEMBL3961	Homo sapiens	Inhibition	%	5.1
	8099441	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	5.8	CHEMBL3961	Homo sapiens	Inhibition	%	5.8
	8099635	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	44.54	CHEMBL3961	Homo sapiens	Inhibition	%	44.54
	8099859	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	74.75	CHEMBL3961	Homo sapiens	Inhibition	%	74.75
	8100006	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.15	CHEMBL3961	Homo sapiens	Inhibition	%	1.15
	8100152	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.39	CHEMBL3961	Homo sapiens	Inhibition	%	1.39
	8100376	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.43	CHEMBL3961	Homo sapiens	Inhibition	%	0.43
	8100492	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	20.19	CHEMBL3961	Homo sapiens	Inhibition	%	20.19
	8100856	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	5.76	CHEMBL3961	Homo sapiens	Inhibition	%	5.76
	8101016	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	-0.28	CHEMBL3961	Homo sapiens	Inhibition	%	-0.28
	8101382	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	1.4	CHEMBL3961	Homo sapiens	Inhibition	%	1.4
	8101567	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.23	CHEMBL3961	Homo sapiens	Inhibition	%	2.23
	8101820	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	2.44	CHEMBL3961	Homo sapiens	Inhibition	%	2.44
	8102044	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	7.25	CHEMBL3961	Homo sapiens	Inhibition	%	7.25
	8102199	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.99	CHEMBL3961	Homo sapiens	Inhibition	%	-1.99
	8102554	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	3.74	CHEMBL3961	Homo sapiens	Inhibition	%	3.74
	8102674	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	4.36	CHEMBL3961	Homo sapiens	Inhibition	%	4.36
	8103076	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.27	CHEMBL3961	Homo sapiens	Inhibition	%	0.27
	8103272	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.41	CHEMBL3961	Homo sapiens	Inhibition	%	3.41
	8103634	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.85	CHEMBL3961	Homo sapiens	Inhibition	%	0.85
	8103784	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	4.79	CHEMBL3961	Homo sapiens	Inhibition	%	4.79
	8104193	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	3.94	CHEMBL3961	Homo sapiens	Inhibition	%	3.94
	8104341	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.42	CHEMBL3961	Homo sapiens	Inhibition	%	4.42
	8104711	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.84	CHEMBL3961	Homo sapiens	Inhibition	%	2.84
	8104825	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	7.7	CHEMBL3961	Homo sapiens	Inhibition	%	7.7
	8105049	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	15.03	CHEMBL3961	Homo sapiens	Inhibition	%	15.03
	8105189	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	8.68	CHEMBL3961	Homo sapiens	Inhibition	%	8.68
	8105355	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.04	CHEMBL3961	Homo sapiens	Inhibition	%	5.04
	8105579	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.89	CHEMBL3961	Homo sapiens	Inhibition	%	2.89
	8105717	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.04	CHEMBL3961	Homo sapiens	Inhibition	%	0.04
	8105997	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.27	CHEMBL3961	Homo sapiens	Inhibition	%	0.27
	8106386	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	5.1	CHEMBL3961	Homo sapiens	Inhibition	%	5.1
	8106542	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	3.32	CHEMBL3961	Homo sapiens	Inhibition	%	3.32
	8106895	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	4.45	CHEMBL3961	Homo sapiens	Inhibition	%	4.45
	8107016	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	5.07	CHEMBL3961	Homo sapiens	Inhibition	%	5.07
	8107240	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	3.29	CHEMBL3961	Homo sapiens	Inhibition	%	3.29
	8107412	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	4.23	CHEMBL3961	Homo sapiens	Inhibition	%	4.23
	8107613	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.89	CHEMBL3961	Homo sapiens	Inhibition	%	4.89
	8107972	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.67	CHEMBL3961	Homo sapiens	Inhibition	%	1.67
	8108130	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.76	CHEMBL3961	Homo sapiens	Inhibition	%	4.76
	8108354	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.92	CHEMBL3961	Homo sapiens	Inhibition	%	4.92
	8108529	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	8.82	CHEMBL3961	Homo sapiens	Inhibition	%	8.82
	8108676	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.71	CHEMBL3961	Homo sapiens	Inhibition	%	3.71
	8108900	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.93	CHEMBL3961	Homo sapiens	Inhibition	%	5.93
	8109042	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.78	CHEMBL3961	Homo sapiens	Inhibition	%	-0.78
	8109380	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	34.41	CHEMBL3961	Homo sapiens	Inhibition	%	34.41
	8109510	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	42.5	CHEMBL3961	Homo sapiens	Inhibition	%	42.5
	8109905	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.75	CHEMBL3961	Homo sapiens	Inhibition	%	3.75
	8110037	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.87	CHEMBL3961	Homo sapiens	Inhibition	%	2.87
	8110261	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.59	CHEMBL3961	Homo sapiens	Inhibition	%	5.59
	8110316	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.34	CHEMBL3961	Homo sapiens	Inhibition	%	1.34
	8110540	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.59	CHEMBL3961	Homo sapiens	Inhibition	%	4.59
	8110706	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	17.85	CHEMBL3961	Homo sapiens	Inhibition	%	17.85
	8110864	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.25	CHEMBL3961	Homo sapiens	Inhibition	%	-2.25
	8111088	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.63	CHEMBL3961	Homo sapiens	Inhibition	%	0.63
	8111211	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.54	CHEMBL3961	Homo sapiens	Inhibition	%	1.54
	8111562	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.96	CHEMBL3961	Homo sapiens	Inhibition	%	1.96
	8111728	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	4.66	CHEMBL3961	Homo sapiens	Inhibition	%	4.66
	8111933	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.23	CHEMBL3961	Homo sapiens	Inhibition	%	3.23
	8112157	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	6.62	CHEMBL3961	Homo sapiens	Inhibition	%	6.62
	8112294	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.51	CHEMBL3961	Homo sapiens	Inhibition	%	1.51
	8112686	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	21.81	CHEMBL3961	Homo sapiens	Inhibition	%	21.81
	8112858	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.25	CHEMBL3961	Homo sapiens	Inhibition	%	2.25
	8113234	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.05	CHEMBL3961	Homo sapiens	Inhibition	%	2.05
	8113370	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.75	CHEMBL3961	Homo sapiens	Inhibition	%	-0.75
	8113718	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	68.23	CHEMBL3961	Homo sapiens	Inhibition	%	68.23
	8113834	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	5.28	CHEMBL3961	Homo sapiens	Inhibition	%	5.28
	8114058	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	30.41	CHEMBL3961	Homo sapiens	Inhibition	%	30.41
	8114234	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.8	CHEMBL3961	Homo sapiens	Inhibition	%	1.8
	8114590	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.57	CHEMBL3961	Homo sapiens	Inhibition	%	4.57
	8114866	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	14.23	CHEMBL3961	Homo sapiens	Inhibition	%	14.23
	8115032	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	6.21	CHEMBL3961	Homo sapiens	Inhibition	%	6.21
	8115421	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.21	CHEMBL3961	Homo sapiens	Inhibition	%	0.21
	8115541	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	6.14	CHEMBL3961	Homo sapiens	Inhibition	%	6.14
	8115898	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.41	CHEMBL3961	Homo sapiens	Inhibition	%	1.41
	8116057	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	2.96	CHEMBL3961	Homo sapiens	Inhibition	%	2.96
	8116281	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	9.13	CHEMBL3961	Homo sapiens	Inhibition	%	9.13
	8116484	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.59	CHEMBL3961	Homo sapiens	Inhibition	%	1.59
	8116618	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.17	CHEMBL3961	Homo sapiens	Inhibition	%	0.17
	8116842	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.84	CHEMBL3961	Homo sapiens	Inhibition	%	-1.84
	8117014	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	62.26	CHEMBL3961	Homo sapiens	Inhibition	%	62.26
	8117185	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.9	CHEMBL3961	Homo sapiens	Inhibition	%	1.9
	8117567	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.15	CHEMBL3961	Homo sapiens	Inhibition	%	2.15
	8117697	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-1.17	CHEMBL3961	Homo sapiens	Inhibition	%	-1.17
	8117921	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.8	CHEMBL3961	Homo sapiens	Inhibition	%	0.8
	8118059	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	6.82	CHEMBL3961	Homo sapiens	Inhibition	%	6.82
	8118399	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.78	CHEMBL3961	Homo sapiens	Inhibition	%	4.78
	8118571	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.06	CHEMBL3961	Homo sapiens	Inhibition	%	5.06
	8118931	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	6.75	CHEMBL3961	Homo sapiens	Inhibition	%	6.75
	8119202	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.27	CHEMBL3961	Homo sapiens	Inhibition	%	3.27
	8119361	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	38.96	CHEMBL3961	Homo sapiens	Inhibition	%	38.96
	8119752	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.12	CHEMBL3961	Homo sapiens	Inhibition	%	3.12
	8119871	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.75	CHEMBL3961	Homo sapiens	Inhibition	%	2.75
	8120095	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	5.6	CHEMBL3961	Homo sapiens	Inhibition	%	5.6
	8120234	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.91	CHEMBL3961	Homo sapiens	Inhibition	%	1.91
	8120618	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.51	CHEMBL3961	Homo sapiens	Inhibition	%	1.51
	8120819	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	7.19	CHEMBL3961	Homo sapiens	Inhibition	%	7.19
	8121171	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	3.37	CHEMBL3961	Homo sapiens	Inhibition	%	3.37
	8121343	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.92	CHEMBL3961	Homo sapiens	Inhibition	%	0.92
	8121510	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.91	CHEMBL3961	Homo sapiens	Inhibition	%	1.91
	8121734	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	3.6	CHEMBL3961	Homo sapiens	Inhibition	%	3.6
	8121897	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.2	CHEMBL3961	Homo sapiens	Inhibition	%	1.2
	8122242	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	3.71	CHEMBL3961	Homo sapiens	Inhibition	%	3.71
	8122380	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	27.48	CHEMBL3961	Homo sapiens	Inhibition	%	27.48
	8122724	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.22	CHEMBL3961	Homo sapiens	Inhibition	%	4.22
	8122891	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	14.19	CHEMBL3961	Homo sapiens	Inhibition	%	14.19
	8123115	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	54.64	CHEMBL3961	Homo sapiens	Inhibition	%	54.64
	8123257	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.98	CHEMBL3961	Homo sapiens	Inhibition	%	3.98
	8123535	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.23	CHEMBL3961	Homo sapiens	Inhibition	%	3.23
	8123685	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.59	CHEMBL3961	Homo sapiens	Inhibition	%	3.59
	8123909	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	9.09	CHEMBL3961	Homo sapiens	Inhibition	%	9.09
	8124076	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	1.35	CHEMBL3961	Homo sapiens	Inhibition	%	1.35
	8124419	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.7	CHEMBL3961	Homo sapiens	Inhibition	%	4.7
	8124558	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	5.75	CHEMBL3961	Homo sapiens	Inhibition	%	5.75
	8124782	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.03	CHEMBL3961	Homo sapiens	Inhibition	%	3.03
	8124947	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	4.76	CHEMBL3961	Homo sapiens	Inhibition	%	4.76
	8125148	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	41.19	CHEMBL3961	Homo sapiens	Inhibition	%	41.19
	8125502	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.57	CHEMBL3961	Homo sapiens	Inhibition	%	0.57
	8125670	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	4.95	CHEMBL3961	Homo sapiens	Inhibition	%	4.95
	8126058	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.08	CHEMBL3961	Homo sapiens	Inhibition	%	0.08
	8126222	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.68	CHEMBL3961	Homo sapiens	Inhibition	%	4.68
	8126561	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	32.9	CHEMBL3961	Homo sapiens	Inhibition	%	32.9
	8126697	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	4.61	CHEMBL3961	Homo sapiens	Inhibition	%	4.61
	8126921	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	14.97	CHEMBL3961	Homo sapiens	Inhibition	%	14.97
	8127043	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	13.07	CHEMBL3961	Homo sapiens	Inhibition	%	13.07
	8127434	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.8	CHEMBL3961	Homo sapiens	Inhibition	%	4.8
	8127576	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	7.82	CHEMBL3961	Homo sapiens	Inhibition	%	7.82
	8127864	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.51	CHEMBL3961	Homo sapiens	Inhibition	%	0.51
	8128240	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.38	CHEMBL3961	Homo sapiens	Inhibition	%	3.38
	8128407	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.89	CHEMBL3961	Homo sapiens	Inhibition	%	0.89
	8128750	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	7.72	CHEMBL3961	Homo sapiens	Inhibition	%	7.72
	8129111	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.62	CHEMBL3961	Homo sapiens	Inhibition	%	1.62
	8129282	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.55	CHEMBL3961	Homo sapiens	Inhibition	%	-0.55
	8129471	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	76.81	CHEMBL3961	Homo sapiens	Inhibition	%	76.81
	8129695	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	3.2	CHEMBL3961	Homo sapiens	Inhibition	%	3.2
	8129834	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.39	CHEMBL3961	Homo sapiens	Inhibition	%	2.39
	8129995	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.94	CHEMBL3961	Homo sapiens	Inhibition	%	3.94
	8130219	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	6.08	CHEMBL3961	Homo sapiens	Inhibition	%	6.08
	8130391	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.51	CHEMBL3961	Homo sapiens	Inhibition	%	0.51
	8130551	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.23	CHEMBL3961	Homo sapiens	Inhibition	%	3.23
	8130775	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	4.99	CHEMBL3961	Homo sapiens	Inhibition	%	4.99
	8130891	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.92	CHEMBL3961	Homo sapiens	Inhibition	%	4.92
	8131254	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	26.42	CHEMBL3961	Homo sapiens	Inhibition	%	26.42
	8131374	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	54.38	CHEMBL3961	Homo sapiens	Inhibition	%	54.38
	8131598	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	5.66	CHEMBL3961	Homo sapiens	Inhibition	%	5.66
	8131765	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	7.52	CHEMBL3961	Homo sapiens	Inhibition	%	7.52
	8131906	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	9.18	CHEMBL3961	Homo sapiens	Inhibition	%	9.18
	8132130	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	40.98	CHEMBL3961	Homo sapiens	Inhibition	%	40.98
	8132192	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.42	CHEMBL3961	Homo sapiens	Inhibition	%	4.42
	8132416	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.56	CHEMBL3961	Homo sapiens	Inhibition	%	2.56
	8132563	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	8.48	CHEMBL3961	Homo sapiens	Inhibition	%	8.48
	8132731	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.14	CHEMBL3961	Homo sapiens	Inhibition	%	2.14
	8132955	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.01	CHEMBL3961	Homo sapiens	Inhibition	%	2.01
	8133076	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.06	CHEMBL3961	Homo sapiens	Inhibition	%	1.06
	8133438	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.75	CHEMBL3961	Homo sapiens	Inhibition	%	2.75
	8133610	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.57	CHEMBL3961	Homo sapiens	Inhibition	%	1.57
	8134014	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	3.23	CHEMBL3961	Homo sapiens	Inhibition	%	3.23
	8134162	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.4	CHEMBL3961	Homo sapiens	Inhibition	%	-1.4
	8134546	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	27.82	CHEMBL3961	Homo sapiens	Inhibition	%	27.82
	8134730	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.39	CHEMBL3961	Homo sapiens	Inhibition	%	-0.39
	8135114	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.45	CHEMBL3961	Homo sapiens	Inhibition	%	3.45
	8135229	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	15.47	CHEMBL3961	Homo sapiens	Inhibition	%	15.47
	8135453	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.3	CHEMBL3961	Homo sapiens	Inhibition	%	4.3
	8135594	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	71.09	CHEMBL3961	Homo sapiens	Inhibition	%	71.09
	8135939	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	33.1	CHEMBL3961	Homo sapiens	Inhibition	%	33.1
	8136107	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.68	CHEMBL3961	Homo sapiens	Inhibition	%	2.68
	8136475	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	51.66	CHEMBL3961	Homo sapiens	Inhibition	%	51.66
	8136765	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.98	CHEMBL3961	Homo sapiens	Inhibition	%	0.98
	8136900	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.46	CHEMBL3961	Homo sapiens	Inhibition	%	0.46
	8137287	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	4.76	CHEMBL3961	Homo sapiens	Inhibition	%	4.76
	8137407	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	6.53	CHEMBL3961	Homo sapiens	Inhibition	%	6.53
	8137631	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.94	CHEMBL3961	Homo sapiens	Inhibition	%	0.94
	8137779	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	4.66	CHEMBL3961	Homo sapiens	Inhibition	%	4.66
	8137945	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.63	CHEMBL3961	Homo sapiens	Inhibition	%	0.63
	8138169	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	2.26	CHEMBL3961	Homo sapiens	Inhibition	%	2.26
	8138348	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.78	CHEMBL3961	Homo sapiens	Inhibition	%	2.78
	8138496	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.96	CHEMBL3961	Homo sapiens	Inhibition	%	-0.96
	8138720	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	4.42	CHEMBL3961	Homo sapiens	Inhibition	%	4.42
	8138878	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	61.16	CHEMBL3961	Homo sapiens	Inhibition	%	61.16
	8139063	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	3.42	CHEMBL3961	Homo sapiens	Inhibition	%	3.42
	8139287	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.97	CHEMBL3961	Homo sapiens	Inhibition	%	1.97
	8139446	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.89	CHEMBL3961	Homo sapiens	Inhibition	%	1.89
	8139784	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	5.41	CHEMBL3961	Homo sapiens	Inhibition	%	5.41
	8139925	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.73	CHEMBL3961	Homo sapiens	Inhibition	%	7.73
	8140272	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.43	CHEMBL3961	Homo sapiens	Inhibition	%	4.43
	8140431	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.6	CHEMBL3961	Homo sapiens	Inhibition	%	2.6
	8140655	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.39	CHEMBL3961	Homo sapiens	Inhibition	%	1.39
	8140798	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	78.94	CHEMBL3961	Homo sapiens	Inhibition	%	78.94
	8141100	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.84	CHEMBL3961	Homo sapiens	Inhibition	%	2.84
	8141230	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.24	CHEMBL3961	Homo sapiens	Inhibition	%	0.24
	8141454	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.81	CHEMBL3961	Homo sapiens	Inhibition	%	1.81
	8141614	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	25.53	CHEMBL3961	Homo sapiens	Inhibition	%	25.53
	8141957	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	2.24	CHEMBL3961	Homo sapiens	Inhibition	%	2.24
	8142118	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	48.64	CHEMBL3961	Homo sapiens	Inhibition	%	48.64
	8142510	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	1.51	CHEMBL3961	Homo sapiens	Inhibition	%	1.51
	8142686	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.51	CHEMBL3961	Homo sapiens	Inhibition	%	1.51
	8143059	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	37.0	CHEMBL3961	Homo sapiens	Inhibition	%	37.0
	8143214	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	5.64	CHEMBL3961	Homo sapiens	Inhibition	%	5.64
	8143625	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.59	CHEMBL3961	Homo sapiens	Inhibition	%	4.59
	8143784	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	6.89	CHEMBL3961	Homo sapiens	Inhibition	%	6.89
	8144122	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	3.98	CHEMBL3961	Homo sapiens	Inhibition	%	3.98
	8144261	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.99	CHEMBL3961	Homo sapiens	Inhibition	%	6.99
	8144485	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	47.87	CHEMBL3961	Homo sapiens	Inhibition	%	47.87
	8144615	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	14.84	CHEMBL3961	Homo sapiens	Inhibition	%	14.84
	8144992	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.19	CHEMBL3961	Homo sapiens	Inhibition	%	3.19
	8145129	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.03	CHEMBL3961	Homo sapiens	Inhibition	%	6.03
	8145442	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.85	CHEMBL3961	Homo sapiens	Inhibition	%	1.85
	8145790	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.59	CHEMBL3961	Homo sapiens	Inhibition	%	1.59
	8145951	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.5	CHEMBL3961	Homo sapiens	Inhibition	%	1.5
	8146295	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	3.62	CHEMBL3961	Homo sapiens	Inhibition	%	3.62
	8146455	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	75.37	CHEMBL3961	Homo sapiens	Inhibition	%	75.37
	8146679	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.67	CHEMBL3961	Homo sapiens	Inhibition	%	2.67
	8146846	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	3.33	CHEMBL3961	Homo sapiens	Inhibition	%	3.33
	8147015	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.05	CHEMBL3961	Homo sapiens	Inhibition	%	2.05
	8147381	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.08	CHEMBL3961	Homo sapiens	Inhibition	%	3.08
	8147534	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	6.16	CHEMBL3961	Homo sapiens	Inhibition	%	6.16
	8147758	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	7.58	CHEMBL3961	Homo sapiens	Inhibition	%	7.58
	8147945	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.64	CHEMBL3961	Homo sapiens	Inhibition	%	2.64
	8148103	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	45.11	CHEMBL3961	Homo sapiens	Inhibition	%	45.11
	8148441	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	5.45	CHEMBL3961	Homo sapiens	Inhibition	%	5.45
	8148804	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	81.33	CHEMBL3961	Homo sapiens	Inhibition	%	81.33
	8148942	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.38	CHEMBL3961	Homo sapiens	Inhibition	%	4.38
	8149325	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.26	CHEMBL3961	Homo sapiens	Inhibition	%	1.26
	8149459	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.99	CHEMBL3961	Homo sapiens	Inhibition	%	6.99
	8149683	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.08	CHEMBL3961	Homo sapiens	Inhibition	%	4.08
	8149781	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.39	CHEMBL3961	Homo sapiens	Inhibition	%	1.39
	8150130	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	4.14	CHEMBL3961	Homo sapiens	Inhibition	%	4.14
	8150290	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	4.6	CHEMBL3961	Homo sapiens	Inhibition	%	4.6
	8150514	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.64	CHEMBL3961	Homo sapiens	Inhibition	%	1.64
	8150634	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	34.27	CHEMBL3961	Homo sapiens	Inhibition	%	34.27
	8151023	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	6.9	CHEMBL3961	Homo sapiens	Inhibition	%	6.9
	8151186	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	4.23	CHEMBL3961	Homo sapiens	Inhibition	%	4.23
	8151363	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	8.93	CHEMBL3961	Homo sapiens	Inhibition	%	8.93
	8151587	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	5.64	CHEMBL3961	Homo sapiens	Inhibition	%	5.64
	8151725	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.39	CHEMBL3961	Homo sapiens	Inhibition	%	3.39
	8152103	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	24.71	CHEMBL3961	Homo sapiens	Inhibition	%	24.71
	8152291	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	4.68	CHEMBL3961	Homo sapiens	Inhibition	%	4.68
	8152449	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.86	CHEMBL3961	Homo sapiens	Inhibition	%	5.86
	8152673	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.93	CHEMBL3961	Homo sapiens	Inhibition	%	5.93
	8152787	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.01	CHEMBL3961	Homo sapiens	Inhibition	%	3.01
	8153150	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.76	CHEMBL3961	Homo sapiens	Inhibition	%	7.76
	8153287	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	30.1	CHEMBL3961	Homo sapiens	Inhibition	%	30.1
	8153511	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.86	CHEMBL3961	Homo sapiens	Inhibition	%	5.86
	8153668	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.56	CHEMBL3961	Homo sapiens	Inhibition	%	0.56
	8154025	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.55	CHEMBL3961	Homo sapiens	Inhibition	%	3.55
	8154122	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.35	CHEMBL3961	Homo sapiens	Inhibition	%	2.35
	8154346	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.58	CHEMBL3961	Homo sapiens	Inhibition	%	3.58
	8154472	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	31.72	CHEMBL3961	Homo sapiens	Inhibition	%	31.72
	8154855	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.73	CHEMBL3961	Homo sapiens	Inhibition	%	1.73
	8154975	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	68.5	CHEMBL3961	Homo sapiens	Inhibition	%	68.5
	8155199	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	79.36	CHEMBL3961	Homo sapiens	Inhibition	%	79.36
	8155375	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	4.49	CHEMBL3961	Homo sapiens	Inhibition	%	4.49
	8155536	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	28.22	CHEMBL3961	Homo sapiens	Inhibition	%	28.22
	8155938	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	7.82	CHEMBL3961	Homo sapiens	Inhibition	%	7.82
	8156076	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	5.24	CHEMBL3961	Homo sapiens	Inhibition	%	5.24
	8156512	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.17	CHEMBL3961	Homo sapiens	Inhibition	%	1.17
	8156662	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.42	CHEMBL3961	Homo sapiens	Inhibition	%	3.42
	8157029	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	7.67	CHEMBL3961	Homo sapiens	Inhibition	%	7.67
	8157149	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	-0.15	CHEMBL3961	Homo sapiens	Inhibition	%	-0.15
	8157373	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	0.38	CHEMBL3961	Homo sapiens	Inhibition	%	0.38
	8157514	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.99	CHEMBL3961	Homo sapiens	Inhibition	%	3.99
	8157868	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.59	CHEMBL3961	Homo sapiens	Inhibition	%	3.59
	8158029	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.0	CHEMBL3961	Homo sapiens	Inhibition	%	1.0
	8158279	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	11.0	CHEMBL3961	Homo sapiens	Inhibition	%	11.0
	8158661	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	78.86	CHEMBL3961	Homo sapiens	Inhibition	%	78.86
	8158830	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.95	CHEMBL3961	Homo sapiens	Inhibition	%	3.95
	8159189	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.95	CHEMBL3961	Homo sapiens	Inhibition	%	5.95
	8159533	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.9	CHEMBL3961	Homo sapiens	Inhibition	%	1.9
	8159664	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	9.77	CHEMBL3961	Homo sapiens	Inhibition	%	9.77
	8160029	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.77	CHEMBL3961	Homo sapiens	Inhibition	%	2.77
	8160166	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.86	CHEMBL3961	Homo sapiens	Inhibition	%	1.86
	8160390	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	7.38	CHEMBL3961	Homo sapiens	Inhibition	%	7.38
	8160540	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	14.87	CHEMBL3961	Homo sapiens	Inhibition	%	14.87
	8160834	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	7.45	CHEMBL3961	Homo sapiens	Inhibition	%	7.45
	8160984	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.13	CHEMBL3961	Homo sapiens	Inhibition	%	4.13
	8161208	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	6.58	CHEMBL3961	Homo sapiens	Inhibition	%	6.58
	8161351	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	3.66	CHEMBL3961	Homo sapiens	Inhibition	%	3.66
	8161700	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.37	CHEMBL3961	Homo sapiens	Inhibition	%	2.37
	8161838	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	8.89	CHEMBL3961	Homo sapiens	Inhibition	%	8.89
	8162192	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.91	CHEMBL3961	Homo sapiens	Inhibition	%	5.91
	8162352	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	5.1	CHEMBL3961	Homo sapiens	Inhibition	%	5.1
	8162576	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	22.06	CHEMBL3961	Homo sapiens	Inhibition	%	22.06
	8162605	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.38	CHEMBL3961	Homo sapiens	Inhibition	%	3.38
	8162829	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	9.04	CHEMBL3961	Homo sapiens	Inhibition	%	9.04
	8162977	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	9.06	CHEMBL3961	Homo sapiens	Inhibition	%	9.06
	8163146	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	7.57	CHEMBL3961	Homo sapiens	Inhibition	%	7.57
	8163370	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.78	CHEMBL3961	Homo sapiens	Inhibition	%	0.78
	8163504	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.11	CHEMBL3961	Homo sapiens	Inhibition	%	5.11
	8163851	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.65	CHEMBL3961	Homo sapiens	Inhibition	%	0.65
	8163985	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	7.57	CHEMBL3961	Homo sapiens	Inhibition	%	7.57
	8164209	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	14.48	CHEMBL3961	Homo sapiens	Inhibition	%	14.48
	8164349	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	13.64	CHEMBL3961	Homo sapiens	Inhibition	%	13.64
	8164728	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	3.01	CHEMBL3961	Homo sapiens	Inhibition	%	3.01
	8164872	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	62.18	CHEMBL3961	Homo sapiens	Inhibition	%	62.18
	8165166	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.41	CHEMBL3961	Homo sapiens	Inhibition	%	4.41
	8165531	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.74	CHEMBL3961	Homo sapiens	Inhibition	%	2.74
	8165674	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	9.95	CHEMBL3961	Homo sapiens	Inhibition	%	9.95
	8166024	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.91	CHEMBL3961	Homo sapiens	Inhibition	%	0.91
	8166162	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.06	CHEMBL3961	Homo sapiens	Inhibition	%	1.06
	8166386	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	5.29	CHEMBL3961	Homo sapiens	Inhibition	%	5.29
	8166516	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	10.68	CHEMBL3961	Homo sapiens	Inhibition	%	10.68
	8166841	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	6.13	CHEMBL3961	Homo sapiens	Inhibition	%	6.13
	8167153	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.84	CHEMBL3961	Homo sapiens	Inhibition	%	0.84
	8167294	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	27.26	CHEMBL3961	Homo sapiens	Inhibition	%	27.26
	8167682	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.42	CHEMBL3961	Homo sapiens	Inhibition	%	4.42
	8167815	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	7.69	CHEMBL3961	Homo sapiens	Inhibition	%	7.69
	8168039	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	9.2	CHEMBL3961	Homo sapiens	Inhibition	%	9.2
	8168163	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.94	CHEMBL3961	Homo sapiens	Inhibition	%	2.94
	8168528	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	49.52	CHEMBL3961	Homo sapiens	Inhibition	%	49.52
	8168664	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	55.73	CHEMBL3961	Homo sapiens	Inhibition	%	55.73
	8169052	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	13.97	CHEMBL3961	Homo sapiens	Inhibition	%	13.97
	8169194	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.53	CHEMBL3961	Homo sapiens	Inhibition	%	1.53
	8169418	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	0.3	CHEMBL3961	Homo sapiens	Inhibition	%	0.3
	8169498	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.4	CHEMBL3961	Homo sapiens	Inhibition	%	4.4
	8169856	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	5.93	CHEMBL3961	Homo sapiens	Inhibition	%	5.93
	8170001	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.21	CHEMBL3961	Homo sapiens	Inhibition	%	0.21
	8170225	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	8.68	CHEMBL3961	Homo sapiens	Inhibition	%	8.68
	8170350	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.05	CHEMBL3961	Homo sapiens	Inhibition	%	1.05
	8170714	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	3.7	CHEMBL3961	Homo sapiens	Inhibition	%	3.7
	8170849	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	47.74	CHEMBL3961	Homo sapiens	Inhibition	%	47.74
	8171270	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.04	CHEMBL3961	Homo sapiens	Inhibition	%	2.04
	8171487	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.06	CHEMBL3961	Homo sapiens	Inhibition	%	1.06
	8171628	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	5.19	CHEMBL3961	Homo sapiens	Inhibition	%	5.19
	8171852	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	8.81	CHEMBL3961	Homo sapiens	Inhibition	%	8.81
	8172005	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.19	CHEMBL3961	Homo sapiens	Inhibition	%	3.19
	8172361	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	5.12	CHEMBL3961	Homo sapiens	Inhibition	%	5.12
	8172489	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.88	CHEMBL3961	Homo sapiens	Inhibition	%	3.88
	8172855	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	68.69	CHEMBL3961	Homo sapiens	Inhibition	%	68.69
	8172991	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.5	CHEMBL3961	Homo sapiens	Inhibition	%	1.5
	8173215	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	5.3	CHEMBL3961	Homo sapiens	Inhibition	%	5.3
	8173380	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.02	CHEMBL3961	Homo sapiens	Inhibition	%	4.02
	8173745	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.48	CHEMBL3961	Homo sapiens	Inhibition	%	1.48
	8173832	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.37	CHEMBL3961	Homo sapiens	Inhibition	%	3.37
	8174056	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	6.34	CHEMBL3961	Homo sapiens	Inhibition	%	6.34
	8174188	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	0.99	CHEMBL3961	Homo sapiens	Inhibition	%	0.99
	8174560	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.37	CHEMBL3961	Homo sapiens	Inhibition	%	2.37
	8174682	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.3	CHEMBL3961	Homo sapiens	Inhibition	%	1.3
	8174906	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.81	CHEMBL3961	Homo sapiens	Inhibition	%	4.81
	8175049	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.04	CHEMBL3961	Homo sapiens	Inhibition	%	4.04
	8175185	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.54	CHEMBL3961	Homo sapiens	Inhibition	%	2.54
	8175409	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	5.44	CHEMBL3961	Homo sapiens	Inhibition	%	5.44
	8175665	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	8.05	CHEMBL3961	Homo sapiens	Inhibition	%	8.05
	8175828	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.77	CHEMBL3961	Homo sapiens	Inhibition	%	3.77
	8176205	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	5.07	CHEMBL3961	Homo sapiens	Inhibition	%	5.07
	8176354	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	Inhibition	%	0.0
	8176710	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	9.63	CHEMBL3961	Homo sapiens	Inhibition	%	9.63
	8176840	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.39	CHEMBL3961	Homo sapiens	Inhibition	%	1.39
	8177064	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	9.38	CHEMBL3961	Homo sapiens	Inhibition	%	9.38
	8177206	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.52	CHEMBL3961	Homo sapiens	Inhibition	%	3.52
	8177568	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	3.15	CHEMBL3961	Homo sapiens	Inhibition	%	3.15
	8177732	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	10.85	CHEMBL3961	Homo sapiens	Inhibition	%	10.85
	8178096	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.36	CHEMBL3961	Homo sapiens	Inhibition	%	1.36
	8178408	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.51	CHEMBL3961	Homo sapiens	Inhibition	%	0.51
	8178535	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.92	CHEMBL3961	Homo sapiens	Inhibition	%	3.92
	8178759	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.13	CHEMBL3961	Homo sapiens	Inhibition	%	4.13
	8178908	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	7.97	CHEMBL3961	Homo sapiens	Inhibition	%	7.97
	8179255	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	-1.11	CHEMBL3961	Homo sapiens	Inhibition	%	-1.11
	8179399	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.53	CHEMBL3961	Homo sapiens	Inhibition	%	4.53
	8179760	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.78	CHEMBL3961	Homo sapiens	Inhibition	%	0.78
	8180017	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.95	CHEMBL3961	Homo sapiens	Inhibition	%	5.95
	8180171	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	25.12	CHEMBL3961	Homo sapiens	Inhibition	%	25.12
	8180395	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.23	CHEMBL3961	Homo sapiens	Inhibition	%	0.23
	8180551	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	10.97	CHEMBL3961	Homo sapiens	Inhibition	%	10.97
	8180699	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.4	CHEMBL3961	Homo sapiens	Inhibition	%	1.4
	8180923	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.72	CHEMBL3961	Homo sapiens	Inhibition	%	0.72
	8181056	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	9.0	CHEMBL3961	Homo sapiens	Inhibition	%	9.0
	8181411	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.67	CHEMBL3961	Homo sapiens	Inhibition	%	1.67
	8181551	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.01	CHEMBL3961	Homo sapiens	Inhibition	%	3.01
	8181775	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.66	CHEMBL3961	Homo sapiens	Inhibition	%	4.66
	8181914	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	7.66	CHEMBL3961	Homo sapiens	Inhibition	%	7.66
	8182077	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	7.76	CHEMBL3961	Homo sapiens	Inhibition	%	7.76
	8182301	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	33.1	CHEMBL3961	Homo sapiens	Inhibition	%	33.1
	8182441	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.28	CHEMBL3961	Homo sapiens	Inhibition	%	1.28
	8182757	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.53	CHEMBL3961	Homo sapiens	Inhibition	%	1.53
	8183103	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	6.02	CHEMBL3961	Homo sapiens	Inhibition	%	6.02
	8183252	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.06	CHEMBL3961	Homo sapiens	Inhibition	%	1.06
	8183605	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	3.8	CHEMBL3961	Homo sapiens	Inhibition	%	3.8
	8183747	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	9.75	CHEMBL3961	Homo sapiens	Inhibition	%	9.75
	8183971	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.71	CHEMBL3961	Homo sapiens	Inhibition	%	3.71
	8184107	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.65	CHEMBL3961	Homo sapiens	Inhibition	%	0.65
	8184373	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.33	CHEMBL3961	Homo sapiens	Inhibition	%	5.33
	8184744	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.16	CHEMBL3961	Homo sapiens	Inhibition	%	-0.16
	8184901	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	48.61	CHEMBL3961	Homo sapiens	Inhibition	%	48.61
	8185274	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.26	CHEMBL3961	Homo sapiens	Inhibition	%	1.26
	8185405	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	34.16	CHEMBL3961	Homo sapiens	Inhibition	%	34.16
	8185629	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.69	CHEMBL3961	Homo sapiens	Inhibition	%	4.69
	8185760	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	7.87	CHEMBL3961	Homo sapiens	Inhibition	%	7.87
	8186123	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	6.34	CHEMBL3961	Homo sapiens	Inhibition	%	6.34
	8186264	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	11.93	CHEMBL3961	Homo sapiens	Inhibition	%	11.93
	8186652	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.81	CHEMBL3961	Homo sapiens	Inhibition	%	4.81
	8186791	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.29	CHEMBL3961	Homo sapiens	Inhibition	%	3.29
	8187113	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.52	CHEMBL3961	Homo sapiens	Inhibition	%	0.52
	8187461	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	0.17	CHEMBL3961	Homo sapiens	Inhibition	%	0.17
	8187609	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	5.17	CHEMBL3961	Homo sapiens	Inhibition	%	5.17
	8187833	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	4.41	CHEMBL3961	Homo sapiens	Inhibition	%	4.41
	8187962	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	36.75	CHEMBL3961	Homo sapiens	Inhibition	%	36.75
	8188329	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	5.91	CHEMBL3961	Homo sapiens	Inhibition	%	5.91
	8188464	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.81	CHEMBL3961	Homo sapiens	Inhibition	%	0.81
	8188738	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.78	CHEMBL3961	Homo sapiens	Inhibition	%	7.78
	8189110	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.99	CHEMBL3961	Homo sapiens	Inhibition	%	0.99
	8189266	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	78.7	CHEMBL3961	Homo sapiens	Inhibition	%	78.7
	8189490	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	6.33	CHEMBL3961	Homo sapiens	Inhibition	%	6.33
	8189639	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.84	CHEMBL3961	Homo sapiens	Inhibition	%	-0.84
	8189995	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	7.25	CHEMBL3961	Homo sapiens	Inhibition	%	7.25
	8190127	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.59	CHEMBL3961	Homo sapiens	Inhibition	%	5.59
	8190491	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.98	CHEMBL3961	Homo sapiens	Inhibition	%	6.98
	8190628	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	50.85	CHEMBL3961	Homo sapiens	Inhibition	%	50.85
	8190852	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	12.94	CHEMBL3961	Homo sapiens	Inhibition	%	12.94
	8191016	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	8.67	CHEMBL3961	Homo sapiens	Inhibition	%	8.67
	8191154	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.16	CHEMBL3961	Homo sapiens	Inhibition	%	2.16
	8191378	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.52	CHEMBL3961	Homo sapiens	Inhibition	%	2.52
	8191474	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.8	CHEMBL3961	Homo sapiens	Inhibition	%	0.8
	8191698	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.24	CHEMBL3961	Homo sapiens	Inhibition	%	0.24
	8191820	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.04	CHEMBL3961	Homo sapiens	Inhibition	%	5.04
	8192193	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	4.99	CHEMBL3961	Homo sapiens	Inhibition	%	4.99
	8192322	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	10.1	CHEMBL3961	Homo sapiens	Inhibition	%	10.1
	8192690	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.82	CHEMBL3961	Homo sapiens	Inhibition	%	4.82
	8192826	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.99	CHEMBL3961	Homo sapiens	Inhibition	%	1.99
	8193050	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.59	CHEMBL3961	Homo sapiens	Inhibition	%	-0.59
	8193098	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	9.04	CHEMBL3961	Homo sapiens	Inhibition	%	9.04
	8193322	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.26	CHEMBL3961	Homo sapiens	Inhibition	%	2.26
	8193467	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	2.61	CHEMBL3961	Homo sapiens	Inhibition	%	2.61
	8193848	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	9.54	CHEMBL3961	Homo sapiens	Inhibition	%	9.54
	8193997	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.58	CHEMBL3961	Homo sapiens	Inhibition	%	0.58
	8194352	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.38	CHEMBL3961	Homo sapiens	Inhibition	%	6.38
	8194483	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.73	CHEMBL3961	Homo sapiens	Inhibition	%	5.73
	8194707	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.07	CHEMBL3961	Homo sapiens	Inhibition	%	5.07
	8194850	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	14.78	CHEMBL3961	Homo sapiens	Inhibition	%	14.78
	8195207	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	52.52	CHEMBL3961	Homo sapiens	Inhibition	%	52.52
	8195371	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.71	CHEMBL3961	Homo sapiens	Inhibition	%	1.71
	8195734	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.13	CHEMBL3961	Homo sapiens	Inhibition	%	4.13
	8196056	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.12	CHEMBL3961	Homo sapiens	Inhibition	%	2.12
	8196173	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.73	CHEMBL3961	Homo sapiens	Inhibition	%	2.73
	8196547	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	34.13	CHEMBL3961	Homo sapiens	Inhibition	%	34.13
	8196675	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	46.27	CHEMBL3961	Homo sapiens	Inhibition	%	46.27
	8196899	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	3.88	CHEMBL3961	Homo sapiens	Inhibition	%	3.88
	8197040	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	7.21	CHEMBL3961	Homo sapiens	Inhibition	%	7.21
	8197401	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.71	CHEMBL3961	Homo sapiens	Inhibition	%	1.71
	8197676	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.45	CHEMBL3961	Homo sapiens	Inhibition	%	5.45
	8197816	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.39	CHEMBL3961	Homo sapiens	Inhibition	%	1.39
	8198197	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	8.81	CHEMBL3961	Homo sapiens	Inhibition	%	8.81
	8198335	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.54	CHEMBL3961	Homo sapiens	Inhibition	%	2.54
	8198559	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.12	CHEMBL3961	Homo sapiens	Inhibition	%	5.12
	8198689	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	17.35	CHEMBL3961	Homo sapiens	Inhibition	%	17.35
	8199044	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.84	CHEMBL3961	Homo sapiens	Inhibition	%	4.84
	8199192	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	1.34	CHEMBL3961	Homo sapiens	Inhibition	%	1.34
	8199550	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.77	CHEMBL3961	Homo sapiens	Inhibition	%	3.77
	8199713	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.75	CHEMBL3961	Homo sapiens	Inhibition	%	3.75
	8199937	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.86	CHEMBL3961	Homo sapiens	Inhibition	%	1.86
	8200075	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.4	CHEMBL3961	Homo sapiens	Inhibition	%	4.4
	8200403	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	13.1	CHEMBL3961	Homo sapiens	Inhibition	%	13.1
	8200518	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.79	CHEMBL3961	Homo sapiens	Inhibition	%	2.79
	8200742	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.13	CHEMBL3961	Homo sapiens	Inhibition	%	4.13
	8200892	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	73.31	CHEMBL3961	Homo sapiens	Inhibition	%	73.31
	8201246	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	5.4	CHEMBL3961	Homo sapiens	Inhibition	%	5.4
	8201381	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.71	CHEMBL3961	Homo sapiens	Inhibition	%	2.71
	8201738	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.91	CHEMBL3961	Homo sapiens	Inhibition	%	-1.91
	8202017	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.77	CHEMBL3961	Homo sapiens	Inhibition	%	3.77
	8202157	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	4.07	CHEMBL3961	Homo sapiens	Inhibition	%	4.07
	8202381	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-2.08	CHEMBL3961	Homo sapiens	Inhibition	%	-2.08
	8202548	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	13.09	CHEMBL3961	Homo sapiens	Inhibition	%	13.09
	8202897	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	12.54	CHEMBL3961	Homo sapiens	Inhibition	%	12.54
	8203027	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	5.95	CHEMBL3961	Homo sapiens	Inhibition	%	5.95
	8203382	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	7.06	CHEMBL3961	Homo sapiens	Inhibition	%	7.06
	8203528	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1	Outside typical range	CHEMBL531804	=	Inhibition	%	-17.88	CHEMBL3961	Homo sapiens	Inhibition	%	-17.88
	8203752	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.39	CHEMBL3961	Homo sapiens	Inhibition	%	2.39
	8203886	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	8.28	CHEMBL3961	Homo sapiens	Inhibition	%	8.28
	8204276	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	5.95	CHEMBL3961	Homo sapiens	Inhibition	%	5.95
	8204413	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.81	CHEMBL3961	Homo sapiens	Inhibition	%	4.81
	8204742	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	58.75	CHEMBL3961	Homo sapiens	Inhibition	%	58.75
	8205081	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.56	CHEMBL3961	Homo sapiens	Inhibition	%	4.56
	8205230	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.09	CHEMBL3961	Homo sapiens	Inhibition	%	3.09
	8205590	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.87	CHEMBL3961	Homo sapiens	Inhibition	%	3.87
	8205729	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	6.57	CHEMBL3961	Homo sapiens	Inhibition	%	6.57
	8205953	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	17.17	CHEMBL3961	Homo sapiens	Inhibition	%	17.17
	8206085	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	9.09	CHEMBL3961	Homo sapiens	Inhibition	%	9.09
	8206361	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	8.93	CHEMBL3961	Homo sapiens	Inhibition	%	8.93
	8206728	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.83	CHEMBL3961	Homo sapiens	Inhibition	%	2.83
	8206908	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.87	CHEMBL3961	Homo sapiens	Inhibition	%	3.87
	8207258	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.89	CHEMBL3961	Homo sapiens	Inhibition	%	5.89
	8207388	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.14	CHEMBL3961	Homo sapiens	Inhibition	%	6.14
	8207612	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	11.05	CHEMBL3961	Homo sapiens	Inhibition	%	11.05
	8207744	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	16.03	CHEMBL3961	Homo sapiens	Inhibition	%	16.03
	8208113	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	4.06	CHEMBL3961	Homo sapiens	Inhibition	%	4.06
	8208245	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.7	CHEMBL3961	Homo sapiens	Inhibition	%	4.7
	8208469	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	14.09	CHEMBL3961	Homo sapiens	Inhibition	%	14.09
	8208635	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	-1.05	CHEMBL3961	Homo sapiens	Inhibition	%	-1.05
	8208768	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	9.25	CHEMBL3961	Homo sapiens	Inhibition	%	9.25
	8208992	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.95	CHEMBL3961	Homo sapiens	Inhibition	%	3.95
	8209097	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.03	CHEMBL3961	Homo sapiens	Inhibition	%	0.03
	8209437	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.28	CHEMBL3961	Homo sapiens	Inhibition	%	1.28
	8209587	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	13.07	CHEMBL3961	Homo sapiens	Inhibition	%	13.07
	8209811	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.34	CHEMBL3961	Homo sapiens	Inhibition	%	2.34
	8209947	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	7.56	CHEMBL3961	Homo sapiens	Inhibition	%	7.56
	8210312	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	60.75	CHEMBL3961	Homo sapiens	Inhibition	%	60.75
	8210448	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.99	CHEMBL3961	Homo sapiens	Inhibition	%	-1.99
	8210707	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	6.73	CHEMBL3961	Homo sapiens	Inhibition	%	6.73
	8210931	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	27.73	CHEMBL3961	Homo sapiens	Inhibition	%	27.73
	8211075	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	6.02	CHEMBL3961	Homo sapiens	Inhibition	%	6.02
	8211245	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	8.3	CHEMBL3961	Homo sapiens	Inhibition	%	8.3
	8211469	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.16	CHEMBL3961	Homo sapiens	Inhibition	%	3.16
	8211592	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	19.09	CHEMBL3961	Homo sapiens	Inhibition	%	19.09
	8211945	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	38.76	CHEMBL3961	Homo sapiens	Inhibition	%	38.76
	8212077	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.17	CHEMBL3961	Homo sapiens	Inhibition	%	3.17
	8212301	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.6	CHEMBL3961	Homo sapiens	Inhibition	%	5.6
	8212442	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.42	CHEMBL3961	Homo sapiens	Inhibition	%	3.42
	8212799	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.66	CHEMBL3961	Homo sapiens	Inhibition	%	3.66
	8212969	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.44	CHEMBL3961	Homo sapiens	Inhibition	%	2.44
	8213322	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	6.89	CHEMBL3961	Homo sapiens	Inhibition	%	6.89
	8213426	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	4.77	CHEMBL3961	Homo sapiens	Inhibition	%	4.77
	8213650	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.36	CHEMBL3961	Homo sapiens	Inhibition	%	-1.36
	8213763	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.29	CHEMBL3961	Homo sapiens	Inhibition	%	3.29
	8214134	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-1.13	CHEMBL3961	Homo sapiens	Inhibition	%	-1.13
	8214271	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.71	CHEMBL3961	Homo sapiens	Inhibition	%	3.71
	8214495	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.9	CHEMBL3961	Homo sapiens	Inhibition	%	4.9
	8214629	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	3.7	CHEMBL3961	Homo sapiens	Inhibition	%	3.7
	8214781	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	3.07	CHEMBL3961	Homo sapiens	Inhibition	%	3.07
	8215005	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.65	CHEMBL3961	Homo sapiens	Inhibition	%	-0.65
	8215256	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	6.8	CHEMBL3961	Homo sapiens	Inhibition	%	6.8
	8215409	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	8.21	CHEMBL3961	Homo sapiens	Inhibition	%	8.21
	8215797	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.47	CHEMBL3961	Homo sapiens	Inhibition	%	5.47
	8215916	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.89	CHEMBL3961	Homo sapiens	Inhibition	%	4.89
	8216259	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.71	CHEMBL3961	Homo sapiens	Inhibition	%	2.71
	8216619	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	4.9	CHEMBL3961	Homo sapiens	Inhibition	%	4.9
	8216757	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	7.25	CHEMBL3961	Homo sapiens	Inhibition	%	7.25
	8217115	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	7.35	CHEMBL3961	Homo sapiens	Inhibition	%	7.35
	8217289	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.05	CHEMBL3961	Homo sapiens	Inhibition	%	-0.05
	8217644	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.79	CHEMBL3961	Homo sapiens	Inhibition	%	2.79
	8217969	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.39	CHEMBL3961	Homo sapiens	Inhibition	%	-1.39
	8218084	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.37	CHEMBL3961	Homo sapiens	Inhibition	%	2.37
	8218308	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	6.69	CHEMBL3961	Homo sapiens	Inhibition	%	6.69
	8218435	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	0.2	CHEMBL3961	Homo sapiens	Inhibition	%	0.2
	8218802	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	5.32	CHEMBL3961	Homo sapiens	Inhibition	%	5.32
	8218933	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	17.68	CHEMBL3961	Homo sapiens	Inhibition	%	17.68
	8219317	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	5.15	CHEMBL3961	Homo sapiens	Inhibition	%	5.15
	8219567	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	20.19	CHEMBL3961	Homo sapiens	Inhibition	%	20.19
	8219728	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.69	CHEMBL3961	Homo sapiens	Inhibition	%	4.69
	8219952	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	7.25	CHEMBL3961	Homo sapiens	Inhibition	%	7.25
	8220121	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.32	CHEMBL3961	Homo sapiens	Inhibition	%	5.32
	8220250	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	6.16	CHEMBL3961	Homo sapiens	Inhibition	%	6.16
	8220474	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.75	CHEMBL3961	Homo sapiens	Inhibition	%	5.75
	8220588	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.44	CHEMBL3961	Homo sapiens	Inhibition	%	5.44
	8220950	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.91	CHEMBL3961	Homo sapiens	Inhibition	%	5.91
	8221086	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.62	CHEMBL3961	Homo sapiens	Inhibition	%	1.62
	8221310	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.76	CHEMBL3961	Homo sapiens	Inhibition	%	0.76
	8221443	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.15	CHEMBL3961	Homo sapiens	Inhibition	%	3.15
	8221608	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	4.25	CHEMBL3961	Homo sapiens	Inhibition	%	4.25
	8221832	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	13.87	CHEMBL3961	Homo sapiens	Inhibition	%	13.87
	8221963	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	6.97	CHEMBL3961	Homo sapiens	Inhibition	%	6.97
	8222285	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.95	CHEMBL3961	Homo sapiens	Inhibition	%	3.95
	8222643	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	6.06	CHEMBL3961	Homo sapiens	Inhibition	%	6.06
	8222761	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	3.19	CHEMBL3961	Homo sapiens	Inhibition	%	3.19
	8223129	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	37.76	CHEMBL3961	Homo sapiens	Inhibition	%	37.76
	8223258	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	5.44	CHEMBL3961	Homo sapiens	Inhibition	%	5.44
	8223482	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	32.54	CHEMBL3961	Homo sapiens	Inhibition	%	32.54
	8223643	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.44	CHEMBL3961	Homo sapiens	Inhibition	%	2.44
	8223893	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.54	CHEMBL3961	Homo sapiens	Inhibition	%	2.54
	8224279	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	40.91	CHEMBL3961	Homo sapiens	Inhibition	%	40.91
	8224449	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.6	CHEMBL3961	Homo sapiens	Inhibition	%	4.6
	8224808	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.81	CHEMBL3961	Homo sapiens	Inhibition	%	5.81
	8224922	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.37	CHEMBL3961	Homo sapiens	Inhibition	%	1.37
	8225146	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.31	CHEMBL3961	Homo sapiens	Inhibition	%	2.31
	8225280	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	7.39	CHEMBL3961	Homo sapiens	Inhibition	%	7.39
	8225642	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.27	CHEMBL3961	Homo sapiens	Inhibition	%	0.27
	8225777	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.38	CHEMBL3961	Homo sapiens	Inhibition	%	5.38
	8226159	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	59.46	CHEMBL3961	Homo sapiens	Inhibition	%	59.46
	8226284	CHEMBL1962060	GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	0.46	CHEMBL3961	Homo sapiens	Inhibition	%	0.46
	8226508	CHEMBL1962061	GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.43	CHEMBL3961	Homo sapiens	Inhibition	%	4.43
	10839429	CHEMBL2015414	Inhibition of p38beta at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	5.0	CHEMBL3961	Homo sapiens	INH	%	5.0
	10839580	CHEMBL2015174	Inhibition of p38beta MAPK assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	92.0	CHEMBL3961	Homo sapiens	Activity	%	92.0
	10840390	CHEMBL2016306	Inhibition of p38beta MAPK assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	10867377	CHEMBL2027478	Inhibition of p38beta kinase	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	430.0	CHEMBL3961	Homo sapiens	IC50	uM	0.43
	10867383	CHEMBL2027261	Inhibition of p38beta using KRELVEPLTPSGEAPNQALLR as substrate for 10 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Ki	nM	220.0	CHEMBL3961	Homo sapiens	Ki	nM	220.0
Not Active	10867384	CHEMBL2027263	Inhibition of p38beta kinase using KRELVEPLTPSGEAPNQALLR as substrate at 100 uM by spectrophotometric enzyme-coupled assay	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	10867536	CHEMBL2027426	Inhibition of p38beta at 2 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Inhibition	%	84.0	CHEMBL3961	Homo sapiens	INH	%	84.0
	10926150	CHEMBL2046224	Inhibition of human SAPK2b assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	-3.0	CHEMBL3961	Homo sapiens	Activity	%	-3.0
	10926151	CHEMBL2046224	Inhibition of human SAPK2b assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	9.0	CHEMBL3961	Homo sapiens	Activity	%	9.0
	10962867	CHEMBL2060381	Inhibition of SAPk2 assessed as remaining enzyme activity at 10 uM	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	Activity	%	0.0	CHEMBL3961	Homo sapiens	Activity	%	0.0
Not Active	10986940	CHEMBL2072244	Inhibition of SAPK2b at 10 uM	B	NS(=O)(=O)c1cc(-c2nc3ccccc3s2)cs1		CHEMBL2069711		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	10995987	CHEMBL2073530	Inhibition of MAPK p38beta	B	NC(=O)c1ccc(Oc2ccc(/C=C3\SC(=S)N(c4ccc(OCCCN5CCCC5)cc4)C3=O)cc2)cc1		CHEMBL2070416	>	IC50	nM	30000.0	CHEMBL3961	Homo sapiens	IC50	uM	30.0
	10995988	CHEMBL2073530	Inhibition of MAPK p38beta	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5cccc(C(N)=O)c5)cc4)SC3=S)cc2)CC1		CHEMBL2070412	>	IC50	nM	30000.0	CHEMBL3961	Homo sapiens	IC50	uM	30.0
	10995989	CHEMBL2073530	Inhibition of MAPK p38beta	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(C(N)=O)cc5)cc4)SC3=S)cc2)CC1		CHEMBL2070413	>	IC50	nM	30000.0	CHEMBL3961	Homo sapiens	IC50	uM	30.0
	12047286	CHEMBL2157311	Inhibition of p38beta at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	6.6	CHEMBL3961	Homo sapiens	INH	%	6.6
	12074704	CHEMBL2161425	Inhibition of SAPK2beta at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	12094399	CHEMBL2166391	Inhibition of human p38beta at 10 uM	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1	Outside typical range	CHEMBL1235213	=	Inhibition	%	-14.0	CHEMBL3961	Homo sapiens	INH	%	-14.0
	12115089	CHEMBL2172907	Inhibition of human MAPK p38beta by Z'-LYTE assay	B	Cc1ccccc1-n1nc(-c2c(-c3ccc(F)cc3)nn3c2NC[C@@H](CO)C3)ccc1=O		CHEMBL2170294	=	IC50	nM	36.0	CHEMBL3961	Homo sapiens	IC50	nM	36.0
	12135274	CHEMBL2184762	Inhibition of MAP kinase p38beta at 10 uM	B	O=C(Nc1cc(Nc2ccc3c(c2)CCCCC3=O)ccc1F)c1ccccc1		CHEMBL2177219	>	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	12155953	CHEMBL2185152	Inhibition of MAPK11 assessed as residual activity at 1000 nM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179119	=	Activity	%	2.5	CHEMBL3961	Homo sapiens	Activity	%	2.5
Active	12155956	CHEMBL2185152	Inhibition of MAPK11 assessed as residual activity at 1000 nM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	12170763	CHEMBL2209890	Inhibition of p38b MAPK assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	104.0	CHEMBL3961	Homo sapiens	Activity	%	104.0
	12170894	CHEMBL2213213	Inhibition of p38b MAPK assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	98.0	CHEMBL3961	Homo sapiens	Activity	%	98.0
	12172307	CHEMBL2215422	Inhibition of p38-beta assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	74.0	CHEMBL3961	Homo sapiens	Activity	%	74.0
	12183854	CHEMBL2211534	Inhibition of MAPK11	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	pIC50		5.0
	12265138	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	110.0	CHEMBL3961	Homo sapiens	Residual Activity	%	110.0
	12265139	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12265140	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	92.0	CHEMBL3961	Homo sapiens	Residual Activity	%	92.0
	12265141	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	106.0	CHEMBL3961	Homo sapiens	Residual Activity	%	106.0
	12265142	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12265143	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12265144	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12265145	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	95.0	CHEMBL3961	Homo sapiens	Residual Activity	%	95.0
	12265146	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	100.0	CHEMBL3961	Homo sapiens	Residual Activity	%	100.0
	12265147	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	91.0	CHEMBL3961	Homo sapiens	Residual Activity	%	91.0
	12265148	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	90.0	CHEMBL3961	Homo sapiens	Residual Activity	%	90.0
	12265149	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12265150	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	91.0	CHEMBL3961	Homo sapiens	Residual Activity	%	91.0
	12265151	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	64.0	CHEMBL3961	Homo sapiens	Residual Activity	%	64.0
	12265152	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	96.0	CHEMBL3961	Homo sapiens	Residual Activity	%	96.0
	12265153	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12265154	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	107.0	CHEMBL3961	Homo sapiens	Residual Activity	%	107.0
	12265155	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	107.0	CHEMBL3961	Homo sapiens	Residual Activity	%	107.0
	12265156	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	96.0	CHEMBL3961	Homo sapiens	Residual Activity	%	96.0
	12265157	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	62.0	CHEMBL3961	Homo sapiens	Residual Activity	%	62.0
	12265158	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	104.0	CHEMBL3961	Homo sapiens	Residual Activity	%	104.0
	12265159	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	95.0	CHEMBL3961	Homo sapiens	Residual Activity	%	95.0
	12265160	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12265161	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	91.0	CHEMBL3961	Homo sapiens	Residual Activity	%	91.0
	12265162	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	108.0	CHEMBL3961	Homo sapiens	Residual Activity	%	108.0
	12265163	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12265164	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12265165	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	93.0	CHEMBL3961	Homo sapiens	Residual Activity	%	93.0
	12265166	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	95.0	CHEMBL3961	Homo sapiens	Residual Activity	%	95.0
	12265167	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12265168	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	99.0	CHEMBL3961	Homo sapiens	Residual Activity	%	99.0
	12265169	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	19.0	CHEMBL3961	Homo sapiens	Residual Activity	%	19.0
	12265170	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	100.0	CHEMBL3961	Homo sapiens	Residual Activity	%	100.0
	12265171	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	93.0	CHEMBL3961	Homo sapiens	Residual Activity	%	93.0
	12265172	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	95.0	CHEMBL3961	Homo sapiens	Residual Activity	%	95.0
	12265173	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12265174	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	60.0	CHEMBL3961	Homo sapiens	Residual Activity	%	60.0
	12265175	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12265176	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12265177	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12265178	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	106.0	CHEMBL3961	Homo sapiens	Residual Activity	%	106.0
	12265179	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	106.0	CHEMBL3961	Homo sapiens	Residual Activity	%	106.0
	12265180	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12265181	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	83.0	CHEMBL3961	Homo sapiens	Residual Activity	%	83.0
	12265182	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	83.0	CHEMBL3961	Homo sapiens	Residual Activity	%	83.0
	12265183	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	96.0	CHEMBL3961	Homo sapiens	Residual Activity	%	96.0
	12265184	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12265185	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12265186	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12265187	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12265188	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	105.0	CHEMBL3961	Homo sapiens	Residual Activity	%	105.0
	12265189	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	87.0	CHEMBL3961	Homo sapiens	Residual Activity	%	87.0
	12265190	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	71.0	CHEMBL3961	Homo sapiens	Residual Activity	%	71.0
	12265191	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	100.0	CHEMBL3961	Homo sapiens	Residual Activity	%	100.0
	12265192	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	106.0	CHEMBL3961	Homo sapiens	Residual Activity	%	106.0
	12265193	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12265194	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	103.0	CHEMBL3961	Homo sapiens	Residual Activity	%	103.0
	12265195	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	103.0	CHEMBL3961	Homo sapiens	Residual Activity	%	103.0
	12265196	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12265197	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12265198	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	88.0	CHEMBL3961	Homo sapiens	Residual Activity	%	88.0
	12265199	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	86.0	CHEMBL3961	Homo sapiens	Residual Activity	%	86.0
	12265200	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	104.0	CHEMBL3961	Homo sapiens	Residual Activity	%	104.0
	12265201	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	96.0	CHEMBL3961	Homo sapiens	Residual Activity	%	96.0
	12265202	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	106.0	CHEMBL3961	Homo sapiens	Residual Activity	%	106.0
	12265203	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	107.0	CHEMBL3961	Homo sapiens	Residual Activity	%	107.0
	12265204	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12265205	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	95.0	CHEMBL3961	Homo sapiens	Residual Activity	%	95.0
	12265206	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	95.0	CHEMBL3961	Homo sapiens	Residual Activity	%	95.0
	12265207	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12265208	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	114.0	CHEMBL3961	Homo sapiens	Residual Activity	%	114.0
	12265209	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	103.0	CHEMBL3961	Homo sapiens	Residual Activity	%	103.0
	12265210	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	106.0	CHEMBL3961	Homo sapiens	Residual Activity	%	106.0
	12265211	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	107.0	CHEMBL3961	Homo sapiens	Residual Activity	%	107.0
	12265212	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	93.0	CHEMBL3961	Homo sapiens	Residual Activity	%	93.0
	12265213	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	104.0	CHEMBL3961	Homo sapiens	Residual Activity	%	104.0
	12265214	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12265215	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	95.0	CHEMBL3961	Homo sapiens	Residual Activity	%	95.0
	12265216	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12265217	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12265218	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	113.0	CHEMBL3961	Homo sapiens	Residual Activity	%	113.0
	12265219	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12265220	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	105.0	CHEMBL3961	Homo sapiens	Residual Activity	%	105.0
	12265221	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	114.0	CHEMBL3961	Homo sapiens	Residual Activity	%	114.0
	12265222	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12265223	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	105.0	CHEMBL3961	Homo sapiens	Residual Activity	%	105.0
	12265224	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	10.0	CHEMBL3961	Homo sapiens	Residual Activity	%	10.0
	12265225	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	24.0	CHEMBL3961	Homo sapiens	Residual Activity	%	24.0
	12265226	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	111.0	CHEMBL3961	Homo sapiens	Residual Activity	%	111.0
	12265227	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12265228	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	112.0	CHEMBL3961	Homo sapiens	Residual Activity	%	112.0
	12265229	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12265230	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12265231	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12265232	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	23.0	CHEMBL3961	Homo sapiens	Residual Activity	%	23.0
	12265233	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	118.0	CHEMBL3961	Homo sapiens	Residual Activity	%	118.0
	12265234	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12265235	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12265236	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12265237	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12265238	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	90.0	CHEMBL3961	Homo sapiens	Residual Activity	%	90.0
	12265239	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	77.0	CHEMBL3961	Homo sapiens	Residual Activity	%	77.0
	12265240	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12266887	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	115.0	CHEMBL3961	Homo sapiens	Residual Activity	%	115.0
	12266888	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	100.0	CHEMBL3961	Homo sapiens	Residual Activity	%	100.0
	12266889	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	100.0	CHEMBL3961	Homo sapiens	Residual Activity	%	100.0
	12266890	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	104.0	CHEMBL3961	Homo sapiens	Residual Activity	%	104.0
	12266891	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12266892	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	99.0	CHEMBL3961	Homo sapiens	Residual Activity	%	99.0
	12266893	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12266894	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	5.0	CHEMBL3961	Homo sapiens	Residual Activity	%	5.0
	12266895	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	105.0	CHEMBL3961	Homo sapiens	Residual Activity	%	105.0
	12266896	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	90.0	CHEMBL3961	Homo sapiens	Residual Activity	%	90.0
	12266897	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	99.0	CHEMBL3961	Homo sapiens	Residual Activity	%	99.0
	12266898	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	99.0	CHEMBL3961	Homo sapiens	Residual Activity	%	99.0
	12266899	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	89.0	CHEMBL3961	Homo sapiens	Residual Activity	%	89.0
	12266900	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	89.0	CHEMBL3961	Homo sapiens	Residual Activity	%	89.0
	12266901	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12266902	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	58.0	CHEMBL3961	Homo sapiens	Residual Activity	%	58.0
	12266903	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	80.0	CHEMBL3961	Homo sapiens	Residual Activity	%	80.0
	12266904	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12266905	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12266906	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12266907	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12266908	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	85.0	CHEMBL3961	Homo sapiens	Residual Activity	%	85.0
	12266909	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	93.0	CHEMBL3961	Homo sapiens	Residual Activity	%	93.0
	12266910	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12266911	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	113.0	CHEMBL3961	Homo sapiens	Residual Activity	%	113.0
	12266912	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	106.0	CHEMBL3961	Homo sapiens	Residual Activity	%	106.0
	12266913	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	56.0	CHEMBL3961	Homo sapiens	Residual Activity	%	56.0
	12266914	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	100.0	CHEMBL3961	Homo sapiens	Residual Activity	%	100.0
	12266915	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	99.0	CHEMBL3961	Homo sapiens	Residual Activity	%	99.0
	12266916	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	88.0	CHEMBL3961	Homo sapiens	Residual Activity	%	88.0
	12266917	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	106.0	CHEMBL3961	Homo sapiens	Residual Activity	%	106.0
	12266918	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	28.0	CHEMBL3961	Homo sapiens	Residual Activity	%	28.0
	12266919	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	119.0	CHEMBL3961	Homo sapiens	Residual Activity	%	119.0
	12266920	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	103.0	CHEMBL3961	Homo sapiens	Residual Activity	%	103.0
	12266921	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	91.0	CHEMBL3961	Homo sapiens	Residual Activity	%	91.0
	12266922	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12266923	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12266924	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	104.0	CHEMBL3961	Homo sapiens	Residual Activity	%	104.0
	12266925	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12266926	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	116.0	CHEMBL3961	Homo sapiens	Residual Activity	%	116.0
	12266927	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	107.0	CHEMBL3961	Homo sapiens	Residual Activity	%	107.0
	12266928	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	93.0	CHEMBL3961	Homo sapiens	Residual Activity	%	93.0
	12266929	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	118.0	CHEMBL3961	Homo sapiens	Residual Activity	%	118.0
	12266930	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12266931	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12266932	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	103.0	CHEMBL3961	Homo sapiens	Residual Activity	%	103.0
	12266933	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	56.0	CHEMBL3961	Homo sapiens	Residual Activity	%	56.0
	12266934	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	106.0	CHEMBL3961	Homo sapiens	Residual Activity	%	106.0
	12266935	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	107.0	CHEMBL3961	Homo sapiens	Residual Activity	%	107.0
	12266936	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12266937	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	86.0	CHEMBL3961	Homo sapiens	Residual Activity	%	86.0
	12266938	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	114.0	CHEMBL3961	Homo sapiens	Residual Activity	%	114.0
	12266939	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	107.0	CHEMBL3961	Homo sapiens	Residual Activity	%	107.0
	12266940	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	2.0	CHEMBL3961	Homo sapiens	Residual Activity	%	2.0
	12266941	CHEMBL2219173	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	119.0	CHEMBL3961	Homo sapiens	Residual Activity	%	119.0
	12266942	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12266943	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	79.0	CHEMBL3961	Homo sapiens	Residual Activity	%	79.0
	12266944	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	48.0	CHEMBL3961	Homo sapiens	Residual Activity	%	48.0
	12266945	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	96.0	CHEMBL3961	Homo sapiens	Residual Activity	%	96.0
	12266946	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	93.0	CHEMBL3961	Homo sapiens	Residual Activity	%	93.0
	12266947	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	85.0	CHEMBL3961	Homo sapiens	Residual Activity	%	85.0
	12266948	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	99.0	CHEMBL3961	Homo sapiens	Residual Activity	%	99.0
	12266949	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	45.0	CHEMBL3961	Homo sapiens	Residual Activity	%	45.0
	12266950	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12266951	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	89.0	CHEMBL3961	Homo sapiens	Residual Activity	%	89.0
	12266952	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	86.0	CHEMBL3961	Homo sapiens	Residual Activity	%	86.0
	12266953	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12266954	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	88.0	CHEMBL3961	Homo sapiens	Residual Activity	%	88.0
	12266955	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	22.0	CHEMBL3961	Homo sapiens	Residual Activity	%	22.0
	12266956	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	104.0	CHEMBL3961	Homo sapiens	Residual Activity	%	104.0
	12266957	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	77.0	CHEMBL3961	Homo sapiens	Residual Activity	%	77.0
	12266958	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12266959	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	105.0	CHEMBL3961	Homo sapiens	Residual Activity	%	105.0
	12266960	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	105.0	CHEMBL3961	Homo sapiens	Residual Activity	%	105.0
	12266961	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	69.0	CHEMBL3961	Homo sapiens	Residual Activity	%	69.0
	12266962	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12266963	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	72.0	CHEMBL3961	Homo sapiens	Residual Activity	%	72.0
	12266964	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	110.0	CHEMBL3961	Homo sapiens	Residual Activity	%	110.0
	12266965	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	84.0	CHEMBL3961	Homo sapiens	Residual Activity	%	84.0
	12266966	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	108.0	CHEMBL3961	Homo sapiens	Residual Activity	%	108.0
	12266967	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	50.0	CHEMBL3961	Homo sapiens	Residual Activity	%	50.0
	12266968	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	69.0	CHEMBL3961	Homo sapiens	Residual Activity	%	69.0
	12266969	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	58.0	CHEMBL3961	Homo sapiens	Residual Activity	%	58.0
	12266970	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	91.0	CHEMBL3961	Homo sapiens	Residual Activity	%	91.0
	12266971	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12266972	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	76.0	CHEMBL3961	Homo sapiens	Residual Activity	%	76.0
	12266973	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	5.0	CHEMBL3961	Homo sapiens	Residual Activity	%	5.0
	12266974	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	103.0	CHEMBL3961	Homo sapiens	Residual Activity	%	103.0
	12266975	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12266976	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	99.0	CHEMBL3961	Homo sapiens	Residual Activity	%	99.0
	12266977	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	95.0	CHEMBL3961	Homo sapiens	Residual Activity	%	95.0
	12266978	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	25.0	CHEMBL3961	Homo sapiens	Residual Activity	%	25.0
	12266979	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	103.0	CHEMBL3961	Homo sapiens	Residual Activity	%	103.0
	12266980	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	64.0	CHEMBL3961	Homo sapiens	Residual Activity	%	64.0
	12266981	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	79.0	CHEMBL3961	Homo sapiens	Residual Activity	%	79.0
	12266982	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12266983	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	104.0	CHEMBL3961	Homo sapiens	Residual Activity	%	104.0
	12266984	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	100.0	CHEMBL3961	Homo sapiens	Residual Activity	%	100.0
	12266985	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	73.0	CHEMBL3961	Homo sapiens	Residual Activity	%	73.0
	12266986	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	87.0	CHEMBL3961	Homo sapiens	Residual Activity	%	87.0
	12266987	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12266988	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12266989	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	85.0	CHEMBL3961	Homo sapiens	Residual Activity	%	85.0
	12266990	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	104.0	CHEMBL3961	Homo sapiens	Residual Activity	%	104.0
	12266991	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	111.0	CHEMBL3961	Homo sapiens	Residual Activity	%	111.0
	12266992	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12266993	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	75.0	CHEMBL3961	Homo sapiens	Residual Activity	%	75.0
	12266994	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	35.0	CHEMBL3961	Homo sapiens	Residual Activity	%	35.0
	12266995	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	95.0	CHEMBL3961	Homo sapiens	Residual Activity	%	95.0
	12266996	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	118.0	CHEMBL3961	Homo sapiens	Residual Activity	%	118.0
	12266997	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	95.0	CHEMBL3961	Homo sapiens	Residual Activity	%	95.0
	12266998	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12266999	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12267000	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	84.0	CHEMBL3961	Homo sapiens	Residual Activity	%	84.0
	12267001	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	96.0	CHEMBL3961	Homo sapiens	Residual Activity	%	96.0
	12267002	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	67.0	CHEMBL3961	Homo sapiens	Residual Activity	%	67.0
	12267003	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12267004	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	109.0	CHEMBL3961	Homo sapiens	Residual Activity	%	109.0
	12267005	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	91.0	CHEMBL3961	Homo sapiens	Residual Activity	%	91.0
	12267006	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12267007	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	99.0	CHEMBL3961	Homo sapiens	Residual Activity	%	99.0
	12267008	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12267009	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	105.0	CHEMBL3961	Homo sapiens	Residual Activity	%	105.0
	12267010	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12267011	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	90.0	CHEMBL3961	Homo sapiens	Residual Activity	%	90.0
	12267012	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	105.0	CHEMBL3961	Homo sapiens	Residual Activity	%	105.0
	12267013	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	88.0	CHEMBL3961	Homo sapiens	Residual Activity	%	88.0
	12267014	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	96.0	CHEMBL3961	Homo sapiens	Residual Activity	%	96.0
	12267015	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	102.0	CHEMBL3961	Homo sapiens	Residual Activity	%	102.0
	12267016	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	76.0	CHEMBL3961	Homo sapiens	Residual Activity	%	76.0
	12267017	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	92.0	CHEMBL3961	Homo sapiens	Residual Activity	%	92.0
	12267018	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	117.0	CHEMBL3961	Homo sapiens	Residual Activity	%	117.0
	12267019	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	92.0	CHEMBL3961	Homo sapiens	Residual Activity	%	92.0
	12267020	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	103.0	CHEMBL3961	Homo sapiens	Residual Activity	%	103.0
	12267021	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	89.0	CHEMBL3961	Homo sapiens	Residual Activity	%	89.0
	12267022	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12267023	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	77.0	CHEMBL3961	Homo sapiens	Residual Activity	%	77.0
	12267024	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	107.0	CHEMBL3961	Homo sapiens	Residual Activity	%	107.0
	12267025	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	120.0	CHEMBL3961	Homo sapiens	Residual Activity	%	120.0
	12267026	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	104.0	CHEMBL3961	Homo sapiens	Residual Activity	%	104.0
	12267027	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	95.0	CHEMBL3961	Homo sapiens	Residual Activity	%	95.0
	12267028	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	-2.0	CHEMBL3961	Homo sapiens	Residual Activity	%	-2.0
	12267029	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	2.0	CHEMBL3961	Homo sapiens	Residual Activity	%	2.0
	12267030	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	109.0	CHEMBL3961	Homo sapiens	Residual Activity	%	109.0
	12267031	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	90.0	CHEMBL3961	Homo sapiens	Residual Activity	%	90.0
	12267032	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	96.0	CHEMBL3961	Homo sapiens	Residual Activity	%	96.0
	12267033	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	66.0	CHEMBL3961	Homo sapiens	Residual Activity	%	66.0
	12267034	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	89.0	CHEMBL3961	Homo sapiens	Residual Activity	%	89.0
	12267035	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12267036	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	5.0	CHEMBL3961	Homo sapiens	Residual Activity	%	5.0
	12267037	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	109.0	CHEMBL3961	Homo sapiens	Residual Activity	%	109.0
	12267038	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12267039	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	104.0	CHEMBL3961	Homo sapiens	Residual Activity	%	104.0
	12267040	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	100.0	CHEMBL3961	Homo sapiens	Residual Activity	%	100.0
	12267041	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	91.0	CHEMBL3961	Homo sapiens	Residual Activity	%	91.0
	12267042	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	87.0	CHEMBL3961	Homo sapiens	Residual Activity	%	87.0
	12267043	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	29.0	CHEMBL3961	Homo sapiens	Residual Activity	%	29.0
	12267044	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	92.0	CHEMBL3961	Homo sapiens	Residual Activity	%	92.0
	12267045	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	105.0	CHEMBL3961	Homo sapiens	Residual Activity	%	105.0
	12267046	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	103.0	CHEMBL3961	Homo sapiens	Residual Activity	%	103.0
	12267047	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	109.0	CHEMBL3961	Homo sapiens	Residual Activity	%	109.0
	12267048	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	95.0	CHEMBL3961	Homo sapiens	Residual Activity	%	95.0
	12267049	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	89.0	CHEMBL3961	Homo sapiens	Residual Activity	%	89.0
	12267050	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	92.0	CHEMBL3961	Homo sapiens	Residual Activity	%	92.0
	12267051	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	89.0	CHEMBL3961	Homo sapiens	Residual Activity	%	89.0
	12267052	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	3.0	CHEMBL3961	Homo sapiens	Residual Activity	%	3.0
	12267053	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	58.0	CHEMBL3961	Homo sapiens	Residual Activity	%	58.0
	12267054	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	87.0	CHEMBL3961	Homo sapiens	Residual Activity	%	87.0
	12267055	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	91.0	CHEMBL3961	Homo sapiens	Residual Activity	%	91.0
	12267056	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12267057	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	89.0	CHEMBL3961	Homo sapiens	Residual Activity	%	89.0
	12267058	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	68.0	CHEMBL3961	Homo sapiens	Residual Activity	%	68.0
	12267059	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	88.0	CHEMBL3961	Homo sapiens	Residual Activity	%	88.0
	12267060	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	13.0	CHEMBL3961	Homo sapiens	Residual Activity	%	13.0
	12267061	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	23.0	CHEMBL3961	Homo sapiens	Residual Activity	%	23.0
	12267062	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	98.0	CHEMBL3961	Homo sapiens	Residual Activity	%	98.0
	12267063	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	76.0	CHEMBL3961	Homo sapiens	Residual Activity	%	76.0
	12267064	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	94.0	CHEMBL3961	Homo sapiens	Residual Activity	%	94.0
	12267065	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	92.0	CHEMBL3961	Homo sapiens	Residual Activity	%	92.0
	12267066	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	77.0	CHEMBL3961	Homo sapiens	Residual Activity	%	77.0
	12267067	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	85.0	CHEMBL3961	Homo sapiens	Residual Activity	%	85.0
	12267068	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	96.0	CHEMBL3961	Homo sapiens	Residual Activity	%	96.0
	12267069	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	105.0	CHEMBL3961	Homo sapiens	Residual Activity	%	105.0
	12267070	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	93.0	CHEMBL3961	Homo sapiens	Residual Activity	%	93.0
	12267071	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	24.0	CHEMBL3961	Homo sapiens	Residual Activity	%	24.0
	12267072	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	92.0	CHEMBL3961	Homo sapiens	Residual Activity	%	92.0
	12267073	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	90.0	CHEMBL3961	Homo sapiens	Residual Activity	%	90.0
	12267074	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	79.0	CHEMBL3961	Homo sapiens	Residual Activity	%	79.0
	12267075	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	92.0	CHEMBL3961	Homo sapiens	Residual Activity	%	92.0
	12267076	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	7.0	CHEMBL3961	Homo sapiens	Residual Activity	%	7.0
	12267077	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	99.0	CHEMBL3961	Homo sapiens	Residual Activity	%	99.0
	12267078	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	99.0	CHEMBL3961	Homo sapiens	Residual Activity	%	99.0
	12267079	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	32.0	CHEMBL3961	Homo sapiens	Residual Activity	%	32.0
	12267080	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	92.0	CHEMBL3961	Homo sapiens	Residual Activity	%	92.0
	12267081	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	92.0	CHEMBL3961	Homo sapiens	Residual Activity	%	92.0
	12267082	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12267083	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	97.0	CHEMBL3961	Homo sapiens	Residual Activity	%	97.0
	12267084	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	48.0	CHEMBL3961	Homo sapiens	Residual Activity	%	48.0
	12267085	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	85.0	CHEMBL3961	Homo sapiens	Residual Activity	%	85.0
	12267086	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	88.0	CHEMBL3961	Homo sapiens	Residual Activity	%	88.0
	12267087	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	105.0	CHEMBL3961	Homo sapiens	Residual Activity	%	105.0
	12267088	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	100.0	CHEMBL3961	Homo sapiens	Residual Activity	%	100.0
	12267089	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	90.0	CHEMBL3961	Homo sapiens	Residual Activity	%	90.0
	12267090	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	89.0	CHEMBL3961	Homo sapiens	Residual Activity	%	89.0
	12267091	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	72.0	CHEMBL3961	Homo sapiens	Residual Activity	%	72.0
	12267092	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	30.0	CHEMBL3961	Homo sapiens	Residual Activity	%	30.0
	12267093	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	126.0	CHEMBL3961	Homo sapiens	Residual Activity	%	126.0
	12267094	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12267095	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	104.0	CHEMBL3961	Homo sapiens	Residual Activity	%	104.0
	12267096	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	116.0	CHEMBL3961	Homo sapiens	Residual Activity	%	116.0
	12267097	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	101.0	CHEMBL3961	Homo sapiens	Residual Activity	%	101.0
	12267098	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	-1.0	CHEMBL3961	Homo sapiens	Residual Activity	%	-1.0
	12267099	CHEMBL2219174	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	107.0	CHEMBL3961	Homo sapiens	Residual Activity	%	107.0
	12628452	CHEMBL2321175	Inhibition of P38beta MAPK (unknown origin) at 10 uM	B	N#Cc1c(N)nc2sc(C(=O)c3cccc(Cl)c3)c(N)c2c1-c1ccccc1Cl		CHEMBL2313853	>	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
Active	12641788	CHEMBL2317227	Inhibition of p38beta MAP kinase (unknown origin)	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
Active	12641789	CHEMBL2317227	Inhibition of p38beta MAP kinase (unknown origin)	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316479		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	12672951	CHEMBL2339292	Inhibition of recombinant p38 MAPKbeta (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	66.0	CHEMBL3961	Homo sapiens	Activity	%	66.0
	12672952	CHEMBL2339292	Inhibition of recombinant p38 MAPKbeta (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	64.0	CHEMBL3961	Homo sapiens	Activity	%	64.0
	12727625	CHEMBL2353924	Inhibition of p38beta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	98.0	CHEMBL3961	Homo sapiens	Activity	%	98.0
	12728909	CHEMBL2352808	Inhibition of p38beta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	101.0	CHEMBL3961	Homo sapiens	Activity	%	101.0
	12729877	CHEMBL2349781	Inhibition of P38b (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	103.0	CHEMBL3961	Homo sapiens	Activity	%	103.0
	12730052	CHEMBL2353924	Inhibition of p38beta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	93.0	CHEMBL3961	Homo sapiens	Activity	%	93.0
	13351580	CHEMBL2399770	Inhibition of human SAPK2B at 10 uM relative to control	B	Cl.O=c1[nH]nc2c(NCCCc3ccncc3)cc(Cl)cn12		CHEMBL2397859	=	Inhibition	%	1.0	CHEMBL3961	Homo sapiens	INH	%	1.0
	13371648	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnc(-c2ccccc2Cl)s1		CHEMBL2401978	=	IC50	nM	18.0	CHEMBL3961	Homo sapiens	IC50	nM	18.0
	13371663	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2ccn(C)c2c1		CHEMBL2402003	=	IC50	nM	21920.0	CHEMBL3961	Homo sapiens	IC50	nM	21920.0
	13371664	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2ccn(C(C)C)c2c1		CHEMBL2402004	=	IC50	nM	14890.0	CHEMBL3961	Homo sapiens	IC50	nM	14890.0
	13371665	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	CCOC(=O)n1ccc2ccc(C(=O)Nc3cc(C(=O)NC4CC4)ccc3C)cc21		CHEMBL2402005	=	IC50	nM	7084.0	CHEMBL3961	Homo sapiens	IC50	nM	7084.0
	13371666	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccccn2)s1		CHEMBL2401996	=	IC50	nM	6799.0	CHEMBL3961	Homo sapiens	IC50	nM	6799.0
	13371667	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2cc[nH]c2c1		CHEMBL2402002	=	IC50	nM	6173.0	CHEMBL3961	Homo sapiens	IC50	nM	6173.0
	13371668	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL2401980	=	IC50	nM	3875.0	CHEMBL3961	Homo sapiens	IC50	nM	3875.0
	13371669	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)s1		CHEMBL2401985	=	IC50	nM	3455.0	CHEMBL3961	Homo sapiens	IC50	nM	3455.0
	13371670	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2cncc(F)c2)s1		CHEMBL2401999	=	IC50	nM	2402.0	CHEMBL3961	Homo sapiens	IC50	nM	2402.0
	13371672	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2cccnc2)s1		CHEMBL2401997	=	IC50	nM	1800.0	CHEMBL3961	Homo sapiens	IC50	nM	1800.0
	13371673	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(CN(C)C)cc2)s1		CHEMBL2401992	=	IC50	nM	1514.0	CHEMBL3961	Homo sapiens	IC50	nM	1514.0
	13371676	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccccc2)s1		CHEMBL2401986	=	IC50	nM	1021.0	CHEMBL3961	Homo sapiens	IC50	nM	1021.0
	13371678	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(C#N)cc2)s1		CHEMBL2401990	=	IC50	nM	830.0	CHEMBL3961	Homo sapiens	IC50	nM	830.0
	13371679	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccncc2)s1		CHEMBL2401998	=	IC50	nM	771.0	CHEMBL3961	Homo sapiens	IC50	nM	771.0
	13371680	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2cccc(Cl)c2)s1		CHEMBL2401982	=	IC50	nM	679.0	CHEMBL3961	Homo sapiens	IC50	nM	679.0
	13371683	CHEMBL2405968	Binding affinity to human p38beta expressed in Escherichia coli by surface plasmon resonance analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2cccnc2)s1		CHEMBL2401997	=	Kd	nM	500.0	CHEMBL3961	Homo sapiens	Kd	nM	500.0
	13371684	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(N)cc2)s1		CHEMBL2401988	=	IC50	nM	492.0	CHEMBL3961	Homo sapiens	IC50	nM	492.0
	13371685	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(F)cc2)s1		CHEMBL2401984	=	IC50	nM	485.0	CHEMBL3961	Homo sapiens	IC50	nM	485.0
	13371686	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(C(=O)N(C)C)cc2)s1		CHEMBL2401993	=	IC50	nM	441.0	CHEMBL3961	Homo sapiens	IC50	nM	441.0
	13371688	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(-c2ccc(C(=O)Nc3cc(C(=O)NC4CC4)ccc3C)s2)cn1		CHEMBL2402001	=	IC50	nM	409.0	CHEMBL3961	Homo sapiens	IC50	nM	409.0
	13371690	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(O)cc2)s1		CHEMBL2401987	=	IC50	nM	390.0	CHEMBL3961	Homo sapiens	IC50	nM	390.0
	13371691	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(CO)cc2)s1		CHEMBL2401991	=	IC50	nM	332.0	CHEMBL3961	Homo sapiens	IC50	nM	332.0
	13371696	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(Cl)cc2)s1		CHEMBL2401981	=	IC50	nM	270.0	CHEMBL3961	Homo sapiens	IC50	nM	270.0
	13371697	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	COc1ccc(-c2ccc(C(=O)Nc3cc(C(=O)NC4CC4)ccc3C)s2)cc1		CHEMBL2401989	=	IC50	nM	267.0	CHEMBL3961	Homo sapiens	IC50	nM	267.0
	13371698	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL2401983	=	IC50	nM	265.0	CHEMBL3961	Homo sapiens	IC50	nM	265.0
	13371699	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2cnccc2N2CCOCC2)s1		CHEMBL2402000	=	IC50	nM	254.0	CHEMBL3961	Homo sapiens	IC50	nM	254.0
	13371712	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(C(=O)N3CCCCC3)cc2)s1		CHEMBL2401995	=	IC50	nM	109.0	CHEMBL3961	Homo sapiens	IC50	nM	109.0
	13371720	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(C(=O)N3CCOCC3)cc2)s1		CHEMBL2401994	=	IC50	nM	81.0	CHEMBL3961	Homo sapiens	IC50	nM	81.0
	13371727	CHEMBL2405972	Inhibition of p38beta (unknown origin)	B	CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C		CHEMBL1230065	=	IC50	nM	62.0	CHEMBL3961	Homo sapiens	IC50	nM	62.0
	13371745	CHEMBL2405968	Binding affinity to human p38beta expressed in Escherichia coli by surface plasmon resonance analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnn(-c2ncccc2C(F)(F)F)c1C		CHEMBL2401979	=	Ka	10'5/M/s	10.0	CHEMBL3961	Homo sapiens	Ka	10'5/M/s	10.0
	13371752	CHEMBL2405968	Binding affinity to human p38beta expressed in Escherichia coli by surface plasmon resonance analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnn(-c2ncccc2C(F)(F)F)c1C		CHEMBL2401979	=	Kd	nM	6.2	CHEMBL3961	Homo sapiens	Kd	nM	6.2
	13371762	CHEMBL2405972	Inhibition of p38beta (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnn(-c2ncccc2C(F)(F)F)c1C		CHEMBL2401979	=	IC50	nM	4.0	CHEMBL3961	Homo sapiens	IC50	nM	4.0
	13371765	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnn(-c2ncccc2C(F)(F)F)c1C		CHEMBL2401979	=	IC50	nM	4.0	CHEMBL3961	Homo sapiens	IC50	nM	4.0
	13371774	CHEMBL2405972	Inhibition of p38beta (unknown origin)	B	CC[C@@H](C)Nc1ncc(C(=O)Nc2cc(C(=O)NC)ccc2C)s1		CHEMBL258202	=	IC50	nM	2.0	CHEMBL3961	Homo sapiens	IC50	nM	2.0
	13371775	CHEMBL2405978	Inhibition of human p38beta expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	CC[C@@H](C)Nc1ncc(C(=O)Nc2cc(C(=O)NC)ccc2C)s1		CHEMBL258202	=	IC50	nM	2.0	CHEMBL3961	Homo sapiens	IC50	nM	2.0
	13371779	CHEMBL2405968	Binding affinity to human p38beta expressed in Escherichia coli by surface plasmon resonance analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2cccnc2)s1		CHEMBL2401997	=	Ka	10'6/M/s	1.2	CHEMBL3961	Homo sapiens	Ka	10'6/M/s	1.2
	13375796	CHEMBL2404192	Inhibition of p38beta (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	2.0	CHEMBL3961	Homo sapiens	INH	%	2.0
	13419655	CHEMBL2422091	Inhibition of p38beta-2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	3.0	CHEMBL3961	Homo sapiens	INH	%	3.0
	13419656	CHEMBL2422091	Inhibition of p38beta-2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	8.0	CHEMBL3961	Homo sapiens	INH	%	8.0
	13419657	CHEMBL2422091	Inhibition of p38beta-2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	4.0	CHEMBL3961	Homo sapiens	INH	%	4.0
	13434618	CHEMBL2424241	Inhibition of p38beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL3961	Homo sapiens	INH	%	35.0
	13434619	CHEMBL2424241	Inhibition of p38beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL3961	Homo sapiens	INH	%	35.0
	13434620	CHEMBL2424241	Inhibition of p38beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL3961	Homo sapiens	INH	%	35.0
	13434621	CHEMBL2424241	Inhibition of p38beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL3961	Homo sapiens	INH	%	35.0
	13434622	CHEMBL2424241	Inhibition of p38beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL3961	Homo sapiens	INH	%	35.0
	13434623	CHEMBL2424241	Inhibition of p38beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL3961	Homo sapiens	INH	%	35.0
	13434624	CHEMBL2424241	Inhibition of p38beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL3961	Homo sapiens	INH	%	35.0
	13434625	CHEMBL2424241	Inhibition of p38beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL3961	Homo sapiens	INH	%	35.0
	13434626	CHEMBL2424241	Inhibition of p38beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL3961	Homo sapiens	INH	%	35.0
	13434627	CHEMBL2424241	Inhibition of p38beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL3961	Homo sapiens	INH	%	35.0
	13434628	CHEMBL2424241	Inhibition of p38beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL3961	Homo sapiens	INH	%	35.0
	13434629	CHEMBL2424241	Inhibition of p38beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL3961	Homo sapiens	INH	%	35.0
	13442327	CHEMBL2429495	Competitive binding affinity to p38-beta (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	13442440	CHEMBL2429495	Competitive binding affinity to p38-beta (unknown origin) at 10 uM in presence of ATP relative to control	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	>	Inhibition	%	85.0	CHEMBL3961	Homo sapiens	INH	%	85.0
	13442480	CHEMBL2429174	Binding affinity to p38-beta (unknown origin)	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	=	Kd	nM	3200.0	CHEMBL3961	Homo sapiens	Kd	uM	3.2
	13445462	CHEMBL2429495	Competitive binding affinity to p38-beta (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	13448517	CHEMBL2429495	Competitive binding affinity to p38-beta (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	13448653	CHEMBL2429495	Competitive binding affinity to p38-beta (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	13451448	CHEMBL2429495	Competitive binding affinity to p38-beta (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	13453008	CHEMBL2429438	Inhibition of SAPK2-b (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1	Outside typical range	CHEMBL2425156	=	Inhibition	%	-73.0	CHEMBL3961	Homo sapiens	INH	%	-73.0
	13453056	CHEMBL2429438	Inhibition of SAPK2-b (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1	Outside typical range	CHEMBL2425145	=	Inhibition	%	-73.0	CHEMBL3961	Homo sapiens	INH	%	-73.0
	13453104	CHEMBL2429438	Inhibition of SAPK2-b (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-98.0	CHEMBL3961	Homo sapiens	INH	%	-98.0
	13454633	CHEMBL2429495	Competitive binding affinity to p38-beta (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
Not Active	13475284	CHEMBL2439110	Inhibition of human wild type p38b at 1 uM by qPCR analysis	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
Not Active	13508503	CHEMBL2447376	Inhibition of p38beta (unknown origin) at 30 uM	B	O=C(Nc1ccc2c(c1)B(O)OC2)c1c(C(F)(F)F)ccc(Cl)c1F		CHEMBL2441375		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	13827729	CHEMBL3090391	Inhibition of p38beta MAP kinase (unknown origin) at 10 uM	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)OCc1ccc(OC[C@H](O)CO)cc1C2=O		CHEMBL3087471	>	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	13871748	CHEMBL3100784	Inhibition of human SAPK2beta assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	147.0	CHEMBL3961	Homo sapiens	Activity	%	147.0
	14553636	CHEMBL3225776	Inhibition of P38beta (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	97.8	CHEMBL3961	Homo sapiens	Activity	%	97.8
	14585363	CHEMBL3240783	Inhibition of human p38beta assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	109.5	CHEMBL3961	Homo sapiens	Activity	%	109.5
	14710326	CHEMBL3292198	Inhibition of human SAPK2beta assessed as residual activity at 10 uM relative to control	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4ccccc4)c23)C1=O		CHEMBL3290628	=	Activity	%	98.0	CHEMBL3961	Homo sapiens	Activity	%	98.0
	14710327	CHEMBL3292198	Inhibition of human SAPK2beta assessed as residual activity at 10 uM relative to control	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4cccc(OCCN5CCCCC5)c4)c23)C1=O.Cl		CHEMBL3290631	=	Activity	%	103.0	CHEMBL3961	Homo sapiens	Activity	%	103.0
	15018654	CHEMBL3361546	Inhibition of p38 beta (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	18.2	CHEMBL3961	Homo sapiens	INH	%	18.2
	15061124	CHEMBL3378770	Inhibition of p38beta (unknown origin) at 1 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CNCCO1		CHEMBL3322987	=	Inhibition	%	2.0	CHEMBL3961	Homo sapiens	INH	%	2.0
	15062564	CHEMBL3370283	Inhibition of human p38beta MAP kinase by Off-chip mobility shift assay	B	Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310138	=	IC50	nM	9714.0	CHEMBL3961	Homo sapiens	IC50	nM	9714.0
	15062565	CHEMBL3370283	Inhibition of human p38beta MAP kinase by Off-chip mobility shift assay	B	O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310142	=	IC50	nM	326.0	CHEMBL3961	Homo sapiens	IC50	nM	326.0
	15072487	CHEMBL3379508	Inhibition of p38beta (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	107.0	CHEMBL3961	Homo sapiens	Activity	%	107.0
	15116504	CHEMBL3377058	Inhibition of p38beta (unknown origin)	B	CC(=O)c1ccc(N2CCN(C(=O)CN3CC[C@@H](C(=O)Nc4ccc(O)c(Cl)c4)C3)CC2)cc1		CHEMBL3356117	>	IC50	nM	50000.0	CHEMBL3961	Homo sapiens	IC50	uM	50.0
	15126916	CHEMBL3367704	Inhibition of human SAPK2b assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331445	=	Activity	%	114.0	CHEMBL3961	Homo sapiens	Activity	%	114.0
	15126975	CHEMBL3367704	Inhibition of human SAPK2b assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(O)c(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331446	=	Activity	%	101.0	CHEMBL3961	Homo sapiens	Activity	%	101.0
	15127007	CHEMBL3367704	Inhibition of human SAPK2b assessed as residual activity at 10 uM by KinaseProfiler assay	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Activity	%	112.0	CHEMBL3961	Homo sapiens	Activity	%	112.0
	15251826	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	83.0	CHEMBL3961	Homo sapiens	Activity	%	83.0
	15251971	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	31.0	CHEMBL3961	Homo sapiens	Activity	%	31.0
	15252073	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	81.0	CHEMBL3961	Homo sapiens	Activity	%	81.0
	15252718	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	68.0	CHEMBL3961	Homo sapiens	Activity	%	68.0
	15252820	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	67.0	CHEMBL3961	Homo sapiens	Activity	%	67.0
	15252922	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	72.0	CHEMBL3961	Homo sapiens	Activity	%	72.0
	15253596	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	88.0	CHEMBL3961	Homo sapiens	Activity	%	88.0
	15253698	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	89.0	CHEMBL3961	Homo sapiens	Activity	%	89.0
	15254364	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	90.0	CHEMBL3961	Homo sapiens	Activity	%	90.0
	15254466	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	82.0	CHEMBL3961	Homo sapiens	Activity	%	82.0
	15254568	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	106.0	CHEMBL3961	Homo sapiens	Activity	%	106.0
	15255258	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	101.0	CHEMBL3961	Homo sapiens	Activity	%	101.0
	15255361	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	92.0	CHEMBL3961	Homo sapiens	Activity	%	92.0
	15255463	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	95.0	CHEMBL3961	Homo sapiens	Activity	%	95.0
	15256195	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	97.0	CHEMBL3961	Homo sapiens	Activity	%	97.0
	15256297	CHEMBL3428394	Inhibition of p38beta MAPK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	113.0	CHEMBL3961	Homo sapiens	Activity	%	113.0
	15258356	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	-0.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.4
	15258416	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	0.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.0
	15258476	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	-0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.1
	15258536	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.1
	15258596	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	5.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	5.4
	15258656	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	-0.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.4
	15258716	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	0.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.0
	15258776	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	0.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.8
	15258836	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	0.6	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.6
	15258896	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	2.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	2.0
	15258956	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	-0.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.5
	15259016	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	2.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	2.4
	15259076	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	0.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.5
	15259136	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	2.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	2.4
	15259196	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	1.9	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.9
	15259256	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	0.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.2
	15259316	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	3.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	3.8
	15259376	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	0.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.5
	15259436	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	7.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	7.1
	15259496	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	9.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	9.5
	15259556	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	5.6	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	5.6
	15259616	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	6.6	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	6.6
	15259676	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.3
	15259736	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.1
	15259796	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	-0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.3
	15259856	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.3
	15259916	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	-0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.1
	15259976	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	2.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	2.0
	15260036	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.1
	15260096	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	4.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	4.5
	15260156	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.1
	15260216	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	0.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.4
	15260276	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	2.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	2.8
	15260336	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	0.7	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.7
	15260396	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	0.7	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.7
	15260456	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-0.6	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.6
	15260516	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	1.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.2
	15260576	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	0.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.8
	15260636	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	1.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.2
	15260696	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	2.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	2.8
	15260756	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	1.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.4
	15260816	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	4.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	4.3
	15260876	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	4.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	4.1
	15260936	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	0.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.4
	15260996	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	0.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.5
	15261056	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	0.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.0
	15261116	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	0.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.8
	15261199	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	14.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	14.8
	15261259	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	0.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.8
	15261319	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	2.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	2.5
	15261379	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	2.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	2.2
	15261434	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	-0.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.4
	15261494	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	-0.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261554	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	1.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.2
	15261614	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	0.6	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.6
	15261687	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	1.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.8
	15261747	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	1.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.5
	15261807	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	1.7	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.7
	15261867	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	0.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.0
	15261923	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	-0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.3
	15261983	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.1
	15262043	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	-0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.3
	15262103	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	-0.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.2
	15262176	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	2.9	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	2.9
	15262236	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	4.6	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	4.6
	15262296	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	-0.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.4
	15262356	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	0.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.2
	15262416	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	0.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.0
	15262476	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.3
	15262536	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	-0.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.2
	15262596	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.1
	15262656	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.1
	15262716	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	0.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.8
	15262776	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	-0.7	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.7
	15262836	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	1.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.5
	15262896	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	1.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.0
	15262956	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	-0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.1
	15263016	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	0.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.2
	15263076	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	-0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.1
	15263136	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.3
	15263196	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.4
	15263256	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	0.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.2
	15263316	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	-0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.3
	15263376	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.3
	15263412	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	-2.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-2.5
	15263472	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	0.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.0
	15263527	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	0.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.8
	15263587	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	0.7	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.7
	15263647	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	-0.7	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.7
	15263707	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	0.6	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.6
	15263781	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	-0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.1
	15263841	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	-0.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.4
	15263901	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.3
	15263961	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	0.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.2
	15264015	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	-0.6	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.6
	15264075	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-1.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-1.3
	15264135	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	-0.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.2
	15264195	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	-0.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.2
	15264268	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	0.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.4
	15264328	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	-0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.3
	15264388	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	3.7	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	3.7
	15264448	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.1
	15264504	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	0.7	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.7
	15264564	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	0.7	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.7
	15264624	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	0.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.2
	15264684	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	-0.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.2
	15264756	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	2.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	2.3
	15264816	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	-1.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-1.5
	15264876	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	3.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	3.0
	15264936	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	-0.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.4
	15264992	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	-0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.3
	15265052	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	1.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.5
	15265112	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	1.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.0
	15265172	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	0.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.4
	15265245	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	-0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265305	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	-0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265365	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.1
	15265425	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	1.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.2
	15265481	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	0.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.4
	15265541	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	4.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	4.1
	15265601	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	1.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.0
	15265661	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	0.7	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.7
	15265733	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	1.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.1
	15265793	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	1.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.0
	15265853	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.3
	15265913	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	0.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.2
	15265970	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	1.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.1
	15266030	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	0.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.8
	15266090	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	0.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.0
	15266150	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	1.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.3
	15266222	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	1.6	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.6
	15266282	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	8.6	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	8.6
	15266342	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	-0.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.4
	15266402	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.3
	15266457	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	1.4	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.4
	15266517	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	1.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.1
	15266577	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	0.7	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.7
	15266637	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	0.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.5
	15266697	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	0.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.5
	15266710	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	2.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	2.2
	15266770	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.6	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.6
	15266830	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	0.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.8
	15266890	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	1.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.2
	15266950	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	1.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.0
	15267005	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	2.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	2.0
	15267065	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	-0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.1
	15267125	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	-0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.3
	15267185	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	0.5	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.5
	15267258	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	1.2	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	1.2
	15267318	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	0.8	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.8
	15267378	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	10.9	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	10.9
	15267438	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	9.6	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	9.6
	15267493	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	-0.3	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.3
	15267553	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	-0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.1
	15267613	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	0.0	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	0.0
	15267673	CHEMBL3430815	Delta TM value showing the stabilisation of p38beta produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	-0.1	CHEMBL3961	Homo sapiens	Thermal melting change	degrees C	-0.1
	15755907	CHEMBL3630850	Inhibition of p38-beta (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	79.0	CHEMBL3961	Homo sapiens	Activity	%	79.0
	15756881	CHEMBL3630747	Inhibition of P38beta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	96.21	CHEMBL3961	Homo sapiens	INH	%	96.21
	15757842	CHEMBL3630747	Inhibition of P38beta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	-5.84	CHEMBL3961	Homo sapiens	INH	%	-5.84
	15758821	CHEMBL3630747	Inhibition of P38beta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	10.0	CHEMBL3961	Homo sapiens	INH	%	10.0
	16425367	CHEMBL3751225	Inhibition of p38 beta (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	8.7	CHEMBL3961	Homo sapiens	INH	%	8.7
	16431937	CHEMBL3748030	Inhibition of human P38beta using MBP as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	16451649	CHEMBL3761291	Inhibition of p38beta(unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	8.7	CHEMBL3961	Homo sapiens	INH	%	8.7
	16486366	CHEMBL3771600	Inhibition of human recombinant p38beta assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	16495221	CHEMBL3777763	Inhibition of N-terminal His6-tagged recombinant human SAPK2B expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	32.0	CHEMBL3961	Homo sapiens	Activity	%	32.0
	16496140	CHEMBL3777763	Inhibition of N-terminal His6-tagged recombinant human SAPK2B expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-10.0	CHEMBL3961	Homo sapiens	Activity	%	-10.0
	16508930	CHEMBL3777763	Inhibition of N-terminal His6-tagged recombinant human SAPK2B expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	48.0	CHEMBL3961	Homo sapiens	Activity	%	48.0
Not Active	16514151	CHEMBL3782372	Inhibition of partial length human p38beta expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
Not Active	16535256	CHEMBL3791883	Inhibition of full length recombinant human N-terminal GST-tagged p38-beta (1 to 364 residues) expressed in Escherichia coli using modified erktide as substrate at 0.05 to 50 uM after 1 hr by microfluidic assay	B	COc1ccc(/C=C/C(=O)NCCNC(=O)/C=C/c2ccc(OC)cc2OC)c(OC)c1		CHEMBL3787558		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	16594863	CHEMBL3812874	Inhibition of full length human p38-beta expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	92.0	CHEMBL3961	Homo sapiens	Activity	%	92.0
	16612709	CHEMBL3815731	Inhibition of SAPK2b (unknown origin) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-4.0	CHEMBL3961	Homo sapiens	Activity	%	-4.0
	16612710	CHEMBL3815731	Inhibition of SAPK2b (unknown origin) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-5.0	CHEMBL3961	Homo sapiens	Activity	%	-5.0
	16612711	CHEMBL3815731	Inhibition of SAPK2b (unknown origin) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-18.0	CHEMBL3961	Homo sapiens	Activity	%	-18.0
	16612712	CHEMBL3815731	Inhibition of SAPK2b (unknown origin) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-21.0	CHEMBL3961	Homo sapiens	Activity	%	-21.0
	16614569	CHEMBL3817600	Inhibition of human P38beta at 1 uM using MBP as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	3.0	CHEMBL3961	Homo sapiens	INH	%	3.0
	16618679	CHEMBL3816101	Inhibition of full length recombinant human His-tagged p38beta MAP kinase expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	16628483	CHEMBL3820186	Inhibition of human recombinant full-length p38beta at 1 uM after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL3961	Homo sapiens	INH	%	80.0
	16654180	CHEMBL3830955	Inhibition of human p38beta MAPK (1 to 364 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	76.0	CHEMBL3961	Homo sapiens	Activity	%	76.0
	16737971	CHEMBL3856688	Inhibition of human SAPK2b assessed as remaining activity at 10 uM in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	90.0	CHEMBL3961	Homo sapiens	Activity	%	90.0
	16761078	CHEMBL3862235	Inhibition of full length wild type human p38beta expressed in bacterial system at 2 uM by ADP quest assay	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL3939964		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	16844163	CHEMBL3877198	Inhibition of p38beta (unknown origin)	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	9.8	CHEMBL3961	Homo sapiens	IC50	nM	9.8
	16844164	CHEMBL3877198	Inhibition of p38beta (unknown origin)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	12.0	CHEMBL3961	Homo sapiens	IC50	nM	12.0
Inactive	17914961	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914962	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914963	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914964	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914965	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914966	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914967	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914968	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914969	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914970	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914971	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914972	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914973	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914974	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914975	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Active	17914976	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	872.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	872.0
Inactive	17914977	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914978	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914979	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914980	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914981	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914982	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914983	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914984	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914985	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914986	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914987	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914988	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914989	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914990	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914991	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914992	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914993	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914994	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914995	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914996	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Active	17914997	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Kd	nM	1911.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	1911.0
Inactive	17914998	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17914999	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915000	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915001	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915002	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915003	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915004	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915005	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915006	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915007	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915008	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915009	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915010	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915011	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915012	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915013	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915014	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915015	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915016	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915017	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915018	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915019	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915020	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915021	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915022	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915023	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915024	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915025	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915026	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915027	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915028	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915029	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915030	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915031	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915032	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915033	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915034	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915035	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915036	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915037	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915038	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915039	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915040	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915041	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915042	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915043	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915044	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915045	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915046	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915047	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915048	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915049	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Active	17915050	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	192.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	192.0
Inactive	17915051	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915052	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915053	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915054	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915055	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915056	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915057	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915058	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915059	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915060	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915061	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915062	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915063	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915064	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915065	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915066	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915067	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915068	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915069	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915070	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915071	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915072	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Active	17915073	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	=	Kd	nM	29.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	29.0
Inactive	17915074	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915075	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915076	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915077	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915078	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915079	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915080	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915081	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915082	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915083	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915084	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915085	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915086	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915087	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915088	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915089	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915090	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915091	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915092	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915093	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915094	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915095	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915096	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915097	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915098	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915099	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915100	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915101	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915102	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915103	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915104	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915105	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915106	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Active	17915107	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	=	Kd	nM	684.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	684.0
Inactive	17915108	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915109	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915110	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915111	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915112	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915113	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915114	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915115	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915116	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915117	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915118	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915119	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915120	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915121	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915122	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915123	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915124	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915125	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915126	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915127	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915128	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Active	17915129	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	Kd	nM	102.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	102.0
Inactive	17915130	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915131	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915132	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915133	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915134	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915135	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915136	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915137	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915138	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915139	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915140	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915141	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Active	17915142	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	2811.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	2811.0
Inactive	17915143	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915144	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915145	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915146	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915147	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915148	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915149	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915150	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915151	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915152	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915153	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915154	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915155	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915156	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915157	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915158	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915159	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915160	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915161	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915162	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915163	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915164	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915165	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915166	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915167	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915168	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Active	17915169	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	3743.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	3743.0
Inactive	17915170	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915171	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915172	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915173	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915174	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Active	17915175	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	=	Kd	nM	5.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	5.0
Inactive	17915176	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915177	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915178	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915179	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915180	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915181	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17915182	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	=	Kd	nM	10.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	10.0
Inactive	17915183	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915184	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Active	17915185	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	1012.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	1012.0
Inactive	17915186	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17915187	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	1723.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	1723.0
Inactive	17915188	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915189	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915190	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915191	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915192	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915193	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915194	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915195	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915196	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915197	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915198	CHEMBL3991771	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3961	Homo sapiens	Kd apparent	nM	30000.0
	17964930	CHEMBL3995039	Inhibition of full length human p38beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	59.0	CHEMBL3961	Homo sapiens	Activity	%	59.0
	18052921	CHEMBL4011933	Inhibition of p38beta (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-2.2	CHEMBL3961	Homo sapiens	INH	%	-2.2
	18114211	CHEMBL4025283	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	18138875	CHEMBL4030407	Inhibition of p38beta (unknown origin) at 10 uM relative to control	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C		CHEMBL432798	>	Inhibition	%	70.0	CHEMBL3961	Homo sapiens	INH	%	70.0
	18138876	CHEMBL4030407	Inhibition of p38beta (unknown origin) at 10 uM relative to control	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1		CHEMBL321494	>	Inhibition	%	70.0	CHEMBL3961	Homo sapiens	INH	%	70.0
Not Active	18138945	CHEMBL4030457	Inhibition of p38MAPK beta (unknown origin) at 10 uM relative to control	B	Cn1c([S+](C)[O-])nc(-c2ccc(F)cc2)c1-c1ccnc(N)c1		CHEMBL4075428		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	18153052	CHEMBL4034437	Inhibition of p38b protein kinase domain (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	0.4	CHEMBL3961	Homo sapiens	INH	%	0.4
	18168198	CHEMBL4036884	Inhibition of full length wild type human p38beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual activity at 2 uM by KINOMEscan assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)C(N)CCCCn1cc(CCCCNC(=O)CCCCCn2nc(N)c3cc(-c4c(-c5ccccc5)nn5ccccc45)nnc32)nn1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C		CHEMBL4079223	=	Activity	%	11.0	CHEMBL3961	Homo sapiens	Activity	%	11.0
	18203807	CHEMBL4044094	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	87.0	CHEMBL3961	Homo sapiens	Activity	%	87.0
	18232087	CHEMBL4050415	Inhibition of human P38b MAPK assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	107.0	CHEMBL3961	Homo sapiens	Activity	%	107.0
	18253447	CHEMBL4055007	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	78.0	CHEMBL3961	Homo sapiens	Activity	%	78.0
	18253448	CHEMBL4055007	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	80.0	CHEMBL3961	Homo sapiens	Activity	%	80.0
	18265844	CHEMBL4057294	Inhibition of p38-beta2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-1.3	CHEMBL3961	Homo sapiens	INH	%	-1.3
	18266040	CHEMBL4057490	Inhibition of p38-beta2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	0.7	CHEMBL3961	Homo sapiens	INH	%	0.7
	18282132	CHEMBL4120087	Inhibition of recombinant full length His-tagged human p38beta expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	9.3	CHEMBL3961	Homo sapiens	INH	%	9.3
	18282451	CHEMBL4120087	Inhibition of recombinant full length His-tagged human p38beta expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	2.5	CHEMBL3961	Homo sapiens	INH	%	2.5
	18282809	CHEMBL4120394	Inhibition of p38-beta2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-1.3	CHEMBL3961	Homo sapiens	INH	%	-1.3
	18283036	CHEMBL4120621	Inhibition of p38-beta2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-1.7	CHEMBL3961	Homo sapiens	INH	%	-1.7
	18283260	CHEMBL4120845	Inhibition of p38-beta2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	1.7	CHEMBL3961	Homo sapiens	INH	%	1.7
	18434128	CHEMBL4156110	Inhibition of recombinant human full length His-tagged p38-beta expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1		CHEMBL4177361	=	Inhibition	%	4.0	CHEMBL3961	Homo sapiens	INH	%	4.0
	18434216	CHEMBL4156110	Inhibition of recombinant human full length His-tagged p38-beta expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	2.0	CHEMBL3961	Homo sapiens	INH	%	2.0
	18434276	CHEMBL4156110	Inhibition of recombinant human full length His-tagged p38-beta expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	2.0	CHEMBL3961	Homo sapiens	INH	%	2.0
	18434348	CHEMBL4156110	Inhibition of recombinant human full length His-tagged p38-beta expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	6.0	CHEMBL3961	Homo sapiens	INH	%	6.0
	18440349	CHEMBL4157173	Binding affinity to wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	18449928	CHEMBL4178162	Inhibition of human p38beta (1 to 364 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	80.0	CHEMBL3961	Homo sapiens	Activity	%	80.0
	18484305	CHEMBL4185952	Binding affinity to wild-type human full length p38-beta (M1 to Q364 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	89.0	CHEMBL3961	Homo sapiens	Activity	%	89.0
	18484789	CHEMBL4185952	Binding affinity to wild-type human full length p38-beta (M1 to Q364 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	18489540	CHEMBL4187281	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	96.0	CHEMBL3961	Homo sapiens	Activity	%	96.0
	18507610	CHEMBL4191183	Inhibition of recombinant full-length human SAPK2b at 1 uM using myelin basic protein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-1.0	CHEMBL3961	Homo sapiens	INH	%	-1.0
	18558665	CHEMBL4201053	Inhibition of human P38beta at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	98.0	CHEMBL3961	Homo sapiens	INH	%	98.0
	18653479	CHEMBL4230164	Inhibition of P38-beta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	23.0	CHEMBL3961	Homo sapiens	INH	%	23.0
	18653480	CHEMBL4230164	Inhibition of P38-beta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	3.0	CHEMBL3961	Homo sapiens	INH	%	3.0
	18655383	CHEMBL4230852	Binding affinity to wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	18663936	CHEMBL4232920	Inhibition of full length human p38beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	18664033	CHEMBL4233017	Binding affinity to full length human p38beta (M1 to Q364 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL3961	Homo sapiens	Kd	uM	5.0
	18665440	CHEMBL4233368	Inhibition of P38beta (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	nM	10000.0
	18674799	CHEMBL4235401	Inhibition of p38beta (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	10000.0	CHEMBL3961	Homo sapiens	Ki	nM	10000.0
Not Determined	18674800	CHEMBL4235401	Inhibition of p38beta (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242		Ki			CHEMBL3961	Homo sapiens	Ki		
	18674801	CHEMBL4235401	Inhibition of p38beta (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	10000.0	CHEMBL3961	Homo sapiens	Ki	nM	10000.0
	18697665	CHEMBL4254338	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	60.0	CHEMBL3961	Homo sapiens	Activity	%	60.0
	18751174	CHEMBL4263883	Inhibition of P38-BETA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	INH	%	0.0
	18752104	CHEMBL4264441	Binding affinity to wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	85.0	CHEMBL3961	Homo sapiens	Activity	%	85.0
Not Active	18847291	CHEMBL4304929	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	18858105	CHEMBL4307951	Binding affinity to wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	96.0	CHEMBL3961	Homo sapiens	Activity	%	96.0
	18886148	CHEMBL4313402	Inhibition of human p38beta at 10 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4553144	=	Inhibition	%	63.23	CHEMBL3961	Homo sapiens	INH	%	63.23
	18892711	CHEMBL4314538	Inhibition of recombinant full-length human SAPK2b assessed as residual activity at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	100.5	CHEMBL3961	Homo sapiens	Activity	%	100.5
	18923859	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL3939964	=	Delta Tm	degrees C	12.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	12.5
	18923860	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(NC(=O)c1cnn(-c2ccccc2)c1N)c1ccc(C(=O)NC(C)(C)C(N)=O)cc1		CHEMBL4581578	=	Delta Tm	degrees C	0.7	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.7
	18923861	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(NC(=O)c1cnn(-c2ccccc2)c1N)c1ccc(C(=O)N[C@@H](CC2CCCCC2)C(N)=O)cc1		CHEMBL4580635	=	Delta Tm	degrees C	1.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.6
	18923862	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1ccc(C(C)NC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4460945	=	Delta Tm	degrees C	1.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.2
	18923863	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(NC(=O)c1cnn(-c2ccccc2)c1N)c1ccc(C(=O)NC2CC2)cc1		CHEMBL4574781	=	Delta Tm	degrees C	1.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.6
	18923864	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)(NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4454896	=	Delta Tm	degrees C	0.4	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.4
	18923865	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2N)s1		CHEMBL4439959	=	Delta Tm	degrees C	9.1	CHEMBL3961	Homo sapiens	deltaTm	degrees C	9.1
	18923866	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4455632	=	Delta Tm	degrees C	3.9	CHEMBL3961	Homo sapiens	deltaTm	degrees C	3.9
	18923867	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Nc1c(C(=O)NCc2ncc(C(=O)NC3CC3)s2)cnn1-c1ccccc1		CHEMBL4444997	=	Delta Tm	degrees C	9.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	9.6
	18923868	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NC(C)(C)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL4440113	=	Delta Tm	degrees C	2.1	CHEMBL3961	Homo sapiens	deltaTm	degrees C	2.1
	18923869	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL4443551	=	Delta Tm	degrees C	12.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	12.5
	18923870	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC(C)C)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL4540969	=	Delta Tm	degrees C	7.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	7.0
	18923871	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL1290404	=	Delta Tm	degrees C	14.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	14.0
	18923872	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)(NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4548688	=	Delta Tm	degrees C	0.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.0
	18923873	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2N)s1		CHEMBL4455604	=	Delta Tm	degrees C	0.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.5
	18923874	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4537345	=	Delta Tm	degrees C	0.1	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.1
	18923875	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Nc1c(C(=O)Nc2ccc(C(=O)NC3CC3)s2)cnn1-c1ccccc1		CHEMBL4544936	=	Delta Tm	degrees C	0.4	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.4
	18923876	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)(NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2)cc1)C(N)=O		CHEMBL4524754	=	Delta Tm	degrees C	0.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.0
	18923877	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2)cc1		CHEMBL4587099	=	Delta Tm	degrees C	0.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.5
	18923878	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2)cc1)C(N)=O		CHEMBL4591811	=	Delta Tm	degrees C	0.1	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.1
	18923879	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	O=C(NCc1ccc(C(=O)NC2CC2)cc1)c1cnn(-c2ccccc2)c1		CHEMBL4441653	=	Delta Tm	degrees C	0.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.0
	18923880	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)NC(C)(C)C(N)=O)cc2)cn1		CHEMBL4474175	=	Delta Tm	degrees C	0.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.2
	18923881	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)N[C@@H](CC3CCCCC3)C(N)=O)cc2)cn1		CHEMBL4440440	=	Delta Tm	degrees C	2.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	2.5
	18923882	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)N[C@@H](CCC(C)C)C(N)=O)cc2)cn1		CHEMBL4545614	=	Delta Tm	degrees C	0.7	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.7
	18923883	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)NC3CC3)cc2)cn1		CHEMBL4447850	=	Delta Tm	degrees C	2.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	2.2
	18923884	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)(NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1)C(N)=O		CHEMBL4448307	=	Delta Tm	degrees C	-0.3	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.3
	18923885	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4524960	=	Delta Tm	degrees C	-0.1	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.1
	18923886	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1)C(N)=O		CHEMBL4534601	=	Delta Tm	degrees C	-0.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.2
	18923887	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	O=C(NC1CC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4464108	=	Delta Tm	degrees C	0.1	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.1
	18923888	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)(NC(=O)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1)C(N)=O		CHEMBL4455243	=	Delta Tm	degrees C	-0.1	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.1
	18923889	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1		CHEMBL4436254	=	Delta Tm	degrees C	0.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.5
	18923890	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1)C(N)=O		CHEMBL4520933	=	Delta Tm	degrees C	-0.1	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.1
	18923891	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	O=C(NC1CC1)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1		CHEMBL4584521	=	Delta Tm	degrees C	0.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.0
	18923892	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2)s1		CHEMBL4531946	=	Delta Tm	degrees C	10.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	10.6
	18923893	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2)s1		CHEMBL4582420	=	Delta Tm	degrees C	-1.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-1.0
	18923894	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1		CHEMBL4473671	=	Delta Tm	degrees C	12.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	12.0
	18923895	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(NC(=O)c1cnn(-c2ccccc2)c1)c1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1		CHEMBL4438679	=	Delta Tm	degrees C	2.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	2.5
	18923896	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)NCc2ncc(C(=O)N[C@@H](CCC3CCCCC3)C(N)=O)s2)cn1		CHEMBL4574467	=	Delta Tm	degrees C	13.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	13.0
	18923897	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)Nc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(N)=O)s2)cn1		CHEMBL4591730	=	Delta Tm	degrees C	-0.9	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.9
	18923898	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2C)c1		CHEMBL4476320	=	Delta Tm	degrees C	15.3	CHEMBL3961	Homo sapiens	deltaTm	degrees C	15.3
	18923899	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)NC(C)c2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(N)=O)cc2)cn1		CHEMBL4440391	=	Delta Tm	degrees C	4.9	CHEMBL3961	Homo sapiens	deltaTm	degrees C	4.9
	18923900	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)s1		CHEMBL4568134	=	Delta Tm	degrees C	7.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	7.2
	18923901	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)s1		CHEMBL4541621	=	Delta Tm	degrees C	-0.8	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.8
	18923902	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1C(F)(F)F		CHEMBL4465031	=	Delta Tm	degrees C	6.7	CHEMBL3961	Homo sapiens	deltaTm	degrees C	6.7
	18923903	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(NC(=O)c1cnn(-c2ccccc2)c1C(F)(F)F)c1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1		CHEMBL4462660	=	Delta Tm	degrees C	0.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.2
	18923904	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)s1		CHEMBL4561109	=	Delta Tm	degrees C	3.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	3.0
	18923905	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cc(-c3ccccc3)n[nH]2)s1		CHEMBL4572186	=	Delta Tm	degrees C	-1.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-1.0
	18923906	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cc(-c2ccccc2)n[nH]1		CHEMBL4549215	=	Delta Tm	degrees C	3.9	CHEMBL3961	Homo sapiens	deltaTm	degrees C	3.9
	18923907	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(NC(=O)c1cc(-c2ccccc2)n[nH]1)c1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1		CHEMBL4584086	=	Delta Tm	degrees C	-0.1	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.1
	18923908	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4471195	=	Delta Tm	degrees C	1.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.6
	18923909	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CNC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4436353	=	Delta Tm	degrees C	1.4	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.4
	18923910	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Nc1c(C(=O)NCc2ccc(C(=O)NC3CC3)cc2)cnn1-c1ccccc1		CHEMBL4536573	=	Delta Tm	degrees C	3.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	3.0
	18923911	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CCCNC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4452908	=	Delta Tm	degrees C	5.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	5.2
Not Determined	18923912	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		deltaTm			CHEMBL3961	Homo sapiens	deltaTm		
	18923913	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)CNC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4466149	=	Delta Tm	degrees C	0.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.6
	18923914	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	C[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4475072	=	Delta Tm	degrees C	1.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.2
	18923915	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)C1(NC(=O)c2ccc(CNC(=O)c3cnn(-c4ccccc4)c3N)cc2)CC1		CHEMBL4473924	=	Delta Tm	degrees C	2.1	CHEMBL3961	Homo sapiens	deltaTm	degrees C	2.1
	18923916	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)C[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4459087	=	Delta Tm	degrees C	0.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.5
	18923917	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CCCC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4522291	=	Delta Tm	degrees C	1.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.2
	18923918	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4513917	=	Delta Tm	degrees C	1.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.6
	18923919	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CN(C)C(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4469162	=	Delta Tm	degrees C	0.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.2
	18923920	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	C[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(=O)N(C)C		CHEMBL4462513	=	Delta Tm	degrees C	0.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.6
	18923921	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CN(C)C(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4465838	=	Delta Tm	degrees C	8.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	8.0
	18923922	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)c2ccc(CNC(=O)c3cnn(-c4ccccc4)c3N)cc2)cc1		CHEMBL4441119	=	Delta Tm	degrees C	5.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	5.5
	18923923	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL2401983	=	Delta Tm	degrees C	3.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	3.6
	18923924	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4552734	=	Delta Tm	degrees C	1.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.2
	18923925	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CNC(=O)c1ccc(C)c(NC(=O)c2ccc(-c3ccccc3Cl)s2)c1		CHEMBL4449421	=	Delta Tm	degrees C	1.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.6
	18923926	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NCCCC(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4539759	=	Delta Tm	degrees C	-0.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.6
	18923927	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NCCCC2CCCCC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4578152	=	Delta Tm	degrees C	2.8	CHEMBL3961	Homo sapiens	deltaTm	degrees C	2.8
	18923928	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NCC(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4447226	=	Delta Tm	degrees C	0.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.2
	18923929	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](C)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4537919	=	Delta Tm	degrees C	0.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.5
	18923930	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NC2(C(N)=O)CC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4457772	=	Delta Tm	degrees C	2.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	2.5
	18923931	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CC(C)C)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4536763	=	Delta Tm	degrees C	1.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.0
	18923932	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CCCC[C@H](NC(=O)c1ccc(C)c(NC(=O)c2ccc(-c3ccccc3Cl)s2)c1)C(N)=O		CHEMBL4556210	=	Delta Tm	degrees C	0.1	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.1
	18923933	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC(C)C)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4530981	=	Delta Tm	degrees C	-0.7	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.7
	18923934	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4462636	=	Delta Tm	degrees C	3.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	3.6
	18923935	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4449398	=	Delta Tm	degrees C	3.7	CHEMBL3961	Homo sapiens	deltaTm	degrees C	3.7
	18923936	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](C)C(=O)N(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4588589	=	Delta Tm	degrees C	-0.3	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.3
	18923937	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(=O)N(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4437864	=	Delta Tm	degrees C	0.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.5
	18923938	CHEMBL4324173	Binding affinity to P38beta MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)c2ccc(C)c(NC(=O)c3ccc(-c4ccccc4Cl)s3)c2)cc1		CHEMBL4445600	=	Delta Tm	degrees C	1.4	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.4
	18924019	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL3939964	=	IC50	nM	250.0	CHEMBL3961	Homo sapiens	IC50	uM	0.25
	18924020	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(NC(=O)c1cnn(-c2ccccc2)c1N)c1ccc(C(=O)NC(C)(C)C(N)=O)cc1		CHEMBL4581578	=	IC50	nM	4800.0	CHEMBL3961	Homo sapiens	IC50	uM	4.8
	18924021	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(NC(=O)c1cnn(-c2ccccc2)c1N)c1ccc(C(=O)N[C@@H](CC2CCCCC2)C(N)=O)cc1		CHEMBL4580635	=	IC50	nM	8700.0	CHEMBL3961	Homo sapiens	IC50	uM	8.7
	18924022	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1ccc(C(C)NC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4460945	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924023	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(NC(=O)c1cnn(-c2ccccc2)c1N)c1ccc(C(=O)NC2CC2)cc1		CHEMBL4574781	=	IC50	nM	7300.0	CHEMBL3961	Homo sapiens	IC50	uM	7.3
	18924024	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)(NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4454896	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924025	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2N)s1		CHEMBL4439959	=	IC50	nM	370.0	CHEMBL3961	Homo sapiens	IC50	uM	0.37
	18924026	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4455632	=	IC50	nM	1700.0	CHEMBL3961	Homo sapiens	IC50	uM	1.7
	18924027	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Nc1c(C(=O)NCc2ncc(C(=O)NC3CC3)s2)cnn1-c1ccccc1		CHEMBL4444997	=	IC50	nM	59.0	CHEMBL3961	Homo sapiens	IC50	uM	0.059
	18924028	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NC(C)(C)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL4440113	=	IC50	nM	960.0	CHEMBL3961	Homo sapiens	IC50	uM	0.96
	18924029	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL4443551	=	IC50	nM	99.0	CHEMBL3961	Homo sapiens	IC50	uM	0.099
	18924030	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC(C)C)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL4540969	=	IC50	nM	736.0	CHEMBL3961	Homo sapiens	IC50	uM	0.736
	18924031	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL1290404	=	IC50	nM	10.0	CHEMBL3961	Homo sapiens	IC50	uM	0.01
	18924032	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)(NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4548688	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924033	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2N)s1		CHEMBL4455604	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924034	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4537345	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924035	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Nc1c(C(=O)Nc2ccc(C(=O)NC3CC3)s2)cnn1-c1ccccc1		CHEMBL4544936	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924036	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)(NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2)cc1)C(N)=O		CHEMBL4524754	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924037	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2)cc1		CHEMBL4587099	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924038	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2)cc1)C(N)=O		CHEMBL4591811	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924039	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	O=C(NCc1ccc(C(=O)NC2CC2)cc1)c1cnn(-c2ccccc2)c1		CHEMBL4441653	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924040	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)NC(C)(C)C(N)=O)cc2)cn1		CHEMBL4474175	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924041	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)N[C@@H](CC3CCCCC3)C(N)=O)cc2)cn1		CHEMBL4440440	=	IC50	nM	1960.0	CHEMBL3961	Homo sapiens	IC50	uM	1.96
	18924042	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)N[C@@H](CCC(C)C)C(N)=O)cc2)cn1		CHEMBL4545614	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924043	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)NC3CC3)cc2)cn1		CHEMBL4447850	=	IC50	nM	2180.0	CHEMBL3961	Homo sapiens	IC50	uM	2.18
	18924044	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)(NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1)C(N)=O		CHEMBL4448307	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924045	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4524960	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924046	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1)C(N)=O		CHEMBL4534601	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924047	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	O=C(NC1CC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4464108	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924048	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)(NC(=O)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1)C(N)=O		CHEMBL4455243	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924049	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1		CHEMBL4436254	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924050	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1)C(N)=O		CHEMBL4520933	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924051	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	O=C(NC1CC1)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1		CHEMBL4584521	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924052	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2)s1		CHEMBL4531946	=	IC50	nM	328.0	CHEMBL3961	Homo sapiens	IC50	uM	0.328
	18924053	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2)s1		CHEMBL4582420	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924054	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1		CHEMBL4473671	=	IC50	nM	209.0	CHEMBL3961	Homo sapiens	IC50	uM	0.209
	18924055	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(NC(=O)c1cnn(-c2ccccc2)c1)c1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1		CHEMBL4438679	=	IC50	nM	5050.0	CHEMBL3961	Homo sapiens	IC50	uM	5.05
	18924056	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)NCc2ncc(C(=O)N[C@@H](CCC3CCCCC3)C(N)=O)s2)cn1		CHEMBL4574467	=	IC50	nM	191.0	CHEMBL3961	Homo sapiens	IC50	uM	0.191
	18924057	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)Nc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(N)=O)s2)cn1		CHEMBL4591730	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924058	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2C)c1		CHEMBL4476320	=	IC50	nM	144.0	CHEMBL3961	Homo sapiens	IC50	uM	0.144
	18924059	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)NC(C)c2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(N)=O)cc2)cn1		CHEMBL4440391	=	IC50	nM	970.0	CHEMBL3961	Homo sapiens	IC50	uM	0.97
	18924060	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)s1		CHEMBL4568134	=	IC50	nM	9890.0	CHEMBL3961	Homo sapiens	IC50	uM	9.89
	18924061	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)s1		CHEMBL4541621	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924062	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1C(F)(F)F		CHEMBL4465031	=	IC50	nM	550.0	CHEMBL3961	Homo sapiens	IC50	uM	0.55
	18924063	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(NC(=O)c1cnn(-c2ccccc2)c1C(F)(F)F)c1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1		CHEMBL4462660	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924064	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)s1		CHEMBL4561109	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924065	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cc(-c3ccccc3)n[nH]2)s1		CHEMBL4572186	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924066	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cc(-c2ccccc2)n[nH]1		CHEMBL4549215	=	IC50	nM	1282.0	CHEMBL3961	Homo sapiens	IC50	uM	1.282
	18924067	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(NC(=O)c1cc(-c2ccccc2)n[nH]1)c1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1		CHEMBL4584086	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924068	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4471195	=	IC50	nM	4540.0	CHEMBL3961	Homo sapiens	IC50	uM	4.54
	18924069	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CNC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4436353	=	IC50	nM	2970.0	CHEMBL3961	Homo sapiens	IC50	uM	2.97
	18924070	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Nc1c(C(=O)NCc2ccc(C(=O)NC3CC3)cc2)cnn1-c1ccccc1		CHEMBL4536573	=	IC50	nM	3830.0	CHEMBL3961	Homo sapiens	IC50	uM	3.83
	18924071	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CCCNC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4452908	=	IC50	nM	730.0	CHEMBL3961	Homo sapiens	IC50	uM	0.73
	18924072	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748	=	IC50	nM	32.0	CHEMBL3961	Homo sapiens	IC50	uM	0.032
	18924073	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)CNC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4466149	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924074	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	C[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4475072	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924075	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)C1(NC(=O)c2ccc(CNC(=O)c3cnn(-c4ccccc4)c3N)cc2)CC1		CHEMBL4473924	=	IC50	nM	6180.0	CHEMBL3961	Homo sapiens	IC50	uM	6.18
	18924076	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)C[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4459087	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924077	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CCCC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4522291	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924078	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4513917	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924079	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CN(C)C(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4469162	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924080	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	C[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(=O)N(C)C		CHEMBL4462513	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924081	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CN(C)C(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4465838	=	IC50	nM	660.0	CHEMBL3961	Homo sapiens	IC50	uM	0.66
	18924082	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)c2ccc(CNC(=O)c3cnn(-c4ccccc4)c3N)cc2)cc1		CHEMBL4441119	=	IC50	nM	1600.0	CHEMBL3961	Homo sapiens	IC50	uM	1.6
	18924083	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL2401983	=	IC50	nM	265.0	CHEMBL3961	Homo sapiens	IC50	uM	0.265
	18924084	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4552734	=	IC50	nM	1990.0	CHEMBL3961	Homo sapiens	IC50	uM	1.99
	18924085	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CNC(=O)c1ccc(C)c(NC(=O)c2ccc(-c3ccccc3Cl)s2)c1		CHEMBL4449421	=	IC50	nM	1160.0	CHEMBL3961	Homo sapiens	IC50	uM	1.16
	18924086	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NCCCC(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4539759	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924087	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NCCCC2CCCCC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4578152	=	IC50	nM	364.0	CHEMBL3961	Homo sapiens	IC50	uM	0.364
	18924088	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NCC(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4447226	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924089	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](C)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4537919	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924090	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NC2(C(N)=O)CC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4457772	=	IC50	nM	2480.0	CHEMBL3961	Homo sapiens	IC50	uM	2.48
	18924091	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CC(C)C)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4536763	=	IC50	nM	7050.0	CHEMBL3961	Homo sapiens	IC50	uM	7.05
	18924092	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CCCC[C@H](NC(=O)c1ccc(C)c(NC(=O)c2ccc(-c3ccccc3Cl)s2)c1)C(N)=O		CHEMBL4556210	=	IC50	nM	7370.0	CHEMBL3961	Homo sapiens	IC50	uM	7.37
	18924093	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC(C)C)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4530981	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924094	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4462636	=	IC50	nM	167.0	CHEMBL3961	Homo sapiens	IC50	uM	0.167
	18924095	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4449398	=	IC50	nM	3530.0	CHEMBL3961	Homo sapiens	IC50	uM	3.53
	18924096	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](C)C(=O)N(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4588589	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924097	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(=O)N(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4437864	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	18924098	CHEMBL4324175	Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)c2ccc(C)c(NC(=O)c3ccc(-c4ccccc4Cl)s3)c2)cc1		CHEMBL4445600	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
Active	18924179	CHEMBL4324187	Inhibition of p38-beta (unknown origin) expressed in human HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	CNC(=O)c1ccc(C)c(NC(=O)c2ccc(-c3ccccc3Cl)s2)c1		CHEMBL4449421		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
Active	18924180	CHEMBL4324187	Inhibition of p38-beta (unknown origin) expressed in human HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	Cc1ccc(C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4552734		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
Active	18924181	CHEMBL4324187	Inhibition of p38-beta (unknown origin) expressed in human HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL2401983		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	18924189	CHEMBL4324179	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	INH	%	0.0
	18924198	CHEMBL4324187	Inhibition of p38-beta (unknown origin) expressed in human HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748	=	IC50	nM	10.0	CHEMBL3961	Homo sapiens	IC50	uM	0.01
	18924199	CHEMBL4324187	Inhibition of p38-beta (unknown origin) expressed in human HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775	=	IC50	nM	11000.0	CHEMBL3961	Homo sapiens	IC50	uM	11.0
	18938163	CHEMBL4327808	Inhibition of human p38beta assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	107.13	CHEMBL3961	Homo sapiens	Activity	%	107.13
	18938164	CHEMBL4327808	Inhibition of human p38beta assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	104.82	CHEMBL3961	Homo sapiens	Activity	%	104.82
	18938653	CHEMBL4328172	Inhibition of human p38beta assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Activity	%	65.0	CHEMBL3961	Homo sapiens	Activity	%	65.0
Not Determined	18939036	CHEMBL4328536	Inhibition of human p38beta using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL3961	Homo sapiens	IC50		
	18939037	CHEMBL4328536	Inhibition of human p38beta using MBP as substrate by [gamma-33P]-ATP assay	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	33.1	CHEMBL3961	Homo sapiens	IC50	10'-8M	3.31
	18958655	CHEMBL4333536	Binding affinity to wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	83.0	CHEMBL3961	Homo sapiens	Activity	%	83.0
	18964678	CHEMBL4335280	Inhibition of recombinant human full length SAPK2b assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	18964679	CHEMBL4335280	Inhibition of recombinant human full length SAPK2b assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	18972095	CHEMBL4337105	Inhibition of recombinant human full length SAPK2b assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	93.0	CHEMBL3961	Homo sapiens	Activity	%	93.0
	18972838	CHEMBL4337341	Inhibition of full-length N-terminal GST-tagged human P38beta (1 to 364 residues) expressed in Escherichia coli at 10 uM using propeptide-8 as substrate after 90 mins by electrophoretic mobility shift assay relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2c(c1)OCCO2		CHEMBL4580637	=	Inhibition	%	90.0	CHEMBL3961	Homo sapiens	INH	%	90.0
	18972856	CHEMBL4337355	Inhibition of full-length N-terminal GST-tagged human P38beta (1 to 364 residues) expressed in Escherichia coli using propeptide-8 as substrate after 90 mins by caliper based analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2c(c1)OCCO2		CHEMBL4580637	=	IC50	nM	784.0	CHEMBL3961	Homo sapiens	IC50	uM	0.784
Not Active	19040153	CHEMBL4352054	Inhibition of recombinant full-length human SAPK2b at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
Active	19041215	CHEMBL4352476	Inhibition of human p38beta at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	19059729	CHEMBL4358030	Binding affinity to wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	98.0	CHEMBL3961	Homo sapiens	Activity	%	98.0
	19090294	CHEMBL4365868	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	89.0	CHEMBL3961	Homo sapiens	Activity	%	89.0
	19092046	CHEMBL4366520	Inhibition of human p38beta at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	9.33	CHEMBL3961	Homo sapiens	INH	%	9.33
	19144840	CHEMBL4377856	Inhibition of recombinant full-length human SAPK2b at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	27.0	CHEMBL3961	Homo sapiens	INH	%	27.0
	19148033	CHEMBL4379429	Inhibition of recombinant human full length SAPK2b using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	19159557	CHEMBL4382661	Binding affinity to wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	96.0	CHEMBL3961	Homo sapiens	Activity	%	96.0
	19181176	CHEMBL4387387	Inhibition of recombinant full length human His-tagged p38beta expressed in baculovirus expression system at 0.1 uM using serine/threonine-15 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	8.0	CHEMBL3961	Homo sapiens	INH	%	8.0
	19181401	CHEMBL4387387	Inhibition of recombinant full length human His-tagged p38beta expressed in baculovirus expression system at 0.1 uM using serine/threonine-15 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	6.0	CHEMBL3961	Homo sapiens	INH	%	6.0
	19191450	CHEMBL4389380	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL3961	Homo sapiens	INH	%	100.0
	19192043	CHEMBL4389857	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	92.0	CHEMBL3961	Homo sapiens	INH	%	92.0
	19200299	CHEMBL4391483	Binding affinity to wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	74.0	CHEMBL3961	Homo sapiens	Activity	%	74.0
	19266543	CHEMBL4405493	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	19271881	CHEMBL4406949	Inhibition of p38beta (unknown origin) using biotinylated maltose peptide as substrate after 60 mins	B	O=S(=O)(O)c1cccc2cccc(Nc3ccccc3)c12		CHEMBL285527	>	IC50	nM	40000.0	CHEMBL3961	Homo sapiens	IC50	uM	40.0
	19276125	CHEMBL4408128	Inhibition of recombinant human full length SAPK2b at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL3961	Homo sapiens	INH	%	0.0
	19371158	CHEMBL4424910	Inhibition of human full-length N-terminal GST-tagged SAPK2b2 expressed in baculovirus infected Sf21 insect cells using MBP as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL3961	Homo sapiens	IC50	nM	1000.0
	20598006	CHEMBL4602785	Inhibition of human p38beta	B	c1ccc(-c2nnc(N3CCN(c4ncccn4)CC3)cc2-c2ccncc2)cc1		CHEMBL4632881	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	20598007	CHEMBL4602785	Inhibition of human p38beta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccccc3)nn2)CC1		CHEMBL4639555	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	20598008	CHEMBL4602785	Inhibition of human p38beta	B	c1ccc(-c2nnc(N3CCNCC3)cc2-c2ccncc2)cc1		CHEMBL4639028	=	IC50	nM	3310.0	CHEMBL3961	Homo sapiens	IC50	uM	3.31
	20598009	CHEMBL4602785	Inhibition of human p38beta	B	CCN(CC)c1cc(-c2ccncc2)c(-c2ccccc2)nn1		CHEMBL4642101	=	IC50	nM	3030.0	CHEMBL3961	Homo sapiens	IC50	uM	3.03
	20598010	CHEMBL4602785	Inhibition of human p38beta	B	CCCN(C)c1cc(-c2ccncc2)c(-c2ccccc2)nn1		CHEMBL4648747	=	IC50	nM	6370.0	CHEMBL3961	Homo sapiens	IC50	uM	6.37
	20598011	CHEMBL4602785	Inhibition of human p38beta	B	CN(C)c1cc(-c2ccncc2)c(-c2ccccc2)nn1		CHEMBL4645737	=	IC50	nM	8020.0	CHEMBL3961	Homo sapiens	IC50	uM	8.02
	20598012	CHEMBL4602785	Inhibition of human p38beta	B	CN(C)c1cc(-c2ccncc2)c(-c2cccc3ccccc23)nn1		CHEMBL4646628	=	IC50	nM	410.0	CHEMBL3961	Homo sapiens	IC50	uM	0.41
	20598013	CHEMBL4602785	Inhibition of human p38beta	B	CN(C)c1cc(-c2ccncc2)c(-c2cccc3ccccc23)nn1		CHEMBL4646628	=	Ki	nM	320.0	CHEMBL3961	Homo sapiens	Ki	uM	0.32
	20598014	CHEMBL4602785	Inhibition of human p38beta	B	CN(C)c1cc(-c2ccncc2)c(-c2ccc3ccccc3c2)nn1		CHEMBL4648060	=	IC50	nM	3030.0	CHEMBL3961	Homo sapiens	IC50	uM	3.03
	20598015	CHEMBL4602785	Inhibition of human p38beta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4ccccc4c3)nn2)CC1		CHEMBL4129018	=	IC50	nM	1850.0	CHEMBL3961	Homo sapiens	IC50	uM	1.85
	20598016	CHEMBL4602785	Inhibition of human p38beta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4cc(F)ccc4c3)nn2)CC1		CHEMBL4643993	=	IC50	nM	3200.0	CHEMBL3961	Homo sapiens	IC50	uM	3.2
	20598017	CHEMBL4602785	Inhibition of human p38beta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4ccc(F)cc4c3)nn2)CC1		CHEMBL4640881	=	IC50	nM	2600.0	CHEMBL3961	Homo sapiens	IC50	uM	2.6
	20598018	CHEMBL4602785	Inhibition of human p38beta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4cccc(F)c4c3)nn2)CC1		CHEMBL4642456	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	20598019	CHEMBL4602785	Inhibition of human p38beta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4c(F)cccc4c3)nn2)CC1		CHEMBL4643060	>	IC50	nM	10000.0	CHEMBL3961	Homo sapiens	IC50	uM	10.0
	20598020	CHEMBL4602785	Inhibition of human p38beta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4[nH]ccc4c3)nn2)CC1		CHEMBL4635980	=	IC50	nM	6740.0	CHEMBL3961	Homo sapiens	IC50	uM	6.74
	20598021	CHEMBL4602785	Inhibition of human p38beta	B	c1ccc2cc(-c3nnc(N4CCNCC4)cc3-c3ccncc3)ccc2c1		CHEMBL4647072	=	IC50	nM	500.0	CHEMBL3961	Homo sapiens	IC50	uM	0.5
	20598022	CHEMBL4602785	Inhibition of human p38beta	B	c1ccc2cc(-c3nnc(N4CCCCC4)cc3-c3ccncc3)ccc2c1		CHEMBL4635988	=	IC50	nM	1300.0	CHEMBL3961	Homo sapiens	IC50	uM	1.3
	20598023	CHEMBL4602785	Inhibition of human p38beta	B	c1ccc2cc(-c3nnc(N4CCCC4)cc3-c3ccncc3)ccc2c1		CHEMBL4639995	=	IC50	nM	2190.0	CHEMBL3961	Homo sapiens	IC50	uM	2.19
	20598024	CHEMBL4602785	Inhibition of human p38beta	B	c1ccc2cc(-c3nnc(N4CCC4)cc3-c3ccncc3)ccc2c1		CHEMBL4643246	=	IC50	nM	3080.0	CHEMBL3961	Homo sapiens	IC50	uM	3.08
	20598025	CHEMBL4602785	Inhibition of human p38beta	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	IC50	nM	1000.0	CHEMBL3961	Homo sapiens	IC50	uM	1.0
	20598026	CHEMBL4602785	Inhibition of human p38beta	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	IC50	nM	1000.0	CHEMBL3961	Homo sapiens	IC50	uM	1.0
	20598027	CHEMBL4602785	Inhibition of human p38beta	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	IC50	nM	1000.0	CHEMBL3961	Homo sapiens	IC50	uM	1.0
	20600578	CHEMBL4603530	Inhibition of recombinant full length human His-tagged p38beta expressed in baculovirus expression system using serine/threonine-15 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3961	Homo sapiens	IC50	uM	100.0
	22391689	CHEMBL4666969	Inhibition of recombinant human His-tagged full length p38 beta expressed in baculovirus expression system using Ser/Thr 15 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	9.0	CHEMBL3961	Homo sapiens	INH	%	9.0
	22391690	CHEMBL4666969	Inhibition of recombinant human His-tagged full length p38 beta expressed in baculovirus expression system using Ser/Thr 15 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	11.0	CHEMBL3961	Homo sapiens	INH	%	11.0
	22391691	CHEMBL4666969	Inhibition of recombinant human His-tagged full length p38 beta expressed in baculovirus expression system using Ser/Thr 15 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	5.0	CHEMBL3961	Homo sapiens	INH	%	5.0
	22392198	CHEMBL4667293	Inhibition of recombinant human His-tagged full length p38 beta expressed in baculovirus expression system using Ser/Thr 15 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	9.0	CHEMBL3961	Homo sapiens	INH	%	9.0
	22421637	CHEMBL4673639	Inhibition of human p38beta MAPK (1 to 364 residues) at 10 uM incubated for 5 mins in presence of [gamma33P]ATP by scintillation counting analysis relative to control	B	O=C(Cc1ccc(F)c(F)c1)N1CCC(Nc2ncc3c(N4CCOCC4)n[nH]c3n2)CC1		CHEMBL4762609	>	Inhibition	%	40.0	CHEMBL3961	Homo sapiens	INH	%	40.0
	22421640	CHEMBL4673642	Inhibition of human p38beta MAPK (1 to 364 residues) incubated for 5 mins in presence of [gamma33P]ATP by scintillation counting analysis	B	O=C(Cc1ccc(F)c(F)c1)N1CCC(Nc2ncc3c(N4CCOCC4)n[nH]c3n2)CC1		CHEMBL4762609	=	IC50	nM	550.0	CHEMBL3961	Homo sapiens	IC50	uM	0.55
	22423381	CHEMBL4674266	Inhibition of human p38beta using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	100.57	CHEMBL3961	Homo sapiens	Activity	%	100.57
	22423382	CHEMBL4674266	Inhibition of human p38beta using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	112.48	CHEMBL3961	Homo sapiens	Activity	%	112.48
	22485831	CHEMBL4688579	Inhibition of p38MAPK beta (unknown origin) by ATP competitive based analysis	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccc(F)cc2)CC1		CHEMBL4747992	>	IC50	nM	300.0	CHEMBL3961	Homo sapiens	IC50	nM	300.0
	22801814	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Delta Tm	degrees C	19.9	CHEMBL3961	Homo sapiens	deltaTm	degrees C	19.9
	22801815	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2ccccc2)n1		CHEMBL312873	=	Delta Tm	degrees C	14.3	CHEMBL3961	Homo sapiens	deltaTm	degrees C	14.3
	22801816	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccccc1NC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1		CHEMBL4790278	=	Delta Tm	degrees C	10.8	CHEMBL3961	Homo sapiens	deltaTm	degrees C	10.8
	22801817	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc3ccccc3c2)n(-c2ccccc2)n1		CHEMBL102547	=	Delta Tm	degrees C	5.3	CHEMBL3961	Homo sapiens	deltaTm	degrees C	5.3
	22801818	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CCOc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL4751695	=	Delta Tm	degrees C	7.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	7.0
	22801819	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(F)cc2)n(-c2ccccc2)n1		CHEMBL4741055	=	Delta Tm	degrees C	8.9	CHEMBL3961	Homo sapiens	deltaTm	degrees C	8.9
	22801820	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccccc2)n1		CHEMBL4762688	=	Delta Tm	degrees C	0.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.0
	22801821	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCc3ccccc3)cc2)n(-c2ccccc2)n1		CHEMBL4785824	=	Delta Tm	degrees C	1.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.5
	22801822	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1cc(C)cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)c1		CHEMBL4783603	=	Delta Tm	degrees C	4.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	4.5
	22801823	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(F)cc1NC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1		CHEMBL4759399	=	Delta Tm	degrees C	12.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	12.6
	22801824	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(F)c(F)c2)n(-c2ccccc2)n1		CHEMBL4765042	=	Delta Tm	degrees C	9.3	CHEMBL3961	Homo sapiens	deltaTm	degrees C	9.3
	22801825	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2ccccc2)n1		CHEMBL314023	=	Delta Tm	degrees C	10.8	CHEMBL3961	Homo sapiens	deltaTm	degrees C	10.8
	22801826	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(S(=O)(=O)NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL4750748	=	Delta Tm	degrees C	-1.3	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-1.3
	22801827	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	COc1cccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)c1		CHEMBL4746299	=	Delta Tm	degrees C	9.8	CHEMBL3961	Homo sapiens	deltaTm	degrees C	9.8
	22801828	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Delta Tm	degrees C	12.3	CHEMBL3961	Homo sapiens	deltaTm	degrees C	12.3
	22801829	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1		CHEMBL4759890	=	Delta Tm	degrees C	-0.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.2
	22801830	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4784705	=	Delta Tm	degrees C	1.4	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.4
	22801831	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc(F)cc2)n1		CHEMBL4784725	=	Delta Tm	degrees C	-0.1	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.1
	22801832	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4744374	=	Delta Tm	degrees C	-0.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.2
	22801833	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(C(C)(C)C)n1		CHEMBL4742158	=	Delta Tm	degrees C	-0.4	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.4
	22801834	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc(Br)cc2)n1		CHEMBL4797231	=	Delta Tm	degrees C	0.3	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.3
	22801835	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(-c2ccccc2)cc1NC(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4787226	=	Delta Tm	degrees C	2.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	2.5
	22801836	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1cc(-c2ccccc2)nn1-c1ccccc1		CHEMBL4777689	=	Delta Tm	degrees C	-0.4	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.4
	22801837	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccccc2)n1		CHEMBL4764223	=	Delta Tm	degrees C	8.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	8.6
	22801838	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(F)cc(F)c2)cc1		CHEMBL4741029	=	Delta Tm	degrees C	8.7	CHEMBL3961	Homo sapiens	deltaTm	degrees C	8.7
	22801839	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cc(F)cc(F)c1		CHEMBL4754583	=	Delta Tm	degrees C	3.4	CHEMBL3961	Homo sapiens	deltaTm	degrees C	3.4
	22801840	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc(F)cc2)n1		CHEMBL4780554	=	Delta Tm	degrees C	6.3	CHEMBL3961	Homo sapiens	deltaTm	degrees C	6.3
	22801841	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4798321	=	Delta Tm	degrees C	6.9	CHEMBL3961	Homo sapiens	deltaTm	degrees C	6.9
	22801842	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(C(C)(C)C)n1		CHEMBL4791471	=	Delta Tm	degrees C	0.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.0
	22801843	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc(Br)cc2)n1		CHEMBL4757882	=	Delta Tm	degrees C	1.8	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.8
	22801844	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(-c2ccccc2)cc1NC(=O)Nc1cc(F)cc(F)c1		CHEMBL4740104	=	Delta Tm	degrees C	-0.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.2
	22801845	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1cc(F)cc(F)c1)Nc1cc(-c2ccccc2)nn1-c1ccccc1		CHEMBL4789547	=	Delta Tm	degrees C	3.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	3.2
	22801846	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Delta Tm	degrees C	0.4	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.4
	22801847	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4787113	=	Delta Tm	degrees C	-0.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.2
	22801848	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(N)cc2)n1		CHEMBL4756419	=	Delta Tm	degrees C	9.4	CHEMBL3961	Homo sapiens	deltaTm	degrees C	9.4
	22801849	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(C(F)(F)F)cc2)n1		CHEMBL4740208	=	Delta Tm	degrees C	0.3	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.3
	22801850	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(OC(F)(F)F)cc2)n1		CHEMBL4756465	=	Delta Tm	degrees C	0.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.6
	22801851	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(C#N)cc2)n1		CHEMBL4786417	=	Delta Tm	degrees C	4.0	CHEMBL3961	Homo sapiens	deltaTm	degrees C	4.0
	22801852	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(S(C)(=O)=O)cc2)n1		CHEMBL4757100	=	Delta Tm	degrees C	7.8	CHEMBL3961	Homo sapiens	deltaTm	degrees C	7.8
	22801853	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(NC(=O)C3CC3)cc2)n1		CHEMBL4788823	=	Delta Tm	degrees C	2.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	2.6
	22801854	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(NS(C)(=O)=O)cc2)n1		CHEMBL4754044	=	Delta Tm	degrees C	7.2	CHEMBL3961	Homo sapiens	deltaTm	degrees C	7.2
	22801855	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)C(=O)Nc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL4782612	=	Delta Tm	degrees C	1.5	CHEMBL3961	Homo sapiens	deltaTm	degrees C	1.5
	22801856	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C2CC2)nn1-c1ccc(OC(F)(F)F)cc1		CHEMBL4790434	=	Delta Tm	degrees C	0.3	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.3
	22801857	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	N#Cc1ccc(-n2nc(C3CC3)cc2NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL4742987	=	Delta Tm	degrees C	-0.3	CHEMBL3961	Homo sapiens	deltaTm	degrees C	-0.3
	22801858	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C2CC2)nn1-c1ccc([N+](=O)[O-])cc1		CHEMBL4755558	=	Delta Tm	degrees C	0.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.6
	22801859	CHEMBL4711693	Inhibition of p38beta (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C(F)(F)F)nn1-c1ccc([N+](=O)[O-])cc1		CHEMBL4794564	=	Delta Tm	degrees C	0.6	CHEMBL3961	Homo sapiens	deltaTm	degrees C	0.6
	22802126	CHEMBL4711704	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4756586	=	Activity	%	3.4	CHEMBL3961	Homo sapiens	Activity	%	3.4
	22802137	CHEMBL4711715	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system by Kinomescan method	B	CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4756586	=	Kd	nM	20.0	CHEMBL3961	Homo sapiens	Kd	uM	0.02
	22802144	CHEMBL4711722	Inhibition of C-terminal NanoLuc-fused full length p38beta (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4756586	=	IC50	nM	17.0	CHEMBL3961	Homo sapiens	IC50	uM	0.017
	22818120	CHEMBL4715343	Inhibition of recombinant human N-terminal GST-tagged full-length p38beta2 expressed in Escherichia coli at 2 uM using MBP as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL3961	Homo sapiens	INH	%	50.0
	22843980	CHEMBL4720966	Inhibition of human p38beta assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	105.11	CHEMBL3961	Homo sapiens	Activity	%	105.11
	22844803	CHEMBL4721478	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	101.43	CHEMBL3961	Homo sapiens	Activity	%	101.43
	22881580	CHEMBL4727233	Inhibition of p38beta MAPK (unknown origin)	B	CNCCOc1ccccc1C(C)(C)Nc1nccn(-c2cc(C(=O)NC3CC3)ccc2C)c1=O		CHEMBL4792347	=	IC50	nM	251.19	CHEMBL3961	Homo sapiens	pIC50		6.6
Not Active	22889537	CHEMBL4729056	Inhibition of wild-type human full length p38-beta (M1 to Q364 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
	22908784	CHEMBL4733716	Inhibition of p38beta (unknown origin) at 300 nM relative to control	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCCCCCCn1cc(COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)nn1		CHEMBL4749204	=	Inhibition	%	6.94	CHEMBL3961	Homo sapiens	INH	%	6.94
	22950614	CHEMBL4766181	Inhibition of human full length recombinant p38beta using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	84.0	CHEMBL3961	Homo sapiens	IC50	uM	0.084
	22952993	CHEMBL4766930	Inhibition of recombinant human full length SAPK2b assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	0.0	CHEMBL3961	Homo sapiens	Activity	%	0.0
	22953077	CHEMBL4767014	Inhibition of recombinant human full length SAPK2b using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	50.0	CHEMBL3961	Homo sapiens	IC50	uM	0.05
	23122714	CHEMBL4805065	Inhibition of human p38-beta assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	80.0	CHEMBL3961	Homo sapiens	Activity	%	80.0
	23123409	CHEMBL4805653	Inhibition of human p38-beta assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	87.0	CHEMBL3961	Homo sapiens	Activity	%	87.0
	23123866	CHEMBL4806110	Inhibition of DNA-tagged human p38-beta assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	23124908	CHEMBL4806670	Inhibition of human p38-beta assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL3961	Homo sapiens	Activity	%	100.0
	23124909	CHEMBL4806670	Inhibition of human p38-beta assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	97.0	CHEMBL3961	Homo sapiens	Activity	%	97.0
	23127448	CHEMBL4807613	Inhibition of p38beta (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	63.0	CHEMBL3961	Homo sapiens	Activity	%	63.0
	23127449	CHEMBL4807613	Inhibition of p38beta (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	63.0	CHEMBL3961	Homo sapiens	Activity	%	63.0
	23128392	CHEMBL4807939	Inhibition of p38beta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL3961	Homo sapiens	Activity	%	25.0
	23128393	CHEMBL4807939	Inhibition of p38beta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	50.0	CHEMBL3961	Homo sapiens	Activity	%	50.0
	23128394	CHEMBL4807939	Inhibition of p38beta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL3961	Homo sapiens	Activity	%	25.0
	23128892	CHEMBL4808084	Inhibition of p38beta (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4859179	=	Inhibition	%	40.0	CHEMBL3961	Homo sapiens	INH	%	40.0
	23128893	CHEMBL4808084	Inhibition of p38beta (unknown origin) at 0.5 uM relative to control	B	CSc1nc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3Br)cc2)c(-c2ccc(F)cc2)o1		CHEMBL4875968	=	Inhibition	%	21.0	CHEMBL3961	Homo sapiens	INH	%	21.0
Not Active	23256057	CHEMBL4832008	Inhibition of p38beta (unknown origin) at 0.3 uM	B	O=C(Nc1cncc(OCC2CCN(Cc3ccc(F)cc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4873612		Inhibition	%		CHEMBL3961	Homo sapiens	INH		
Not Active	23317550	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	82.0	CHEMBL3961	Homo sapiens	% Control	%	82.0
Not Active	23318018	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	82.0	CHEMBL3961	Homo sapiens	% Control	%	82.0
Not Active	23318684	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	90.0	CHEMBL3961	Homo sapiens	% Control	%	90.0
Not Active	23319168	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	96.0	CHEMBL3961	Homo sapiens	% Control	%	96.0
Not Active	23319805	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	94.2	CHEMBL3961	Homo sapiens	% Control	%	94.2
Not Active	23320280	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	99.2	CHEMBL3961	Homo sapiens	% Control	%	99.2
Not Active	23320958	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	88.0	CHEMBL3961	Homo sapiens	% Control	%	88.0
Not Active	23321426	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23322056	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	95.0	CHEMBL3961	Homo sapiens	% Control	%	95.0
Not Active	23322524	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	98.0	CHEMBL3961	Homo sapiens	% Control	%	98.0
Not Active	23323213	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	92.0	CHEMBL3961	Homo sapiens	% Control	%	92.0
Not Active	23323681	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	93.0	CHEMBL3961	Homo sapiens	% Control	%	93.0
Not Active	23324131	CHEMBL4880749	SAPK2b (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-10.0	CHEMBL3961	Homo sapiens	% inhibition	%	-10.0
Not Active	23324535	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	99.8	CHEMBL3961	Homo sapiens	% Control	%	99.8
Not Active	23325170	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	78.0	CHEMBL3961	Homo sapiens	% Control	%	78.0
Not Active	23325638	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	99.0	CHEMBL3961	Homo sapiens	% Control	%	99.0
Not Active	23326285	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23326753	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	68.0	CHEMBL3961	Homo sapiens	% Control	%	68.0
Not Active	23327453	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23327921	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23328508	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	88.0	CHEMBL3961	Homo sapiens	% Control	%	88.0
Not Active	23328976	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	91.0	CHEMBL3961	Homo sapiens	% Control	%	91.0
Not Active	23329520	CHEMBL4881227	SAPK2b(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	103.0	CHEMBL3961	Homo sapiens	% residual kinase activity	%	103.0
Not Active	23329922	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	98.0	CHEMBL3961	Homo sapiens	% Control	%	98.0
Not Active	23330390	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23331146	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23331614	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23332201	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	93.4	CHEMBL3961	Homo sapiens	% Control	%	93.4
Not Active	23332667	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	98.1	CHEMBL3961	Homo sapiens	% Control	%	98.1
Not Active	23333385	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23334024	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	86.0	CHEMBL3961	Homo sapiens	% Control	%	86.0
Not Active	23334492	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23334963	CHEMBL4881583	SAPK2b (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	1.0	CHEMBL3961	Homo sapiens	% inhibition	%	1.0
Not Active	23335471	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	97.0	CHEMBL3961	Homo sapiens	% Control	%	97.0
Not Active	23335939	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23336566	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23337034	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	94.0	CHEMBL3961	Homo sapiens	% Control	%	94.0
Not Active	23337664	CHEMBL4882035	MAPK11 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	93.0	CHEMBL3961	Homo sapiens	% Ctrl	%	93.0
Not Active	23338115	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	97.0	CHEMBL3961	Homo sapiens	% Control	%	97.0
Not Active	23338583	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	86.0	CHEMBL3961	Homo sapiens	% Control	%	86.0
Not Active	23339195	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23339663	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23340300	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23340768	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23341425	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	88.0	CHEMBL3961	Homo sapiens	% Control	%	88.0
Not Active	23341893	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	98.0	CHEMBL3961	Homo sapiens	% Control	%	98.0
Not Active	23342509	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	82.0	CHEMBL3961	Homo sapiens	% Control	%	82.0
Not Active	23342977	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	83.0	CHEMBL3961	Homo sapiens	% Control	%	83.0
Not Active	23343607	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	98.0	CHEMBL3961	Homo sapiens	% Control	%	98.0
Not Active	23344075	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	86.0	CHEMBL3961	Homo sapiens	% Control	%	86.0
Not Active	23344713	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	80.0	CHEMBL3961	Homo sapiens	% Control	%	80.0
Not Active	23345286	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23345754	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23346331	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23346799	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	98.7	CHEMBL3961	Homo sapiens	% Control	%	98.7
Not Active	23347401	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23347891	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23348470	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	93.0	CHEMBL3961	Homo sapiens	% Control	%	93.0
Not Active	23348938	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23349525	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	94.0	CHEMBL3961	Homo sapiens	% Control	%	94.0
Not Active	23350143	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	90.0	CHEMBL3961	Homo sapiens	% Control	%	90.0
Not Active	23350611	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	82.0	CHEMBL3961	Homo sapiens	% Control	%	82.0
Not Active	23351216	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	88.0	CHEMBL3961	Homo sapiens	% Control	%	88.0
Not Active	23351684	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	83.0	CHEMBL3961	Homo sapiens	% Control	%	83.0
Not Active	23352116	CHEMBL4882805	MAPK11 (p38 beta) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	12.96	CHEMBL3961	Homo sapiens	% Inhibition	%	12.9602
Not Active	23352708	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	89.0	CHEMBL3961	Homo sapiens	% Control	%	89.0
Not Active	23353176	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	88.0	CHEMBL3961	Homo sapiens	% Control	%	88.0
Not Active	23354058	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23354526	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23355258	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23355726	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23356362	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23356830	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23357439	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23358086	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	83.0	CHEMBL3961	Homo sapiens	% Control	%	83.0
Not Active	23358554	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23359140	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23359738	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23360206	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	93.0	CHEMBL3961	Homo sapiens	% Control	%	93.0
Not Active	23360791	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23361259	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23361832	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23362368	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	90.0	CHEMBL3961	Homo sapiens	% Control	%	90.0
Not Active	23362836	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	95.0	CHEMBL3961	Homo sapiens	% Control	%	95.0
Not Active	23363276	CHEMBL4883254	MAPK11 (p38 beta) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	0.9296	CHEMBL3961	Homo sapiens	% inhibition	%	0.9296
Not Active	23363277	CHEMBL4883254	MAPK11 (p38 beta) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	0.672	CHEMBL3961	Homo sapiens	% inhibition	%	0.672
Not Active	23364478	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	60.0	CHEMBL3961	Homo sapiens	% Control	%	60.0
Not Active	23364946	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	78.0	CHEMBL3961	Homo sapiens	% Control	%	78.0
Not Active	23365685	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23366228	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	95.0	CHEMBL3961	Homo sapiens	% Control	%	95.0
Active	23366493	CHEMBL4883790	NanoBRET (MAPK11)	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207		IC50	nM	16.9	CHEMBL3961	Homo sapiens	IC50	nM	16.9
Active	23366497	CHEMBL4883794	Radiometric activity assay, ProQinase (MAPK11)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		IC50	nM	32.0	CHEMBL3961	Homo sapiens	IC50	nM	32.0
Active	23366499	CHEMBL4883790	NanoBRET (MAPK11)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		IC50	nM	10.0	CHEMBL3961	Homo sapiens	IC50	nM	10.0
Not Active	23366510	CHEMBL4883790	NanoBRET (MAPK11)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1	Non standard unit for type	CHEMBL4531775		IC50	M	11.0	CHEMBL3961	Homo sapiens	IC50	M	11.0
Active	23366818	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	3.4	CHEMBL3961	Homo sapiens	% Control	%	3.4
Not Active	23367286	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23367678	CHEMBL4884031	p38-beta ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	3.0	CHEMBL3961	Homo sapiens	% Residual activity with Skepinone-L	%	3.0
Active	23367788	CHEMBL4883790	NanoBRET (MAPK11)	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		IC50	nM	40.2	CHEMBL3961	Homo sapiens	IC50	nM	40.2
Not Active	23367793	CHEMBL4883790	NanoBRET (MAPK11)	B	CN(C(=O)c1ccccc1)c1cc(N(C)c2ccc3c(c2)CCc2ccc(C(=O)NCCN4CCOCC4)cc2C3=O)ccc1F	Non standard unit for type	CHEMBL4586225		IC50	M	16.2	CHEMBL3961	Homo sapiens	IC50	M	16.2
Not Active	23368164	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	84.0	CHEMBL3961	Homo sapiens	% Control	%	84.0
Not Active	23368632	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23369231	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	89.0	CHEMBL3961	Homo sapiens	% Control	%	89.0
Not Active	23369699	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	97.0	CHEMBL3961	Homo sapiens	% Control	%	97.0
Not Active	23370237	CHEMBL4884476	SAPK2b(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	110.0	CHEMBL3961	Homo sapiens	% residual kinase activity	%	110.0
Not Active	23370667	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	91.0	CHEMBL3961	Homo sapiens	% Control	%	91.0
Not Active	23371135	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Active	23371627	CHEMBL4884588	Enzyme kinetic assay (Reaction Biology) (MAPK11)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		IC50	nM	45.1	CHEMBL3961	Homo sapiens	IC50	nM	45.1
Active	23371631	CHEMBL4884592	NanoBRET (SGC-Frankfurt) (MAPK11)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		IC50	nM	196.0	CHEMBL3961	Homo sapiens	IC50	nM	196.0
Not Active	23371641	CHEMBL4884592	NanoBRET (SGC-Frankfurt) (MAPK11)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1	Non standard unit for type	CHEMBL4568183		IC50	M	1.63	CHEMBL3961	Homo sapiens	IC50	M	1.63
Slightly Active	23371944	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	36.0	CHEMBL3961	Homo sapiens	% Control	%	36.0
Not Active	23372412	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
	23372796	CHEMBL4884761	p38beta(MP11LGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3961	Homo sapiens	pIC50		6.0
	23373205	CHEMBL4885052	p38beta(MP11LGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3961	Homo sapiens	pIC50		6.0
	23373564	CHEMBL4885341	p38beta(MP11LGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3961	Homo sapiens	pIC50		6.0
Not Active	23375136	CHEMBL4886121	p38_beta Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	4.0	CHEMBL3961	Homo sapiens	% Inhibition	%	4.0
Not Active	23375299	CHEMBL4886281	mitogen-activated protein kinase 11 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-2.0	CHEMBL3961	Homo sapiens	% inhibition	%	-2.0
Not Active	23375839	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	88.0	CHEMBL3961	Homo sapiens	% Control	%	88.0
Not Active	23376307	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23376884	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23377352	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23378212	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	85.0	CHEMBL3961	Homo sapiens	% Control	%	85.0
Not Active	23378680	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23379847	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23380315	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	76.0	CHEMBL3961	Homo sapiens	% Control	%	76.0
Not Active	23381009	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	78.0	CHEMBL3961	Homo sapiens	% Control	%	78.0
Not Active	23381657	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23382125	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL3961	Homo sapiens	% Control	%	100.0
Not Active	23382749	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	76.0	CHEMBL3961	Homo sapiens	% Control	%	76.0
Not Active	23383217	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	85.0	CHEMBL3961	Homo sapiens	% Control	%	85.0
Not Active	23383867	CHEMBL4887489	MAPK11 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	98.0	CHEMBL3961	Homo sapiens	% Ctrl	%	98.0
Not Active	23384457	CHEMBL4888052	SAPK2b(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-2.08	CHEMBL3961	Homo sapiens	% inhibition	%	-2.08
Not Active	23385132	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	79.0	CHEMBL3961	Homo sapiens	% Control	%	79.0
Not Active	23385599	CHEMBL4879856	KinomeScan assay: inhibition of p38-beta	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	86.0	CHEMBL3961	Homo sapiens	% Control	%	86.0
